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Advances in clinical, surgical and peri-operative knowledge have led to an increased survival of 
patients with congenital heart disease (CHD). As a result, the population with CHD has doubled over 
the last decades, and a growing extent of patients are surviving into late adulthood.(1) However, 
despite the improvements in clinical and surgical care, progressive heart failure remains a major 
cause of death during late follow-up of patients with complex CHD.(2) In adult (non-CHD) patients 
with heart failure, the recent advent of cardiac resynchronization therapy (CRT) has improved the 
clinical outcome of heart failure in patients with poor left ventricular (LV) ejection fraction and a 
wide QRS complex. CRT typically involves atrial-synchronized biventricular pacing, and improves 
LV function by inducing a more synchronous contraction pattern. Consequently, CRT has resulted 
in improvements in heart failure symptoms (New York Heart Association (NYHA) functional class, 
exercise capacity or quality of life) and all-cause mortality of heart failure patients.(3-7) Currently, 
CRT is a class I indication for adult non-CHD patients with NYHA functional class III or IV despite 
optimized pharmacological therapy, LV ejection fraction <35% and QRS duration >120 ms.(8,9) 
The excellent outcomes obtained with CRT in adult non-CHD patients have raised interest to apply 
this therapy in CHD patients with heart failure. However, the etiologies of heart failure differ 
substantially between ‘acquired’ heart disease and CHD. An important subgroup of CHD patients 
with heart failure during follow-up are those with failure of the RV, of which the majority are 
patients with corrected Tetralogy of Fallot (cToF).(10) RV dysfunction is an important predictor 
of poor clinical outcome in these patients.(11) The RV differs importantly from the LV from an 
anatomical, embryological and functional point of view. The RV shape has a complex geometry, 
with a crescent shape when viewed in cross-section and a more triangular shape when viewed 
from the side. Embryologically, the RV can be divided into three sections; the sinus (inlet), the 
apical trabecular part, and the infundibulum (outlet).(12,13) Functionally, the RV is coupled to the 
pulmonary circulation which is highly distensible and has a low resistance.
Accordingly, the mechanical activation of the RV and its relation with myocardial performance, 
and hence the appropriate therapeutic strategies in RV failure may be different from the LV. 
Various advanced echocardiographic and cardiac magnetic resonance (CMR) imaging techniques 
have recently been developed, allowing comprehensive assessment of global and regional 
myocardial performance, motion and deformation. With the use of these imaging techniques, the 
mechanical activation pattern of the RV can be characterized in detail. Comprehensive knowledge 
on RV mechanics and performance may guide clinical decision-making with regard to therapeutic 
strategies in patients with RV failure, including the application of CRT.
Right ventricular imaging: echocardiography
Echocardiography is a readily available, non-invasive imaging tool that is routinely used in clinical 
practice for repeated cardiac imaging during follow-up of CHD patients. Various advanced 
echocardiographic imaging modalities allow a detailed characterization of myocardial performance, 
motion and deformation of the RV. Tissue Doppler imaging (TDI) enables the assessment of RV 
mechanics by measuring myocardial velocities and the temporal occurrence of myocardial motion 
with high temporal resolution. With the use of TDI, the velocity of the myocardium with respect 
to the transducer is measured. The assessment of peak systolic velocities at the basal RV free 
wall with TDI has shown to be of incremental value to conventional echocardiography to assess 
global and regional ventricular performance in various clinical conditions.(14,15) Furthermore, 
with TDI, the temporal occurrence of mechanical events can be measured, by calculating the time 
of the events relative to the onset of the QRS complex on the electrocardiogram. The assessment 
of timings of peak systolic velocities provides insight into electromechanical coupling and possible 
mechanical dyssynchrony.(16)
Another advanced echocardiographic technique is two-dimensional strain imaging or speckle- 
tracking strain imaging. Speckle tracking strain imaging permits multidirectional and angle-inde-
pendent assessment of myocardial deformation. With this echocardiographic technique, the so-
called speckles (natural acoustic markers equally distributed within the myocardium in 2-dimen-
sional gray-scale echocardiographic images) are tracked frame-by-frame throughout the cardiac 
cycle. The change of their position relative to their original position is used to calculate myocardial 
strain. The assessment of myocardial strain has demonstrated to be useful to detect subclinical 
cardiac dysfunction in several clinical conditions.(17,18) Similar to TDI, with speckle-tracking 
strain imaging, the timing of peak systolic strain may be assessed, providing insight into possible 
dyssynchrony. Furthermore, speckle-tracking strain imaging permits imaging of torsional mecha-
nics. LV twist takes into account the complex helical disposition of the myofibers and is a sensitive 
index of LV performance. By evaluating RV and LV strain, LV apical and basal rotation and LV twist, 
the ventricular-ventricular interaction between the LV and RV may be assessed at a regional level. 
Finally, reliable assessment of volumes and ejection fraction of the RV is of clinical importance in 
CHD patients with RV failure. Quantification of RV volumes by two-dimensional echocardiography 
is hampered by the complex ventricular geometry. Real-time three-dimensional echocardiography 
of the RV overcomes this problem by imaging the entire RV in a three-dimensional volume. 
Furthermore, real-time three-dimensional echocardiography enables computation of regional 
volumes and function of the various RV segments: RV inlet, apical trabecular part and RV outlet. 
Right ventricular imaging: cardiac magnetic resonance 
CMR is a versatile non-invasive imaging technique during clinical follow-up of post-operative CHD 
patients.(19) With echocardiography, imaging of the RV is hampered by its complex geometry and 
its anterior position within the chest. CMR is independent of geometrical assumptions and of the 
acoustic window. Currently, CMR is the reference standard to quantify RV volumes and function, 
as well for the quantification of flow over the cardiac valves.(19) In addition, various advanced 
CMR techniques have enabled insight into ventricular mechanics. With the use of Tissue-velocity 
magnetic resonance imaging (TV-MRI), myocardial velocities can be assessed. TV-MRI has been 
validated against TDI for the assessment of myocardial velocities and timings of peak systolic 
velocities in the LV.(20-23) In CHD patients undergoing routine CMR evaluation, the validation 
of TV-MRI to assess myocardial velocities of the RV would permit a comprehensive assessment 
of ventricular volumes, function and myocardial velocities during a single integrated MRI 
examination. The evaluation of systolic velocities provides insight into ventricular performance 
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and possible dyssynchrony. In addition, the evaluation of diastolic velocities with TV-MRI or TDI 
yields a detailed quantitative assessment of RV diastolic function at a regional level, which can 
provide insight into the pathophysiological mechanism leading to RV dysfunction in CHD patients. 
In cToF patients, pulmonary regurgitation is a common hemodynamic lesion. Pulmonary regurgitation 
is an important cause of RV dilatation and RV failure. Therefore, reliable assessment of pulmonary 
flow has important clinical implications. Furthermore, comprehensive quantification of pulmonary 
regurgitation with CMR provides the opportunity to investigate the complex relationship among 
chronic volume overload, RV mechanics, and RV failure. Two-dimensional velocity-encoded CMR, 
the current reference standard for assessing PV flow, is hampered by cardiac motion, because 
the acquisition plane is fixed throughout the cardiac cycle. Three-dimensional three-directional 
velocity-encoded flow imaging (3D flow) has recently been introduced for the assessment of 
transvalvar flow.(24-26) The use of 3D velocity-encoded MR imaging resolves the problem of valvar 
annulus motion owing to retrospective valve tracking and velocity-encoding in three orthogonal 
directions. Furthermore, 3D flow imaging allows simultaneous assessment of flow over all four 
cardiac valves. This simultaneous assessment enables evaluation of global RV diastolic function 
of in cToF patients with pulmonary regurgitation. In the presence of pulmonary regurgitation, the 
flow pattern over the tricuspid valve does not reflect RV relaxation, since RV filling occurs also 
from the pulmonary regurgitation. Summation of the 3D time-resolved diastolic flow curves of the 
pulmonary valve and tricuspid valve permits the reconstruction of RV time-volume curves.(27) From 
the time-volume curve of the RV, global RV diastolic function can be comprehensively appreciated.
 
Prediction of outcome of CHD patients with echocardiography
In current clinical practice, echocardiography plays a central role to routinely assess cardiac 
anatomy and function during follow-up of CHD patients. The advent of new echocardiographic 
imaging modalities provides novel anatomical, functional or electromechanical parameters, 
which may improve clinical-decision making by predicting outcome in the individual patient.
(14,15,17,18) Hence, novel imaging techniques may refine risk stratifications in known clinical 
protocols. Conversely, when new therapeutic strategies emerge (such as CRT for heart failure or 
pulmonary valve replacement for pulmonary regurgitation), conventional as well as novel imaging 
techniques may aid the selection of patients that are most likely to benefit from these new 
interventions. Accordingly, an important goal of clinical research on cardiac imaging techniques 
is to ultimately gain insight into the clinical implications with respect to patient outcome and to 
refine therapeutic and interventional protocols.  
Objectives and outline of this thesis
The objective of this thesis was to obtain insight into the electromechanical activation of the 
RV in CHD patients as well as in healthy subjects. Furthermore, the relation between global RV 
performance and electromechanical activation was investigated with various non-invasive 
echocardiographic and CMR imaging techniques. Finally, the clinical role of echocardiography to 
predict outcome in CHD patients was explored.
Part 1 of this thesis focuses on the various advanced echocardiographic imaging tools to assess 
RV and LV mechanics in CHD patients. Chapter 2.1 provides an overview on the application of 
CRT in CHD and pediatric patients and on the echocardiographic techniques to assess cardiac 
dyssynchrony. In chapter 2.2, the normal timings of peak systolic velocities and intra-ventricular 
time differences within the LV and RV in healthy children of various ages are investigated with TDI. 
Chapter 2.3 describes the mechanical activation sequence of the RV, as assessed with speckle 
tracking strain imaging, and its relation with myocardial performance in healthy controls as well 
as in cToF patients. Chapter 2.4 provides insight into ventricular-ventricular interactions with 
speckle tracking strain imaging and evaluation of torsional mechanics in healthy subjects and in 
CHD patients with a dilated RV. Finally, in chapter 2.5, a segmental analysis of RV dilatation and 
ejection fraction is performed and validated with real-time three-dimensional echocardiography, 
and the adaptive response of the various RV segments to chronic volume overload is investigated. 
Subsequently, Part 2 of this thesis focuses on CMR imaging of the RV in CHD patients. Chapter 3.1 
provides an overview on the role of CMR during follow-up of post-operative CHD patients. Chapter 
3.2 describes a study on the validation of TV-MRI against TDI to assess regional systolic myocardial 
velocities and the mechanical activation sequence of the RV. Chapter 3.3 addresses the feasibility 
of TV-MRI and TDI to assess regional diastolic velocities at the RV in cToF patients. Furthermore, 
the clinical use of the assessment of regional diastolic velocities with TV-MRI is addressed in this 
chapter. In chapter 3.4, 3D flow is comprehensively validated against 2D flow and planimetric CMR 
for the assessment of pulmonary and tricuspid flow. In addition, a clinical application of 3D flow is 
provided that can reliably assess diastolic RV function in the presence of pulmonary regurgitation. 
Finally, part 3 of this thesis provides insight into the clinical application of echocardiography to 
predict outcome during long-term follow-up of CHD patients. In chapter 4.1, the predictive value of 
a residual pulmonary stenosis, as assessed with echo Doppler echocardiography in cToF patients is 
demonstrated. In chapter 4.2, TDI is used to predict atrial arrhythmia during follow-up of adult CHD 
patients. In chapter 5, the summary and conclusions of this thesis are provided. 
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ABSTRACT
The number of patients with congenital heart disease (CHD) has significantly increased over the last 
decades. The CHD population has a high prevalence of heart failure during late follow-up and this 
is a major cause of mortality. Cardiac resynchronization therapy (CRT) may be a promising therapy 
to improve the clinical outcome of CHD and pediatric patients with heart failure. However, the CHD 
and pediatric population is a highly heterogeneous group with different anatomical substrates 
that may influence the effects of CRT. Echocardiography is the mainstay imaging modality to 
evaluate CHD and pediatric patients with heart failure and novel echocardiographic tools permit 
a comprehensive assessment of cardiac dyssynchrony that may help selecting candidates for 
CRT. This article reviews the role of CRT in the CHD and pediatric population with heart failure. 
The current inclusion criteria for CRT as well as the outcomes of different anatomical subgroups 
are evaluated. Finally, echocardiographic assessment of mechanical dyssynchrony in the CHD and 
pediatric population and its role in predicting response to CRT is comprehensively discussed.
INTRODUCTION
Heart failure is a major health burden with an estimated overall prevalence of 2-3%.(1) Cardiac 
resynchronization therapy (CRT) has improved the clinical outcome of drug refractory heart 
failure in patients with poor left ventricular ejection fraction (LVEF) and wide QRS complex. CRT 
improves LV function by inducing a more synchronous contraction. Consequently, CRT has resulted 
in improvements in heart failure symptoms (New York Heart Association (NYHA) functional class, 
exercise capacity or quality of life) and all-cause mortality of heart failure patients.(2-7) Currently, 
CRT is a class I indication for patients with NYHA functional class III or IV despite optimized 
pharmacological therapy, LVEF <35% and QRS duration >120 ms.(8;9)
Advances in cardiac surgery have led to an increased survival of patients with congenital heart 
disease (CHD). As a result, the prevalence of CHD in the pediatric population has doubled over 
the last decades.(10) Progressive heart failure is a major cause of death during late follow-up of 
patients with complex CHD.(11;12) The excellent outcomes obtained with CRT in adult patients 
have raised interest to apply this therapy in CHD and pediatric patients with heart failure. However, 
the current inclusion criteria for CRT in adult populations may not be directly applied to pediatric 
patients. Etiologies of heart failure differ substantially between adults and children, with CHD as 
the mainstay cause in the pediatric population.(13) In addition, within the CHD population there 
are several subgroups of patients according to (post-surgical) cardiac anatomy, including patients 
with a systemic LV, patients with a systemic right ventricle (RV) and patients with a single ventricle. 
These different groups may show different responses to CRT.(14-16) Therefore, a detailed 
evaluation prior to CRT implantation may be crucial to identify those who will benefit from this 
therapy within this heterogeneous group of patients.
Cardiac imaging plays a central role in the evaluation of CHD and pediatric patients before CRT 
device implantation. Accurate assessment of ventricular volumes and function is mandatory before 
CRT implantation to assess heart failure severity and to accurately follow-up ventricular function. 
In addition, assessment of cardiac anatomy is crucial to anticipate the ventricular pacing lead 
implantation approach (epicardial or transvenous). Furthermore, the study of ventricular mechanical 
dyssynchrony and identification of the latest activated areas may help to define the most suited 
position of the ventricular pacing lead and may provide meaningful insight into the effects of CRT 
in the CHD and pediatric population. Several echocardiographic methods have been proposed to 
evaluate ventricular mechanical dyssynchrony.(17) The assessment of ventricular dyssynchrony in 
the adult populations has been demonstrated useful to identify patients who will benefit from CRT, 
with subsequently a better clinical outcome.(17) However, the role of established dyssynchrony 
parameters based on tissue Doppler imaging (TDI), 2-dimensional (2D) speckle tracking and 
real-time 3-dimensional (RT3D) echocardiography to evaluate mechanical dyssynchrony has not 
been extensively studied in the CHD and pediatric population. This article reviews the role of CRT 
in chronic heart failure in the CHD and pediatric population, focusing particularly on the current 
inclusion criteria and outcomes of different anatomical subgroups. Finally, the different imaging 
Right ventricular imaging: echocardiography 2.12
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Table 1. Retrospective cohorts on CRT in CHD and pediatric patients
Data of three retrospective CRT studies in CHD and pediatric populations. Continuous data are expressed in means 
± standard deviation unless otherwise specified. Response rates are on an intention to treat basis, i.e. including 
the total amount of patients enrolled in the study, regardless of deaths, follow-up and unsuccessful implantations. 
Complications included: pocket hematomas, infection, lead issues, blood loss, ventricular arrhythmia, pneumothorax, 
pleural effusion, pulmonary edema, cardiac perforation, cardiovascular incidents and pacing threshold problems.
Abbreviations: deaths: any deaths during follow-up period, EF: ejection fraction, mo: months, n/a: not available, 
NYHA: New York Heart Association functional class, successful implantation: all patients alive and receiving CRT 
at latest follow-up date, y: years. * statistical difference (p<0.05) as compared with data before CRT implantation. 
† majority of outcome data obtained at 3 months follow-up.‡ includes early complications (<30 days after CRT im-
plantation).
modalities to assess cardiac mechanical dyssynchrony in the CHD and pediatric population and 
their role in predicting response to CRT will be discussed. 
EXPERIENCE OF CRT IN CHD AND PEDIATRIC PATIENTS
The main CRT trials on CHD and pediatric patients have included highly heterogeneous 
populations. According to an anatomical classification, different subgroups can be defined, 
including patients with:
- systemic LV failure, 
- systemic RV failure, 
- failure of the single ventricle.
The group of patients with systemic LV failure (Figure 1, panel A) consists of both pediatric 
patients with normal cardiac anatomy with heart failure due to cardiomyopathies or congenital 
atrioventricular block, and of patients (children and adults) with LV failure due to underlying 
CHD. Although the majority of evidence is based on case reports and small case series(18-25) 
several retrospective non-randomized trials including heterogeneous populations have reported 
favourable outcomes after CRT in this subgroup of patients.(14-16)
Failure of the systemic right ventricle (Figure 1, panel B) is commonly observed in patients with 
complete transposition of the great arteries who underwent atrial switch operation (Mustard or 
Senning procedure), and patients with congenital corrected transposition of the great arteries 
(double discordance).(26-28) A recent study evaluated the effects of CRT in eight patients with 
systemic RV failure. After a median follow-up of 17 months, RV ejection fraction significantly 
increased (mean change +10%, p=0.004) along with a decrease in QRS duration (from 161 ± 21 ms 
to 116 ± 22 ms, p<0.01).(29) Subsequent small studies further demonstrated favourable clinical 
outcomes in RV systemic failure patients treated with CRT, yielding improvements in NYHA 
functional class, RV ejection fraction and exercise performance.(14-16;21;30-33) 
Finally, patients with failure of the single ventricle (Figure 1, panel C) may constitute the most 
challenging population. According to current surgical practice, most patients with one hypoplastic 
ventricle undergo surgical palliation by a Fontan procedure or total cavo-pulmonary connection. 
The systemic and pulmonary circulations are separated without interposition of a sub-pulmonary 
ventricle, and both caval veins are redirected to the pulmonary artery. The ventricle supporting the 
systemic circulation may be either of RV or LV morphology.  Despite surgical intervention, heart 
failure is common in this subgroup of patients.(28) Bacha and colleagues studied the effects of 
post-operative CRT in 26 single-ventricle patients.(34) Multisite epicardial pacing with maximal 
distance between the wires yielded a significant reduction of QRS duration (from 94 ± 18 ms to 72 
± 11 ms, p<0.01) and a significant improvement in cardiac function. 
The different anatomical classification of CHD patients may account for differences in response 
rates to CRT. In addition, cardiac anatomy may challenge lead implantation. In contrast to adult 
patients with heart failure, a surgical epicardial approach is commonly needed. Particularly, surgical 
Right ventricular imaging: echocardiography 2.12
CRT studies in CHD and pediatric populations
Dubin et al.(15) Cecchin et al.(14) Janousek et al.(16)
Number of patients (n) 103 60 109
Age range (y)  












NYHA functional class n (%)
I 15 (14) 16 (27)
II 49 (48) 25 (42) median: 2.5
III-IV 39 (38) 19 (32)








Successful implantations n (%) n/a 49 (82) 93 (85)
Complications n (%) 20‡ (19) 6 (10) 10 (9)
After CRT
NYHA functional class n (%) n/a n/a median change -1.5
Systemic ventricle EF (%) 40 ± 15* range: n/a
median: 43*
median change +12




Response rates defined as
Systemic ventricle EF improvement 
n (%)
78 (76) n/a n/a
NYHA improvement ≥ 1 class n (%)
n/a 19 (32) n/a
Systemic ventricle EF or NYHA im-
provement  n (%)         
n/a 39 (65) 79 (72)
Survival rate n (%) 98 (95) 65 (92) 102 (94)
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Table 2. Response rates of retrospective cohorts on CRT in CHD and pediatric patients, according 
to anatomical subgroups 
Response rates after CRT in three retrospective studies in CHD and pediatric populations, displayed for every 
anatomical subgroup. Response percentages are on an intention to treat basis, i.e. including the total amount of 
patients enrolled in the study, regardless of deaths, follow-up and unsuccessful implantations. 
Abbreviations:  LVEF: left ventricular ejection fraction, NYHA: New York Heart Association class, RVEF: right 
ventricular ejection fraction.
* statistical difference (p<0.05) as compared with data before CRT Implantation.†patients with concurrent car-
diac surgical procedure excluded
epicardial lead implantation may be preferred in small patients or in patients with a concomitant 
cardiac surgical indication. However, the three largest trials including CHD and pediatric patients 
report no differences in complications during CRT implantation or in clinical outcome between the 
patients with transvenous or epicardial lead implantation.(14-16)
Beyond the anatomical classification as described above, a substantial part of the studies on CRT 
in pediatric and CHD patients includes patients who previously underwent conventional single-site 
pacing for congenital or surgical atrioventricular block.(14-16) In these patients, chronic single-
site ventricular pacing may cause failure of the systemic ventricle at long-term follow-up.(35-38) 
Several small series have reported promising results with significant clinical and echocardiographic 
improvement after CRT upgrading.(21;24;25;30;32;33;39-41) For example, Moak et al describe 
a series of 6 patients with LV failure after long-term single-site pacing. Along with clinical 
improvement in all patients, LVEF significantly increased (from 34 ± 6% to 60 ± 2%, p=0.003) after 
upgrade to CRT.41 
OUTCOME OF CRT IN CHD AND PEDIATRIC PATIENTS
Beyond case reports and small case series, data on mid and long-term outcome, as well as survival 
and complication rates of CRT in pediatric patients are limited to three retrospective studies 
including patients with all anatomical substrates and etiologies (Table 1). 
First, Dubin et al. described the outcomes of 103 CHD and pediatric patients in a multicenter study.
(15) After a mean duration of 4.8 months follow-up, a reduction in QRS duration (from 166 ± 33 ms 
to 126 ± 24 ms, p<0.01) and an increase in ejection fraction of the systemic ventricle (from 26 ± 12% 
to 40 ± 15%, p<0.05) were observed after CRT. Finally, the survival rate in this cohort was 95%. 
Second, Cecchin and colleagues reported mid-term outcomes of 60 CHD and pediatric patients 
treated with CRT.(14) Significant improvement in the ejection fraction of the systemic ventricle 
(from 36% to 43%, p<0.01) and decrease in QRS duration (from 149 ms to 120 ms, p<0.01) were 
reported. A total of 65 (92%) patients survived during follow-up. 
Third, Janousek and co-workers performed a multicenter trial on CRT including 109 CHD and 
pediatric patients.(16) Similar to the other series, a significant improvement in ejection fraction of 
the systemic ventricle (from 27% to 39%, p<0.01) and decrease in QRS duration (from 160 ms to 
130 ms, p<0.01) were noted. Finally, 94% of patients survived during follow-up. 
In these three studies, response rates (based on intention to treat) ranged between 32% and 
76%, depending on the established end points. Dubin and colleagues reported a response rate of 
76%, defined as an improvement in ejection fraction of the systemic ventricle.(15) In the study 
by Cecchin and co-workers, 32% of patients exhibited an improvement in NYHA functional class, 
and 65% of patients improved in either NYHA functional class or ejection fraction of the systemic 
ventricle.(14) Finally, Janousek et al. defined response as improvement in NYHA functional class or 
ejection fraction of the systemic ventricle and reported a response rate of 72%.(16)  
The different anatomical subgroups may account for differences in the response rates to CRT. 
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CRT studies in CHD and pediatric populations
Dubin et al.(15) Cecchin et al.(14) Janousek et al.†(16)
Systemic LV n (%) 79 (77) 38 (63) 62 (67)
    Increase LVEF (%) n/a median: 8* median: 13*
    Decrease QRS (ms) n/a median: 33* median: 40*
Response rate defined as
    Increase LVEF n (%) n/a n/a n/a
    NYHA improvement ≥1 class n (%) n/a n/a n/a
    LVEF increase or NYHA 
    improvement n (%)
n/a n/a 43 (69)
Systemic RV n (%) 17 (16) 9 (15) 27 (29)
    Increase RVEF (%) 13 ± 11* median: 14 7*
    Decrease QRS (ms) 38 ± 29* median: 15 median: 21
Response rate defined as
    increase RVEF  n (%) n/a n/a n/a
    NYHA improvement ≥1 class n (%) 13 (76) n/a n/a
    RVEF increase or NYHA
    improvement n (%)
n/a 2 (22) 19 (70)
Single ventricle n (%) 7 (7) 13 (22) 4 (4)
    Increase LVEF or RVEF (%) 7.3 ± 5.7 median: 10 n/a
    Decrease QRS (ms) 45 ± 26* median: 13 n/a
Response rate defined as
    LVEF or RVEF increase n (%) n/a 10 (77) n/a
    NYHA improvement ≥1 class n (%) 2 (30) 7 (54) 2 (50)
    RVEF/LVEF increase or NYHA 
    improvement n (%)
n/a n/a 3 (75)
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Response rates of the anatomical subgroups are depicted in Table 2. The majority of patients had 
a systemic LV (63% to 77%). Janousek et al. reported a response rate of 69% in this subgroup, 
defi ned by an increase in either LVEF or NYHA functional class.(16) 
The subgroup of patients with a systemic RV made up 15% to 29% of the cohorts (Table 3). Dubin 
and colleagues reported an improvement in NYHA functional class in 76% of this subgroup.(15) In 
addition, defi ning response rate by RV ejection fraction or NYHA functional class improvement, 
the trial by Cecchin et al. reported a response rate of 22%,(14) whereas Janousek and co-workers 
observed improvement in 70% of patients with a systemic RV.(16) 
Single ventricle patients constituted 4% to 22% of the cohorts (Table 3). Improvement in NYHA 
functional class was observed in 30% to 54% of these patients.(14-16) In addition, Janousek et 
al. observed an echocardiographic or clinical response in 75% of the patients of this subgroup.(16)
Finally, 55 to 77% of patients in the three studies on CRT had a pacemaker before up-grading to 
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Figure 1. Anatomical subgroups of CHD and pediatric patients
Panel A: Example of a CHD patient with a systemic left ventricle. Apical 4-camber viewof a patient after cor-
rection of tetralogy of Fallot.The left ventricle is the systemic ventricle in patients with tetralogy of Fallot. The 
right ventricle is dilated in this patient due to pulmonary regurgitation and subsequent chronic volume overload. 
In tetralogy of Fallot, systemic left ventricular failure may occur during late follow-up.  Panel B: Example of a CHD 
patient with a systemic right ventricle. Apical 4-chamber view of a patient with congenital corrected transposi-
tion of the great arteries (double discordance). The (morphological) right ventricle is the systemic ventricle in 
patients with congenital corrected transposition of the great arteries. Note the trabecularization of the systemic 
right ventricle and the (more apical) septal insertion of the atrioventricular valve compared with the (morpholo-
gical) left ventricle. Systemic right ventricular failure is a common problem in patients with congenital corrected 
transposition of the great arteries. Panel C: Example of a CHD patient with a singe ventricle. Apical “4-chamber” 
view of a patient with a hypoplastic left ventricle. The single ventricle is of right ventricular morphology. Note the 
very hypoplastic left ventricle. Failure of the single ventricle is common in patients with a hypoplastic left ventri-
cle. Abbreviations: syst LV: systemic left ventricle, syst RV: systemic right ventricle, V: ventricle. 
Figure 2. Atrioventricular dyssynchrony
Example of a pediatric patient with idiopathic dilated cardiomyopathy and atrioventricular dyssynchrony as as-
sessed with pulsed wave Doppler echocardiography. Left ventricular fi lling time is reduced (<40% of RR interval) 
and the early (E-wave) and late (A-wave) diastolic infl ow waves are fused. Abbreviation: LV: left ventricle
Figure 3. Inter-ventricular dyssynchrony
Example of inter-ventricular dyssynchrony in a patient with congenital atrioventricular block and chronic right 
ventricular pacing. Inter-ventricular dyssynchrony can be evaluated with pulsed wave Doppler echocardio-
graphy. The time from onset of the QRS complex to the onset of fl ow (pre-ejection interval) is measured in 
the pulmonary artery and in the left ventricular outfl ow tract. The difference between both pre-ejection times 
yields the so-called inter-ventricular mechanical delay (IVMD). In this example, the IVMD is 45 ms (>40 ms).(6) 
Abbreviations; Ao: aorta, Pulm: pulmonary artery.
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CRT.(14-16) In the study of Janousek and colleagues, the patients with failure of the systemic LV 
who were upgraded from single-site pacing to biventricular pacing showed the highest response 
rate.(16) In addition, these patients showed a signifi cantly larger improvement in NYHA functional 
class and a larger extent of LV reverse remodeling as compared with the rest of the study 
population. 
Based on this clinical evidence, CRT may be a promising therapy to improve cardiac performance 
and clinical outcome of CHD and pediatric patients with heart failure. However, several issues 
need further investigation. First, the median follow-up duration of the three trials described is 
limited (4.8 to 8.4 months) (Table 1). Additional trials reporting on the long-term effects of CRT 
in CHD and pediatric patients are warranted. Furthermore, comparisons of the CRT response rate 
between heart failure adult patients and CHD and pediatric patients should take into consideration 
patient age and size related differences. Finally, current selection criteria remain controversial in 
CHD and pediatric patients, and accurate selection of patient subgroups that will benefi t from 
CRT is warranted.
SELECTION OF CHD AND PEDIATRIC PATIENTS FOR CRT
Current inclusion criteria for CRT in the adult populations are: NYHA functional class III or IV des-
pite optimal pharmacological therapy,  LVEF <35% and QRS duration >120 ms.(8;9) However, the 
majority of the studies on CRT in CHD and pediatric populations have not applied these criteria 
prospectively.
NYHA functional class III or IV despite optimal pharmacological therapy is one of the inclusion 
criteria. In CRT trials enrolling CHD and pediatric populations, the majority of patients were in 
NYHA functional class I or II, indicating only mild heart failure. This discrepancy with the current 
guidelines likely resulted from a substantial proportion of CHD and pediatric patients with a con-
comitant indication for cardiac surgery (15% to 32%), ICD implantation or anti-bradycardia pa-
cing (55-77%).(14-16) These concomitant indications may well have accelerated decision-making 
on CRT implantation during the same procedure in patients with only mild heart failure. In addition, 
Janousek et al. demonstrated that NYHA functional class is a strong determinant of CRT response 
in CHD and pediatric patients, with a higher favourable response rate in those patients with NYHA 
functional class I-II than in patients in NYHA functional class III-IV.(16)  Indeed, the benefi ts of 
CRT in adult patients with mild symptomatic heart failure have been evaluated. The REsynchroni-
zation reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) trial included over 
600 heart failure patients in NYHA functional class I-II undergoing CRT implantation.(42) After 1 
year follow-up, reverse LV remodeling and improved LVEF was observed, indicating a benefi cial 
effect of CRT even with mild clinical heart failure. Therefore, the implantation of CRT at an early 
stage may help to prevent the progression and/or the development of heart failure. However, when 
CRT is considered in asymptomatic or mildly symptomatic patients, the possible effects of im-
plantation of a device on quality of life need to be weighed against the benefi ts of CRT on cardiac 
performance. Importantly, in young pediatric patients, grading of heart failure by NYHA class may 
not be reliable.(43;44) In those patients, careful monitoring of ventricular performance by measu-
ring ejection fraction may yield more reliable data about response to CRT. 
Another inclusion criterion is LVEF <35%. The mean value of systemic ventricular ejection frac-
tion in the three CHD and pediatric cohorts varied between 26% and 36%. Dubin et al. observed a 
lower baseline ejection fraction of the systemic ventricle in non responders (24 ± 11% versus 32 
± 14%, p=0.04).(15) However, evaluation of this parameter in the CHD and pediatric population is 
hampered by methodological diffi culties. Although echocardiographic LVEF is reliable in patients 
with a systemic LV,(45) in patients with RV failure (systemic RV or single RV), standard echocar-
diography is less accurate for quantifying RV volumes and ejection fraction due to the complex RV 
geometry. In this regard, quantifi cation with magnetic resonance imaging is currently preferred 
Figure 4. Left ventricular dyssynchrony: M-mode septal-to-posterior wall motion delay
Example of left ventricular dyssynchrony in a patient with a truncus arteriosus after aortic and pulmonary valve 
replacement. The patient shows fl attening of the septum in the parasternal short axis view due to right ven-
tricular outfl ow obstruction. Left ventricular dyssynchrony is measured with M-mode septal-to-posterior wall 
motion delay (SPWMD). From the parasternal short-axis M-mode recording of the left ventricle, a delay of 240 
ms is observed between the peak systolic inward motion of the septum and the peak systolic inward motion 
of the posterior wall. (SPWMD ≥130 ms indicates left ventricular dyssynchrony).(59) Abbreviations: SPWMD: 
septal-to-posterior wall motion delay.
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over echocardiography since this imaging tool does not rely on geometrical assumptions.(46;47) 
Nevertheless, the majority of the CRT devices currently implanted are not compatible with magne-
tic resonance scanners and therefore, patient follow-up with this imaging technique is not feasible 
after device implantation. 
Finally, CRT is indicated in patients with wide QRS complex. Current guidelines include width of the 
QRS complex >120 ms as a marker of electrical dyssynchrony. However, it has been shown that the 
relationship between electrical conduction delay and mechanical dyssynchrony is not straightfor-
ward.(2-6) In addition, the value of QRS complex duration to predict response to CRT may be subop-
timal with a sensitivity and specificity of 54%.(48) The mean QRS duration in the three retrospec-
tive CHD and pediatric cohorts described above was >120 ms.(14-16) However, Dubin et al. stated 
that only 54% of included patients met the combined criteria of QRS >120 ms and systemic ventri-
cle ejection fraction <35%. In addition, Pham et al. evaluated the effects of biventricular pacing in 
19 CHD patients with a narrow QRS complex (96 ± 18 ms).(49) Temporary epicardial leads were im-
planted and several pacing modes, including biventricular pacing, were tested for 10 minutes each. 
Compared to conventional pacing modalities, biventricular pacing was associated with significant 
improvements in cardiac index in these patients with narrow QRS complex. Furthermore, various 
imaging studies in pediatric patients with dilated cardiomyopathy have demonstrated the presence 
of LV mechanical dyssynchrony despite narrow QRS complex.(50-52) These findings indicate that 
pediatric patients may benefit from CRT, even in the presence of a narrow QRS complex. Indeed, 
several adult trials included heart failure patients with narrow QRS complex and LV mechanical dys-
synchrony, and observed favourable outcomes after CRT.(53;54) 
As mentioned above, important differences with the current CRT inclusion criteria are observed in 
the pediatric cohorts, especially with regard to clinical heart failure classification and QRS dura-
tion. Moreover, the anatomical substrate may constitute an additional issue to be considered be-
fore CRT implantation in these populations. Cardiac imaging of ventricular function and mechanics 
(dyssynchrony) may provide additional insight into the effects of CRT and improve selection of 
CHD and pediatric patients who will benefit from CRT.
ECHOCARDIOGRAPHIC ASSESSMENT OF DYSSYNCHRONY
As mentioned before, prolonged QRS duration is the only criterion considered by current 
guidelines defining the presence of cardiac dyssynchrony. However, QRS duration might not 
be accurate enough to identify those patients who will benefit from CRT.(17) It has been 
demonstrated that the presence of mechanical dyssynchrony, rather than electrical dys-
synchrony, may be a more robust parameter to select patients who will benefit from CRT.
(17)  Mechanical dyssynchrony may occur at different levels (atrioventricular, inter-ventri-
cular and intra-ventricular(55)) and can be assessed with various cardiac imaging techni-
ques. Echocardiography is the mainstay imaging modality to evaluate cardiac dyssynchrony 
and permits comprehensive assessment of these three different types of dyssynchrony. 
Atrioventricular dyssynchrony
Atrioventricular dyssynchrony refers to a prolonged delay in atrioventricular sequential con-
traction, resulting from prolongation of the PR interval, QRS widening, or both.(56) With the 
use of pulsed-wave Doppler echocardiography, atrioventricular dyssynchrony can be assessed 
by measuring LV filling time from transmitral flow recordings. When the atrioventricular delay 
is prolonged, the early (E-wave) and late (A-wave) diastolic waves fuse and diastolic filling time 
of the ventricles is shortened.(56) In adult patients, a LV filling time/RR interval <40% indicates 
atrioventricular dyssynchrony (Figure 2).(56) In CHD and pediatric patients with LV systemic fai-
lure, no data on LV filling time are available so far. Nevertheless, surgical or congenital atrioventri-
cular block may cause atrioventricular dyssynchrony and therefore the threshold of LV filling time/
RR interval <40% needs investigation. However, in CHD patients with systemic RV failure, one small 
study provided data on RV filling time. Janousek et al. assessed RV filling time before and after CRT 
in eight patients with systemic RV failure and RBBB.(29) RV filling time was calculated from the 
transtricuspid pulsed-wave Doppler spectral signal. At 17 months follow-up, RV filling time (norma-
lized for RR interval) had increased from 45.1 ± 6.5% to 50.0 ± 6.1% (p<0.01).
Inter-ventricular dyssynchrony
Inter-ventricular dyssynchrony refers to contraction delay between the RV and the LV. Several in-
dexes have been proposed to assess this type of cardiac dyssynchrony. One of the first was the 
inter-ventricular mechanical delay (IVMD) assessed with pulsed-wave Doppler echocardiography. 
IVMD is obtained by calculating the difference between aortic and pulmonary pre-ejection intervals 
(the time from the onset of QRS to the onset of flow) (Figure 3). An IVMD >40 ms indicates inter-
ventricular dyssynchrony.(6;56) The CARE-HF trial demonstrated the use of this index to predict 
response to CRT. Differences between CHD patients and adult heart failure patients may account 
for different IVMD cut-off values. For example, in patients with transposition of the great arteries 
(with normal LVEF), the aortic and pulmonary pre-ejection intervals differ from healthy individuals.
(57) Furthermore, in patients with pulmonary stenosis, the pulmonary pre-ejection interval may be 
prolonged.(58) Little is known about IVMD cut-off values predicting response to CRT in pediatric 
and CHD patients.(24;29;31;39) The available studies included too few patients precluding to draw 
robust conclusions regarding the performance of this dyssynchrony index to predict response to 
CRT. However, a consistent reduction in IVMD after CRT was reported in the majority of patients.
(24;29;31;39)
Intra-ventricular dyssynchrony: left ventricle
Intra-ventricular dyssynchrony of the LV (LV dyssynchrony) has shown to be an independent de-
terminant of response to CRT and long-term survival in adult patients with heart failure. The as-
sessment of LV dyssynchrony can be performed with various methods, evaluating time between 
mechanical events of two or more LV segments. Pitzalis et al. introduced the use of M-mode echo-
cardiography to assess LV dyssynchrony.(59) From the parasternal short-axis view of the LV, the 
time difference between the maximal systolic inward motion of the septal and posterior wall was 
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calculated: the so-called septal-to-posterior wall motion delay (SPWMD) (Figure 4). A cut-off value 
of SPWMD of ≥130 ms was proposed to predict response to CRT. In the CHD pediatric popula-
tion several case reports and two small trials have used this index to evaluate the effects of CRT.
(24;39;41;60;61) For example, Tomaske and colleagues described six children with CHD and syste-
mic LV failure who were treated with CRT.(24) In these patients, SPWMD decreased from 312 ± 24 
ms to 95 ± 57 ms (p=0.03) after one month follow-up, along with an improved LVEF (from 41 ± 6% 
to 53 ± 8%, p=0.03) and a trend towards a decreased LV end-diastolic volume (from 70 ± 22 ml/m2 
to 63 ± 18 ml/m2, p=0.09). 
The advent of TDI, measuring regional myocardial velocities, has provided useful parameters to as-
sess LV dyssynchrony, identifying responders to CRT with high specifi city and sensitivity.(17) Both 
pulsed-wave TDI and color-coded TDI can be used to assess LV dyssynchrony. Unlike pulsed-wave 
TDI, color-coded TDI can provide myocardial velocity tracings of two or more segments simulta-
neously (Figure 5). The feasibility and accuracy of color-coded TDI to evaluate LV dyssynchrony 
have been extensively explored in studies on CRT in the adult population.(17;62-64) One of the 
fi rst indices was the time difference between peak systolic velocities of the septal and the lateral 
LV wall. From the apical 4-chamber view, the time difference between peak systolic velocity of the 
basal septal and basal lateral walls was calculated: the so-called septal-to-lateral wall delay.(62) A 
septal-to-lateral wall delay ≥60 ms predicted response to CRT with a sensitivity of 76% and a spe-
cifi city of 78%.(62) Subsequently, a 4-segment model, including the basal segments of the septal, 
lateral, inferior and anterior walls was evaluated.(63) The maximum delay between peak systolic 
velocities among the four LV walls was calculated. A delay ≥65 ms predicted clinical and echocar-
diographic response to CRT with high sensitivity (92%) and specifi city (92%).(63) Finally, Yu et al. 
proposed a 12-segment model, evaluating time to peak systolic velocity at six basal and six mid-
myocardial segments of the LV.(64) A standard deviation ≥32.6 ms predicted LV reverse remodeling 
after CRT with a sensitivity and specifi city of 100%.
Right ventricular imaging: echocardiography 2.12
Figure 6. Left ventricular dyssynchrony: TDI derived radial and longitudinal strain
Panel A: Example of a postoperative tetralogy of Fallot patient with right ventricular dilatation and left ven-
tricular dyssynchrony, assessed with TDI derived radial strain. Left: Regions of interest are placed at the sep-
tal (blue) and posterior (yellow) wall of the left ventricle. Right: Radial strain (thickening of myocardium) cur-
ve. Dyssynchrony can be quantifi ed by measuring time between peak radial strain at the septal and posterior 
walls (white arrow). A delay between the septal and posterior wall >130 ms indicates radial dyssynchrony.(65) 
Panel B: Example of a patient with left ventricular dyssynchrony, assessed with TDI derived longitudinal strain. 
Left: Regions of interest are placed at the inferior (yellow) and anterior wall (blue). Right: Longitudinal strain 
(shortening of myocardium) curve. Dyssynchrony can be quantifi ed by measuring time between peak radial strain 
at the septal and posterior walls (white arrow).(66) Abbreviation: TDI: tissue Doppler imaging.
Figure 5. Left ventricular dyssynchrony: Color-coded TDI septal-to-lateral wall motion delay
Left panel: Example of a patient with tricuspid atresia after Fontan procedure, with septal-to-lateral wall mo-
tion delay. Apical “4-chamber” view assessed with TDI. Two regions of interest are placed off-line at the basal 
septum (yellow) and left ventricular lateral wall (blue). Right panel: Time-velocity curves are reconstructed. 
The time difference between peak systolic velocity of the septal and lateral segments (septal-to-lateral wall 
motion delay) is 75 ms in this patient (>60 ms(62)). Abbreviations: SLWMD: septal-to-lateral wall motion delay. 
TDI: tissue Doppler imaging.
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In pediatric populations, the usefulness of these indices has been demonstrated in several case re-
ports and one small trial.(19;20;24) Tomaske and co-workers applied a 4-segment TDI model in six 
CHD patients with systemic LV failure.(24) At baseline, the maximum intra-LV delay between two 
basal and two mid-ventricular LV segments in the apical 4-chamber view was 64 ± 10 ms and impro-
ved to 37 ± 8 ms after one month of CRT (p=0.03), along with an improved LV systolic performance. 
In addition to myocardial velocity, myocardial strain can be obtained from color-coded TDI ima-
ges (Figure 6). The advantage of strain imaging over myocardial velocity imaging is that strain in-
dicates active myocardial deformation or contraction whereas velocity represents passive motion 
or displacement. Differences in time to peak strain can be calculated to quantify LV dyssynchrony.
(65;66) TDI derived strain has been evaluated in a pediatric study.(67) Abd El Rahman and colle-
agues assessed TDI derived longitudinal strain in 25 patients (median 19 years, range 3-35 years) 
with tetralogy of Fallot and in 25 age-matched controls.(67) The mean time to peak strain was as-
sessed at the LV free wall (basal, mid and apical) as well as at the septum, and the mean septal-to-LV 
free wall time delay was calculated. LV dyssynchrony was defined as a septal-to-LV free wall delay 
two standard deviations above the mean observed in controls (>25.8 ms). Accordingly, 52% of te-
tralogy of Fallot patients showed LV dyssynchrony. These patients had longer QRS duration (155 
± 19 ms vs. 136 ± 23 ms, p=0.018) and an impaired LV performance compared to patients without 
dyssynchrony, as assessed with the Tei index (Tei index in patients with LV dyssynchrony: 0.5 ± 0.08, 
Tei index in patients without LV dyssynchrony: 0.38 ± 0.06, p=0.004).  
Finally, the advent of novel echocardiographic techniques, including 2D strain and RT3DE has ena-
bled assessment of dyssynchrony by evaluating active myocardial deformation (2D strain) or by 
evaluation of volumetric changes in a 3-dimensional fashion (RT3DE).
2D strain imaging or speckle-tracking strain imaging is a novel echocardiographic technique that 
permits multidirectional and angle-independent assessment of LV deformation. With this techni-
que, the so-called speckles (natural acoustic markers equally distributed within the myocardium 
in 2D gray-scale images) are tracked frame-by-frame throughout the cardiac cycle. The change 
of their position relative to their original position is used to calculate myocardial strain. LV dys-
synchrony can be characterized by evaluating radial strain (thickening of the myocardium in the 
short-axis views) (Figure 7). At the mid ventricular short-axis view of the LV, a maximum difference 
of ≥130 ms in time to peak strain between the antero-septal and the posterior LV segments has 
shown to predict favourable response to CRT in adult populations.(68;69) Other adult series have 
evaluated the use of circumferential (LV shortening along the short-axis curvature of the LV) and 
longitudinal strain to measure LV dyssynchrony and to evaluate the effects of CRT.(70;71) Tomaske 
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Figure 8. Left ventricular dyssynchrony assessed with real-time three-dimensional echocardiography
Example of a postoperative tetralogy of Fallot patient with left ventricular dyssynchrony, as assessed with real-
time three-dimensional echocardiography. Contours are drawn at end-systole (Panel A) and end-diastole in the 
short-axis view, 4-chamber view, 2-chamber view and long-axis view. An automated tracking algorithm traces 
the myocardium throughout the cardiac cycle. The time-volume curves (Panel C) are displayed, depicting in-
stantaneous volume of each of the left ventricular segments (Panel B), from which a systolic dyssynchrony index 
(standard deviation of time to minimum systolic volume of left ventricular segments) can be calculated. In this 
example, the systolic dyssynchrony index is 6.6%. A systolic dyssynchrony index >6.4% indicates left ventricular 
dyssynchrony.(75) Abbreviations: SDI: systolic dyssynchrony index.
Figure 7. Left ventricular dyssynchrony: two dimensional speckle tracking
Example of a postoperative patient with atrioventricular septum defect and left ventricular dyssynchrony as 
assessed with two-dimensional speckle tracking radial strain. Left panel: A region of interest can be indicated 
in a two-dimensional gray scale image. The colors of the region of interest correspond with the colors of the 
time-strain curves in the right panel. Right panel: Time-radial strain curves of the different segments of the left 
ventricle. The time delay in peak radial strain between the antero-septal (yellow) and the posterior segments 
(purple curve) is 315 ms (≥130 ms), indicating the presence of significant left ventricular dysynchrony.(69) 
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and co-workers investigated LV dyssynchrony by assessing 2D circumferential strain in 6 CHD 
patients who underwent CRT for systemic LV failure.(24) The maximum difference between the 
earliest and the latest activated segments and the standard deviation of time to peak strain of 
12 segments were calculated at baseline and at one month follow-up. Both dyssynchrony parame-
ters decreased significantly at one month follow-up after CRT (maximum difference decreased 
from 201 ± 35 ms to 99 ± 23 ms, p=0.03; the standard deviation decreased from 72 ± 14 ms to 
40 ± 15 ms; p=0.03). Along with the mechanical resynchronization, the LVEF improved significantly 
at one month follow-up (from 41 ± 6% to 53 ± 8%, p=0.03).(24) In addition, 2D strain imaging per-
mits evaluation of the latest activated areas where the LV pacing lead should ideally be placed. 
In adult populations, the position of the LV pacing lead concordant with the latest activated seg-
ment has demonstrated to be a determinant of positive response to CRT and superior long-term 
outcome.(72) In CHD and pediatric studies, the usefulness of this technique to identify the latest 
activated segment and to guide the LV lead placement has been also demonstrated.(73;74) 
Finally, RT3DE provides regional time-volume curves for the evaluation of LV dyssynchrony (Figure 
8). LV dyssynchrony is assessed by calculating the systolic dyssynchrony index (SDI). The standard 
deviation of time to minimum systolic volume of 16 LV segments is calculated. Marsan et al. de-
monstrated that a SDI cut-off value of 6.4% predicted long-term CRT response with high sensiti-
vity (88%) and specificity (85%).(75) Concerning CHD patients, Bacha et al. performed RT3DE in 
10 single ventricle patients who received multisite pacing post-operatively.(34) At 48 hours after 
CRT, the SDI of the single ventricle decreased significantly (from 10.3 ± 4.8 to 6.0 ± 1.4, p<0.05). 
The proposed inter-ventricular dyssynchrony parameters in the adult trials resemble the ob-
servations on LV dyssynchrony in pediatric and CHD patients. However, the predictive value 
of inter-ventricular dyssynchrony of the LV in CHD and pediatric patients may vary in the vari-
ous anatomical subgroups. Furthermore, several factors such as previous pacing strategies, 
the presence and location of scar tissue and hemodynamic abnormalities may influence the 
CRT response.(76) Additional trials are needed to establish cut-off values of LV dyssynchrony 
in CHD and pediatric patients, taking into consideration the various anatomical subgroups. 
Intra-ventricular dyssynchrony: right ventricle 
Similar to the assessment of intra-ventricular dyssynchrony of the LV in the adult population, in-
tra-ventricular dyssynchrony of the RV has been studied in CHD patients with systemic RV failure. 
Van de Veire et al. assessed septal-to-lateral delay within the RV in the apical four-chamber view 
with color-coded TDI in a patient with RV-systemic failure who was upgraded from conventional 
pacing to CRT.(33) After two weeks, the RV septal-to-lateral delay decreased from 80 ms to com-
pletely synchronous contraction and exercise capacity improved significantly. In addition, Janou-
sek et al. evaluated intra-ventricular dyssynchrony of the RV with TDI derived strain before and 
after CRT in eight patients with RV systemic failure.(29) RV dyssynchrony was quantified by mea-
suring the largest delay in time to peak strain between four mid-ventricular RV segments (septal, 
lateral, anterior, posterior). After 4 days of CRT, RV dyssynchrony significantly reduced (from 138 
± 59 ms to 64 ± 21 ms, p=0.042). In addition, RVEF, as assessed with radionuclide angiography at 4 
months follow-up, improved from 41.5% to 45.5% (p<0.01).
According to these data, assessment of intra-ventricular dyssynchrony of the RV could be useful 
in selecting patients with RV failure for CRT. However, unlike LV dyssynchrony assessment, charac-
terization of RV dyssynchrony has been less explored(77-79), and additional studies evaluating 
RV dyssynchrony are needed to determine its value for predicting success of CRT in RV failure. 
CONCLUSION AND FUTURE PERSPECTIVE
The beneficial effects of CRT on clinical outcomes and LV function of adult heart failure patients 
has encouraged the use of this therapy in other populations, such as CHD and pediatric patients.
(14-16) The population with CHD is growing, and this subgroup of patients has a high prevalence 
of heart failure during late follow-up.(11) Although some studies have demonstrated the benefi-
cial effects of CRT in CHD and pediatric patients, there are several concerns. First, the population 
of CHD and pediatric patients included in the studies is highly heterogeneous, comprising various 
anatomical substrates (systemic LV, systemic RV, single ventricle) and etiologies of heart failure 
(chronic single-site ventricular pacing).(14-16) Furthermore, heterogeneity in this population re-
sults from patient age and size variations. Second, the current adult selection criteria may not be 
suitable for the CHD and pediatric heart failure population. Only a minority of CHD and pediatric 
patients included in studies on CRT fulfilled the adult guidelines of QRS >120 ms, NYHA functio-
nal class III or IV and LVEF <35%.(14-16)  Third, the various anatomical substrates may result in 
patterns of cardiac dyssynchrony that may not be accurately characterized with ECG criteria. The 
study of mechanical dyssynchrony with various imaging modalities may provide a more accurate 
definition of cardiac dyssynchrony and improve selection of those CHD and pediatric patients who 
have the highest likelihood of response to CRT. However, the feasibility and performance of the 
various dyssynchrony parameters in CHD and pediatric patients may differ from those observed in 
adult heart failure patients. 
In conclusion, CRT may be a promising therapy to improve the clinical outcome of CHD and pediatric 
patients with heart failure. However, more studies are needed to establish appropriate guidelines 
for patient selection, taking into account the different anatomical subgroups. 
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2.2 
Tissue Doppler imaging in the left ventricle and 
right ventricle in healthy children: normal  
age-related peak systolic velocities, timings,  
and time differences
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Background: Tissue Doppler imaging (TDI) enables assessment of velocities and timings within the 
left (LV) and right (RV) ventricle with high temporal resolution. Knowledge on normal age-related 
values of peak systolic velocities and timings in healthy children may optimize the benefit of de-
vice-based therapies in pediatric patients with heart failure.
Methods: A total of 123 healthy children (from 1 month to 18 years old) underwent TDI evaluation 
of the RV and LV.  Peak systolic velocity and time to peak systolic velocity were assessed at the 
basal segments of the LV lateral wall, inter-ventricular septum (IVS), RV free wall (RVFW) and at 
the RVOT. Intra-ventricular time differences were calculated. Regression analysis was performed 
to assess the age-dependency of the ventricular mechanics.
  
Results: Median peak velocities were: LV lateral wall 6.3 cm/s, (inter-quartile-range: 5.1-7.9 cm/s), 
IVS: 6.0 cm/s (5.4-6.7 cm/s), RVFW: 10.2 cm/s (8.9-11.3 cm/s), RVOT 7.2 cm/s (6.0-8.2 cm/s). Ti-
mings of peak systolic velocities: LV lateral wall 101 ms (91-112 ms), IVS: 114 ms (100-128 ms), 
RVFW: 177 ms (157-194 ms), RVOT 100 ms (88-113 ms). Timings and peak velocities significantly 
increased with age at both ventricles. No relevant time difference was observed within the LV, 
whereas a considerable time delay was observed within the RV between the RVFW and the IVS (62 
ms, IQR 45-74 ms) and between the RVFW and the RVOT (74 ms, IQR 59-93 ms).  
Conclusions: The present evaluation provides TDI-derived reference values on LV and RV mecha-
nics of healthy children. Within the LV, no relevant time difference was observed whereas a consi-
derable mechanical delay is observed within the healthy RV.
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INTRODUCTION
Echocardiographic tissue Doppler imaging (TDI) enables the assessment of left (LV) and right (RV) 
ventricular mechanics by measuring myocardial velocities and time to peak myocardial velocities 
with high temporal resolution. The assessment of peak systolic velocities of the LV and RV myo-
cardium with TDI is of incremental value to conventional echocardiography to assess global and 
regional ventricular performance in various clinical conditions.(1-5) Furthermore, evaluation of the 
temporal occurrence of peak systolic velocities with TDI provides insight into electromechanical 
coupling and mechanical dyssynchrony.(6) 
TDI-derived peak velocities and time-differences between peak systolic velocities within the myo-
cardium of the LV and RV have been investigated in healthy children.(7-9) However, the absolute 
timings within the LV and the RV have not been reported. The advent of novel device-based the-
rapies, such as cardiac resynchronization therapy (CRT), has encouraged the research on LV and 
RV mechanics with noninvasive imaging. Understanding LV and RV mechanics in healthy children 
may optimize the benefit of these therapies in patients with heart failure. Furthermore, in certain 
patients with congenital heart disease, RV outflow tract (RVOT) mechanics have an influence on 
global RV performance. Abnormal RVOT mechanics have been related to RV failure and poor clinical 
outcome. However, the reference values of normal peak systolic velocities and timings at the RVOT 
in healthy children have not been evaluated. Accurate standardization of reference values of TDI 
velocities at the RVOT would help to understand the mechanisms underlying RV failure in patients 
with congenital heart disease.(5,10,11)
Accordingly, the objectives of this evaluation were to assess peak systolic velocities, timings of 
peak systolic velocities and intra-ventricular time differences with TDI in the LV and RV of healthy 
children. In addition, the age-dependency of the peak systolic velocities, timings to peak systolic 
velocities and intra-ventricular time differences in healthy children were investigated.
METHODS
Study population 
Healthy children of various ages (from 1 month to 18 years) were prospectively included in the cur-
rent study. We did not include patients younger than 1 month since these young patients may still 
have a raised pulmonary pressure, which may interfere with the observed myocardial velocities. All 
subjects underwent transthoracic echocardiography and TDI. Conventional two-dimensional echo-
cardiography confirmed structurally normal hearts. Peak systolic velocities and timings of peak sys-
tolic velocities at the LV and RV were assessed with TDI in all subjects. In addition, intra-ventricular 
time differences between the peak systolic velocities at the various LV and RV regions were calcu-
lated. Finally, the relationship between age and myocardial velocities, time to peak systolic velocity 
and the intra-ventricular time differences were evaluated. The study protocol was approved by our 
hospital institutional review board. All participants or their parents gave written informed consent.
Right ventricular imaging: echocardiography2
Tissue Doppler imaging
Transthoracic echocardiography data were acquired using a commercially available system equip-
ped with a 3.5 MHz transducer (Vivid-7.0.0, GE Vingmed Ultrasound AS, Horten, Norway). Standard 
two-dimensional gray-scale images were acquired from the parasternal (long- and short-axis) 
and apical views (4-chamber and long-axis) and digitally stored in cine-loop format. Acquisition 
of TDI images was performed with adjusted sector width and angle to align the ultrasound beam 
along the direction of the myocardial motion. The color frame rate was ≥120 frames/s, and at 
least three consecutive beats were recorded. Analyses were performed off-line using EchoPac 
version 108.1.5 (General Electric Medical Systems). Longitudinal myocardial velocity curves were 
obtained by placing regions of interest at the basal LV lateral wall (Figure 1, panel A), basal inter-
ventricular septum (IVS) (Figure 1, panel A) and basal RV free wall (RVFW) (Figure 1, panel B) in the 
4-chamber view, and at the lateral wall of the RVOT (Figure 1, panel C) in a dedicated apical RVOT 
view, as previously reported. (5, 12) Semi-automated tissue tracking was used to maintain the 
region of interest within the sample area throughout the cardiac cycle. Peak systolic velocity was 
measured at all LV and RV regions. In addition, time from onset of the Q-wave of the ECG to peak 
systolic velocity was measured in all LV and RV basal segments. Finally, the LV intra-ventricular 
time difference was obtained by calculating the difference between time to peak systolic velo-
Table 1. Ventricular mechanics as assessed by TDI
Abbreviations: IVS: inter-ventricular septum, LV lat: left ventricular lateral wall, RVFW: right ventricular free wall, 
RVOT: right ventricular outflow tract. 
2.2
Peak systolic velocity (cm/s)  
Left ventricle
        LV lat 6.3 (5.1 – 7.9)
        IVS 6.0 (5.4 – 6.7)
Right ventricle
        RVFW 10.2 (8.9 – 11.3)
        RVOT 7.2 (6.0 – 8.2)
Timing peak systolic velocity (ms)
Left ventricle
        LV lat 101 (91 – 112)
        IVS 114 (100 – 128)
Right ventricle
        RVFW 177 (157 – 194)
        RVOT 100 (88 – 113)
Intra-ventricular time differences (ms)
Left ventricle
        LV lat - IVS 10 (0 – 20)
Right ventricle
        IVS - RVFW 62 (45 – 75)
        RVOT - RVFW 74 (59 – 93)
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city at the basal LV lateral segment and at the basal part of the IVS. The RV intra-ventricular time 
difference was calculated by measuring the time delay in peak systolic velocities between the 
basal part of the IVS and RVFW and between the RVOT and basal RVFW. Intra and inter observer 
agreement of all peak velocities and timings of peak velocities was assessed in a blinded manner 
in 15 randomly chosen subjects. Peak velocity and time to peak velocity at the different LV and RV 
regions was reassessed by the same and by an independent observer.
Statistical analysis
Continuous variables are expressed as median and inter-quartile range (IQR). Categorical vari-
ables are presented as numbers and percentages. Linear regression analysis was performed to 
evaluate the relation between age and peak systolic velocities, timings of velocities, and time dif-
ferences. Intra observer and inter observer agreement was assessed by measuring the absolute 
difference between the repeated measurements in percent of the mean, averaged over the study 
subjects and presented as mean ± standard deviation. In addition, 95% reference intervals for 
the linear regression models were calculated. Data were analyzed using the SPSS 17.0 software 
(SPSS Inc, Chicago, Illinois). A p-value of <0.05 was considered statistically significant.
RESULTS
Study population characteristics
A total of 123 healthy children (56% male) were included. The median age at echocardiography 
was 6.3 years (IQR: 3.3-11.7 years) and children of all ages (1 month to 18 years) were represen-
ted in the present study. All subjects showed structurally normal hearts on echocardiography. The 
median heart rate during image acquisition was 90 min-¹ (IQR: 72-111/min-¹) and the median body 
surface area was 0.9 m2 (IQR: 0.6-1.3 m2). The obtained TDI images had sufficient image quality 
for analysis in all subjects. 
Peak systolic velocities
Table 1 summarizes the peak systolic velocities at the different LV and RV regions. The median 
peak systolic velocity at the LV lateral wall was 6.3 cm/s (IQR: 5.1-7.9 cm/s). At the IVS, peak 
systolic velocity was 6.0 cm/s (IQR: 5.4-6.7 cm/s). At the RVFW, the median peak systolic velocity 
was 10.2 cm/s (IQR 8.9-11.3 cm/s). Finally, the median peak systolic velocity at the RVOT was 7.2 
cm/s (IQR 6.0-8.2 cm/s). 
A significant relationship between age and peak systolic velocity measured at the LV lateral wall 
was observed (LV lateral wall: r=0.75, p<0.001) (Figure 2). At the IVS, this relationship, although 
modest, was also observed (IVS: r=0.54 p<0.001) (Figure 2). In contrast, the relationship between 
age and peak systolic velocity at the RVFW and at the RVOT was weak (RVFW: r=0.42 p<0.001, 
RVOT r=0.38, p<0.001) (Figure 3). The results of the intra observer and intra observer agreement 
for the peak velocities were: LV lateral wall: intra observer 7% ± 6%, inter observer: 9% ± 9%, IVS: 
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Figure 1. TDI images of LV and RV in a healthy child
Panel A: TDI image of LV. Yellow region of interest is placed at the basal IVS. Blue region of interest is placed at 
the basal lateral wall. From the corresponding velocity curves the peak systolic velocity (vertical dotted arrow: 
peak systolic velocity IVS, vertical solid arrow: peak systolic velocity LV lateral wall) and time to peak systolic 
velocity (horizontal dotted arrow: time to peak systolic velocity IVS, horizontal solid arrow: time to peak systolic 
velocity LV lateral wall) can be derived. 
Panel B: TDI image of RV. Yellow region of interest is placed at the basal free wall. From the corresponding ve-
locity curve, the peak systolic velocity (vertical arrow) and time to peak systolic velocity (horizontal arrow) can 
be derived. 
Panel C: TDI image of RVOT. Yellow region of interest is placed at the septal side of the RVOT, just below the 
pulmonary valve. From the corresponding velocity curve, the peak systolic velocity (vertical arrow) and time to 
peak systolic velocity (horizontal arrow) can be derived. 
Abbreviations: IVS: inter-ventricular septum, LV: left ventricle, PA: pulmonary artery, RV: right ventricle, RVOT: 
right ventricular outflow tract.
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intra observer: 6% ± 5%, inter observer: 14% ± 13%, RVFW: intra observer: 10% ± 11%, inter ob-
server:  17% ± 14%, RVOT: intra observer: 7% ± 6%, inter observer 12% ± 13 %.
Timings of peak systolic velocities
Timings of peak systolic velocities are summarized in Table 1. The median time to peak systolic 
velocity at the LV lateral wall was 101 ms (IQR: 91-112 ms). At the IVS, the median time to peak 
systolic velocity was 114 ms (IQR 100-118 ms). At the RVFW, the median time to peak systolic 
velocity was 177 ms (IQR 157-194 ms). The peak systolic velocity at the RVOT occurred prior to 
that of the RVFW, at 100 ms (IQR: 88-113 ms). 
Time to peak systolic velocity at the LV lateral wall and IVS were significantly related with age (LV 
lateral wall: r=0.57, p<0.001, IVS: r=0.41, p<0.01) (Figure 4). Similarly, time to peak systolic velo-
city at the RVFW and RVOT increased significantly along with age (RVFW: r=0.58, p<0.001, RVOT: 
r=0.70, p<0.001) (Figure 5). The results of the intra observer and intra observer agreement for 
the timings of peak velocities were: LV lateral wall: intra observer 5% ± 4%, inter observer: 14% 
± 13%, IVS: intra observer: 6% ± 5%, inter observer: 11% ± 8%, RVFW: intra observer: 7% ± 2%, 
inter observer:  7% ± 5%, RVOT: intra observer: 7% ± 5%, inter observer 9% ± 6 %.
Intra-ventricular time differences
Table 1 shows the median inter-ventricular time delays in the LV and RV in the healthy children. The 
median time delay between peak systolic velocity at the LV lateral wall and peak systolic velocity 
at the IVS was very small (median 10 ms, IQR 0-20 ms). In contrast, within the RV, the time diffe-
rence between the IVS and the RVFW was 62 ms (IQR 45-75 ms), and the median time difference 
between the RVOT and the RVFW was 74 ms (IQR 59-93 ms). The observed small intra-ventricular 
time difference within the LV did not change with age. At the RV, the time delay between the IVS 
and the RVFW showed a weak correlation with age (r=0.25, p<0.001), whereas the time difference 
between the RVOT and the RVFW did not relate with age in the healthy subjects.
DISCUSSION
The present study provides age-related values for peak systolic velocities and timings of peak 
systolic velocities as assessed with TDI at the basal segments of the LV, RV and of the RVOT in 
healthy children. The results of the current study show that peak systolic velocities and time to 
peak systolic velocities increase with age in both ventricles. Furthermore, no intra-ventricular time 
differences between the basal LV lateral wall and IVS are observed at any age, whereas within the 
RV, a considerable time delay is present between the basal IVS and the basal RVFW, and between 
the basal RVFW and the RVOT. Finally, the intra-ventricular time differences within RV did not show 
relevant changes with age in healthy children.
Peak systolic velocities
The assessment of peak systolic velocities with TDI provides a quantitative measure of ventricular 
systolic function. Several studies have demonstrated the value of TDI-derived peak systolic velo-
cities to quantify regional LV and RV ventricular performance in adults with various clinical condi-
tions.(1-5) In pediatric patients, the assessment of peak systolic velocities has been shown to be 
a sensitive tool to detect myocardial dysfunction.(13,14) The current study provides age-related 
normal values of peak systolic velocities at the basal LV lateral wall, basal RVFW and at the RVOT 
with TDI. Peak velocities were highest at the basal RVFW (median 10.2 cm/s) and lowest at the 
LV lateral wall (median 6.0 cm/s). The observed pattern of different magnitudes of normal peak 
velocities among the basal LV lateral wall, basal IVS and basal RV is in agreement with previous 
investigations in children.(5,8,9,15) Furthermore, the observed normal peak velocities at the basal 
LV and RV increased significantly with age in the current study. This observation is in line with a 
previous study on the alterations of LV performance during cardiac maturation in healthy children.
(16) Notomi and colleagues assessed LV performance in 45 healthy controls by measuring rota-
tional mechanics with TDI. In their study, LV performance increased significantly with age.(16) In 
contrast, other studies have reported weaker(9) or non-significant(8) relationships between TDI-
derived peak velocities at the basal RV and LV and age in healthy children. Kapusta et al. investiga-
ted age-related peak systolic velocities at the basal RFVW, IVS and LV lateral wall in 160 healthy 
children and observed no significant changes with age.(8) However, the age range (4-18 years) of 
the included subjects was significantly smaller as compared to the present study. 
The current report is the first to investigate normal values of peak systolic velocities at the RVOT. 
The peak systolic velocity at the RVOT was lower than the velocity at the RVFW and showed a sig-
nificant increase with age. Comprehensive insight into normal values of peak systolic velocities 
at the RVOT is of interest to evaluate patients with congenital heart disease, specifically those 
with tetralogy of Fallot.(11,17) Systolic dysfunction at the RVOT has been associated with reduced 
global performance of the RV.(11,17) Accordingly, the observed normal values on the peak systo-
lic velocity at the RVOT provide a framework for future studies on patients with congenital heart 
disease and RV failure. 
Timing of peak systolic velocities and intra-ventricular time 
The assessment of timings of peak systolic velocities with TDI yields insight into electromechani-
cal coupling and possible mechanical dyssynchrony. CRT targets dyssynchrony in patients with LV 
failure by inducing a more synchronous contraction. In pediatric patients, no guidelines for patient 
selection for CRT are available at present.(18-20) Knowledge on normal values of myocardial velo-
cities, timings and time-differences within the LV as assessed with TDI could play an important role 
in defining appropriate recommendations for pediatric patients with LV failure who may benefit 
from CRT. However, a systematic description of the normal temporal occurrence of peak systolic 
velocities and time differences within the LV has not been previously reported in children. The pre-
sent study provides insight into the normal electromechanical activation of the LV in children. With 
a median time difference of 10 ms between the time to peak velocity at the basal LV lateral wall 
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Figure 2.  Relation between age and peak systolic velocity in the LV
Upper: Scatter plot depicting linear relation and 95% reference intervals for age and peak systolic velocity at LV 
lateral wall. Lower: Scatter plot depicting linear relation and reference intervals between age and peak systolic 
velocity at IVS.
Abbreviations: IVS: inter-ventricular septum. LV lat: left ventricular lateral wall.
Figure 3.  Relation between age and peak systolic velocity in the RV
Upper: Scatter plot depicting linear relation and 95% reference intervals for age and peak systolic velocity at 
RVFW. Lower: Scatter plot depicting linear relation and reference intervals between age and peak systolic ve-
locity at RVOT.
Abbreviations: RVFW: right ventricular free wall, RVOT: right ventricular outflow tract.
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Figure 4.  Relation between age and time to peak systolic velocity in the LV
Upper: Scatter plot depicting linear relation and 95% reference intervals for age and time to peak systolic velo-
city at LV lateral wall. Lower: Scatter plot depicting linear relation and reference intervals between age and time 
to peak systolic velocity at IVS.
Abbreviations: IVS: inter-ventricular septum. LV lat: left ventricular lateral wall.
Figure 5.  Relation between age and time to peak systolic velocity in the RV
Upper: Scatter plot depicting linear relation and 95% reference intervals for age and time to peak systolic velo-
city at RVFW. Lower: Scatter plot depicting linear relation and reference intervals between age and time to peak 
systolic velocity at RVOT.
Abbreviations: RVFW: right ventricular free wall, RVOT: right ventricular outflow tract.
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and the basal IVS, no significant time delay within the LV was observed at any age. These normative 
data are in line with the results of previous studies including adult population (15), and provide an 
empirical basis for future studies on LV dyssynchrony in pediatric candidates for CRT. 
The RV differs greatly from the LV in terms of anatomy and function. Accordingly, the mechanical 
activation pattern of the RV may be different from that of the LV. In the current investigation, a sig-
nificant IVS-to-RVFW delay was observed in the healthy subjects, with a median time difference of 
62 ms. Albeit substantially smaller, the presence of an IVS-to-RVFW delay was previously observed 
with TDI by Hui et al. in a study on 98 healthy children.(7) Moreover, based on their observations, 
the authors proposed to consider as normal range any IVS-to-RVFW delay below 70 ms.(7) Of note, 
within the LV, a time delay of 70 ms would indicate significant dyssynchrony.(21) In addition, in the 
present study, the intra-ventricular time difference between the basal RVFW and RVOT was inves-
tigated, yielding a median intra-ventricular time delay of 74 ms. A previous study evaluating RV 
intra-ventricular timings assessed with TDI showed a similar activation pattern with a significant 
time delay between the RVOT and RVFW in healthy adults.(5) In the present study, the observed 
intra-ventricular time differences within the RV did not show a relevant relationship with age. 
Accordingly, significant intra-ventricular time differences between the IVS and RVFW and between 
the RVOT and RVFW are present in children of any age. 
The presence of a mechanical delay within the RV may have important clinical implications. RV fai-
lure is common in pediatric patients with congenital heart disease(22-24) and the best therapeutic 
approach to RV failure remains incompletely elucidated. CRT has been evaluated as novel therapy 
for patients with RV failure.(19,25) However, the pathophysiological basis of CRT is the restoration 
of electromechanical dyssynchrony. With the observed mechanical delay within the healthy RV, this 
concept of resynchronization may not be applicable to the RV. The application of CRT in patients 
with RV failure warrants further studies on RV mechanics and its relation with RV performance.
Study limitations
The relatively small sample size of the study may constitute a limitation. Furthermore, the results 
of the present study were obtained with equipment from one vendor. A previous study demonstra-
ted that for the assessment of myocardial velocities, different ultrasound systems from different 
vendors can not be used interchangeably.(26) Accordingly, the presented reference values should 
be interpreted with caution when using other equipment. Instead of TDI, speckle tracking strain 
analysis is increasingly used in clinical practice for evaluation of patients with heart failure who 
may benefit from CRT and early detection of subtle changes in myocardial performance. Howe-
ver, in the pediatric population, speckle tracking strain analysis has been less explored. The higher 
heart rates observed in small children may challenge the assessment of myocardial strain or even 
velocities with speckle tracking, a technique strongly dependent on frame rate. Therefore, for this 
population, TDI might be still preferable. However, additional studies using speckle tracking will 
confirm whether this technique provides the same results or not.
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CONCLUSIONS
In conclusion, in the present study, reference values are provided on LV and RV peak systolic 
velocities and timings of peak systolic velocities as assessed with TDI in healthy children. Within 
the LV, no relevant time-differences were observed at any age. Within the RV of healthy children, 
an intrinsic time delay was observed, which has implications for future studies on device-based 
therapies for RV failure. 
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2.3
Relationship between temporal sequence of right 
ventricular deformation and right ventricular  
performance in patients with corrected tetralogy  
of Fallot 
Heart 2010; 97: 231-236








Objective: Right ventricular (RV) dysfunction is common in patients with corrected tetralogy 
of Fallot (cToF). Abnormalities in the temporal pattern of RV mechanical activation have been 
observed in cToF patients, however, the relationship with RV performance remains unclear. The 
present study characterizes RV performance and the temporal sequence of RV deformation in cToF 
patients and healthy controls.
Design and patients: Thirty-seven cToF patients were compared to 18 controls. Using two-
dimensional speckle tracking analysis, global RV strain was assessed. In addition, time to peak 
strain, and the time difference between RV inlet and RV outlet (RV time delay) was assessed. 
Main outcome measure: The relation between RV performance and RV time delay was assessed 
with linear regression analysis. 
Results: RV strain was reduced in patients compared to controls (-20.9±4.3% vs. -30.7±3.4%, 
p<0.001). Time to peak strain at the RV inlet showed no differences (cToF patients: 406±55 ms, 
controls: 405±67 ms, p=0.429), whereas time to peak strain at the RV outlet was significantly 
delayed in cToF patients (RV outlet: 339±75 ms vs. 262±85 ms, p=0.003). Consequently, RV time 
delay was significantly shorter in cToF patients (RV time delay: 66±48 ms vs. 143±53 ms, p<0.001). 
A close relation between RV time delay and RV strain was observed (r=-0.70, p<0.001).
Conclusion: In cToF patients, RV outlet deformation is delayed, causing a reduction of RV time delay 
which is significantly related to impairment in RV performance. 
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INTRODUCTION
Right ventricular (RV) dysfunction is common after surgical correction of tetralogy of Fallot (cToF)
(1,2) and is an important predictor of poor clinical outcome in these patients.(1) Although chronic 
volume overload due to pulmonary regurgitation is recognized as an important factor causing RV 
failure in cToF,(3) the exact pathophysiological mechanisms leading to RV failure remain poorly 
understood. Abnormalities in the temporal pattern of RV mechanical activation, in particular 
a delayed activation of the RV outflow tract,(4) have been proposed as one of the determinants 
of RV dysfunction in cToF patients. The complex geometry and myofiber arrangement of the RV 
challenges the assessment of RV systolic function and mechanical activation pattern. From an 
anatomical and embryological perspective, the RV can be divided into two sections; the sinus (inlet), 
and the infundibulum (outlet).(5,6) Previous studies have demonstrated the presence of temporal 
differences in motion between the RV inlet and outlet in cToF patients as well as in healthy subjects.
(4,7) However, the characterization of the RV mechanical activation sequence with different ima-
ging techniques provided conflicting data.(4,7,8) In addition, the relationship between the RV 
temporal mechanical activation pattern and RV performance has not been elucidated. 
Two-dimensional speckle tracking strain imaging is a recently introduced echocardiographic 
imaging modality that permits angle-independent, multi-directional assessment of myocardial 
deformation.(9,10) Two-dimensional speckle tracking strain analysis has demonstrated to 
be a useful method for early detection of myocardial dysfunction.(11-14) In addition, two-
dimensional strain analysis enables the assessment of the temporal occurrence of regional 
myocardial deformation.(15,16) Accordingly, the aim of the present study was to characterize the 
temporal sequence of RV deformation and RV performance in cToF patients and healthy controls 
with two-dimensional speckle tracking echocardiography and with cardiac magnetic resonance 
imaging (CMR). The temporal sequence of RV deformation was related to RV performance to 
comprehensively understand the determinants of RV dysfunction in cToF patients. 
METHODS
Study population and study protocol
A total of 37 consecutive patients with cToF and pulmonary regurgitation (mean age 12.9±2.9 
years) were prospectively enrolled in the present study. Patients were selected from the database 
of the Center of Congenital Heart disease Amsterdam-Leiden. Patients after pulmonary valve 
replacement were excluded. In addition, 18 healthy controls with a similar age and body surface 
area were included. The study protocol was approved by the institutional review board and all 
subjects gave written, informed consent. A standard 12-lead ECG with a paper speed of 25 mm/s 
and 1 mV/mm was acquired for every cToF patient and control subject. The maximum QRS width 
was calculated. In addition, patients and controls were evaluated with CMR, two-dimensional 
echocardiography and speckle tracking echocardiography. RV dimensions and ejection fraction 
Right ventricular imaging: echocardiography 2.32
Table 1. Baseline characteristics and results of right ventricular echocardiography
Abbreviations: AP: arteria pulmonalis, BSA: body surface area, CMR: cardiac magnetic resonance, EDV: end- 
diastolic volume, EF: ejection fraction, ESV: end-systolic volume, RV: right ventricle, RVOT: right ventricular out-
flow tract. TAPSE: tricuspid annular plane systolic excursion.
Baseline characteristics Patients Controls p-value
Number (n) 37 18
Age (y) 12.9 ± 2.9 13.9 ± 2.4 0.151
Male/female n (%) 22/15 (60/40) 11/7 (39/61) 0.907
QRS (ms) 134 ± 19 93 ± 8 <0.001
BSA (m²) 1.4 ± 0.3 1.5 ± 0.3 0.067
Age at repair (y) 0.84 ± 0.6
Type of repair n (%)
            Transannular patch 22 (59)
            RVOT patch 4 (11)
            AP patch 3 (8)
            Infundibulectomy 8 (22)
CMR
RV-EDV (ml/m²) 131 ± 36 98 ± 13 <0.001
RV-ESV (ml/m²) 67 ± 21 46 ± 10 <0.001
RV-EF (%) 50 ± 5 53 ± 4 0.009
Echocardiography
Pulmonary regurgitation n (%)
     mild 10 (28) 0
     moderate 12 (33) 0
     severe 14 (39) 0
Pulmonary stenosis  n (%)
                   none/mild (<20 mmHg) 18 (49) 18 (100)
                   moderate  (20-40 mmHg) 14 (38) 0
                   severe         (>40 mmHg) 5 (13) 0
TAPSE (mm) 16 ± 3 22 ± 3 <0.001
RV global longitudinal strain (%) -20.9 ± 4.3 -30.7 ± 3.4 <0.001
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were assessed with CMR. RV performance was furthermore evaluated with conventional two-
dimensional echocardiography (tricuspid annular plane systolic excursion [TAPSE]) and with speckle 
tracking strain analysis (global longitudinal strain). In addition, the temporal sequence of myocardial 
deformation of the inlet and outlet components of the RV was studied with speckle tracking strain 
analysis. Finally, RV dimensions, as assessed with CMR, and RV performance, as assessed with 
2-dimensional speckle tracking, were related to the temporal sequence of myocardial deformation 
of the RV components. 
CMR
CMR was performed on a 1.5 Tesla pulsar gradient system (Intera, release 11; Philips Medical 
Systems, Best, the Netherlands) with 33 mT/m amplitude, 100 mT/m/ms slew rate, and 0.33 ms rise 
time. A five-element cardiac coil was used for signal reception. After acquiring scout images, multi-
section transversal cine imaging was performed. A stack of slices was planned in the transversal 
plane, covering the RV throughout the cardiac cycle. Images were acquired with a steady-state free 
precession sequence during breath hold at end-expiration (repetition time 3.9 ms, echo time 1.5 ms, 
flip angle 50°, slice thickness 8 mm, matrix 160x256, field-of-view 350 mm, temporal resolution 25 
ms). Images were analyzed using the MASS (Medis, Leiden, The Netherlands) software package.
(17) RV volumes were calculated by manually tracing the endocardial borders at end-systole and 
end-diastole in all slices and multiplying the area with slice thickness. Subsequently, RV ejection 
fractions were automatically calculated by MASS. RV volumes were indexed for body surface area.
Conventional two-dimensional echocardiography
Transthoracic echocardiographic images were acquired by a single experienced sonographer using 
a commercially available system equipped with a 3.5 MHz transducer (Vivid-7.0.0, GE Vingmed 
Ultrasound AS, Horten, Norway). Subjects were in the left lateral decubitus position during image 
acquisition. Standard two-dimensional images and color Doppler data were acquired from the 
parasternal and apical views and digitally stored in cine-loop format. Analyses were performed 
off-line using EchoPac version 108.1.5 (General Electric Medical Systems). TAPSE was evaluated 
by applying the anatomic M-mode to the free wall of the RV at the tricuspid annulus. Pulmonary 
regurgitation was evaluated on parasternal short axis images with color Doppler and continuous-
wave Doppler echocardiography.(18) The maximum pressure gradient over the pulmonary valve 
was assessed with pulsed-wave Doppler on parasternal short axis images. Finally, pulmonary valve 
closure was defined on trans-pulmonary valve pulsed-wave Doppler flow recordings and was used 
as time reference to assess RV deformation parameters. 
Two-dimensional speckle tracking
Global longitudinal RV systolic strain and the temporal sequence of RV deformation were 
evaluated with speckle tracking analysis at the 4-chamber view (Figure 1, panel A and B) and at 
a dedicated apical RV view, depicting both inlet and outlet components of the RV, as previously 
described (Figure 1, panel C).(4) Frame rates ranged from 40 to 100 frames/s. During analysis, the 
endocardial border was manually traced at end-systole and the region of interest width adjusted 
to include the entire myocardium. The software then automatically tracks and accepts segments of 
good tracking quality and rejects poorly tracked segments, while allowing the observer to manually 
override its decisions based on visual assessments of tracking quality. The automated algorithm 
subsequently tracks the myocardium of interest frame by frame providing time-strain curves. Peak 
systolic global longitudinal strain of the RV was measured from the time-strain curves obtained 
at the apical 4-chamber view, (Figure 1, panel B) as described reviously.(13,19) At the dedicated 
RV view, regional longitudinal time-strain curves of the inlet and outlet of the RV were obtained 
(Figure 1, panel C and D). From these curves, peak longitudinal strain of the RV outlet was obtained. 
In addition, the temporal sequence of RV deformation of the inlet and outlet of the RV was derived 
from the time-strain curves by measuring the following parameters: time from QRS onset to peak 
systolic regional strain at the RV inlet (Ts-inlet) and time from QRS onset to peak systolic regional 
strain of the RV outlet (Ts-outlet). Finally, the time difference between Ts-inlet and Ts-outlet (RV 
time delay) was calculated (Figure 1, panel D). 
Intra- and inter-observer agreement of the measurements in the dedicated apical RV view 
was assessed in a blinded manner in 15 randomly chosen subjects. Ts-inlet, Ts-outlet and peak 
longitudinal strain at the RV outlet were re-measured by the same and by an independent observer.
 
Statistical analysis
Continuous variables are expressed as mean values ± standard deviation (SD) and were compared 
with the Mann-Whitney U-test. Categorical data are expressed as numbers and frequencies and 
were compared with the Fisher’s exact test. QRS duration, RV dimensions (as assessed with CMR) 
and RV performance (as assessed with echocardiography) were related to the RV time delay by 
using linear regression analysis. Intra-observer and inter-observer agreement of Ts-inlet, Ts-
outlet and peak longitudinal strain at the RV outlet was assessed using the intra-class correlation 
coefficient (ICC) for absolute agreement. All data were analyzed using software of SPSS version 
16.0. Statistical significance was set at a p-value <0.05. 
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Table 2. Temporal sequence of time to peak strain at RV inlet and RV outlet
Abbreviations: RV time delay: difference between Ts-inlet and Ts-outlet. RV: right ventricle, Ts-inlet: time from 
onset of QRS to peak systolic strain at the RV inlet, Ts-outlet: time from onset of QRS to peak systolic strain at 
the RV outlet.
 Patients Controls p-value
RV inlet
          Ts-inlet (ms) 406 ± 55 405 ± 67 0.429
RV outlet        
          Ts-outlet (ms) 339 ± 75 262 ± 85 0.003
RV inlet – RV outlet        
           RV time delay (ms) 66 ± 48 143 ± 53 <0.001
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RESULTS
Study population
The baseline characteristics of patients and controls are shown in Table 1. All patients were in New 
York Heart Association functional class I. Patients and controls did not differ in age, gender or body 
surface area. The QRS duration in cToF patients was signifi cantly increased (134±19 ms vs. 93±8 ms, 
p<0.001). In all patients the acoustic window was satisfactory to provide suffi cient quality for all images. 
RV performance: CMR, conventional two-dimensional echocardiography and speckle tracking 
analysis
Table 1 outlines the RV dimensions and functional parameters as assessed with CMR and 
echocardiography. RV end-diastolic volume and RV end-systolic volume, as assessed with CMR, 
were signifi cantly enlarged in cToF patients. In addition, RV ejection fraction was signifi cantly 
reduced (50±5% vs. 53±4%, p=0.009). The mean TAPSE value, as assessed with echocardiography, 
was signifi cantly reduced in patients as compared to controls (16±3 mm vs. 22±3 mm, p<0.001). 
Peak longitudinal strain of the RV outlet was signifi cantly reduced in cToF patients (-16.4±5.4%, 
vs. -27.8±7.1%, p<0.001), with excellent intra- and inter-observer agreement (intra-observer ICC: 
0.99, p<0.001, inter-observer ICC 0.86, p<0.001). Finally, global longitudinal strain of the RV was 
signifi cantly impaired in cToF patients (-20.9±4.3% vs. -30.7±3.4%, p<0.001).
Temporal sequence of RV deformation
Analysis of the temporal sequence of myocardial deformation of the RV inlet and outlet and the 
RV time delay are shown in Table 2. In healthy controls and cToF patients, the peak strain of the RV 
outlet occurred earlier than the peak strain of the RV inlet. The time to peak systolic strain at the 
inlet was not signifi cantly different between patients and controls (Ts-inlet: 406±55 ms vs. 405±67 
ms, p=0.429). In contrast, time to peak systolic strain at the outlet was signifi cantly longer in cToF 
patients as compared to controls (Ts-outlet: 339±75 ms vs. 262±85 ms, p=0.003). Consequently, 
cToF patients showed a signifi cantly shorter RV time delay between the RV outlet and RV inlet 
than controls (RV time delay: 66±48 ms vs. 143±53 ms, p<0.001). Moreover, within patients, the RV 
time delay was signifi cantly shorter in the patients with a patch (transannular or RV outfl ow tract 
patch, n=26), as compared with those without (50±28 ms vs. 101±65 ms, p=0.029). Intra- and inter-
observer analysis of Ts-inlet and Ts-outlet yielded excellent agreements (Ts-inlet: intra-observer 
ICC 0.94, p<0.001, inter-observer ICC 0.95, p<0.001, Ts-outlet: intra-observer ICC 0.99, p<0.001, 
inter-observer ICC 0.95, p<0.001) 
Relationship between RV time delay, QRS duration and CMR- and echocardiography-derived pa-
rameters
The relationship between the electrical (duration of QRS complex) and the mechanical (RV time 
delay) activation of the RV was evaluated. A weak correlation between QRS duration and RV time 
delay was observed (r=-0.37, p=0.006). In addition, the relationship between the RV mechanical 
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Figure 1. Two-dimensional speckle tracking at the RV free wall and at RV inlet and RV outlet
Panel A: Example of two-dimensional speckle tracking of the right ventricular (RV) free wall in the 4-chamber 
view of a corrected Tetralogy of Fallot (cToF) patient. The endocardium of the RV free wall is manually traced at 
end-systole. A region of interest, divided in a basal (yellow), a mid-ventricular (blue) and an apical region (green) 
is automatically displayed. Panel B: The software tracks the concerning myocardium frame by frame throughout 
the cardiac cycle, producing regional time-strain curves. A global time-strain curve (dotted line) is automatically 
calculated from a weighted average of the three regions, from which peak global strain can be derived (red line). 
Panel C, left: Example of dedicated apical RV view of a cToF patient, depicting the RV inlet and the RV outlet. 
Right: Example of placement of a region of interest for two-dimensional speckle tracking at the dedicated RV 
view in a cToF patient. The endocardium of the RV is manually traced at end-systole. A region of interest is auto-
matically displayed. The automated tracking mechanism allows manual adjustment of width and position of the 
region of interest. Panel D: Example of time-strain curves of inlet and outlet of dedicated apical RV view in a cToF 
patient. Yellow curve; regional time-strain curve at the RV inlet. Red curve; regional time-strain curve at the RV 
outlet. Time to peak strain at the RV inlet (Ts-inlet), time to peak strain at the RV outlet (Ts-outlet) and RV time 
delay (difference between Ts-inlet and Ts-outlet, white arrows) can be derived. Abbreviations: Ao: Aorta, RA: 
Right atrium, RV: right ventricle, RVOT: right ventricular outfl ow tract.
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activation pattern and CMR-derived RV dimensions was assessed. Significant relations were 
observed between the RV time delay and RV end-diastolic volume (r=-0.45, p=0.001). Furthermore, 
the relation between RV time delay and degree of pulmonary regurgitation and stenosis, as 
assessed with echocardiography, was evaluated. Although RV longitudinal strain was related to 
degree of pulmonary stenosis (r=0.41, p=0.002), no significant relationship was noted between RV 
time delay and pulmonary stenosis (r=-0.23, p=0.099). In contrast, RV time delay was significantly 
related to degree of pulmonary regurgitation (r=-0.55, p <0.001). Finally, the relationship between 
RV time delay and RV performance, as assessed with TAPSE and two-dimensional speckle tracking, 
was evaluated. RV time delay was significantly related to TAPSE (r=0.53, p<0.001) (Figure 2, panel 
A). Moreover, a significant relation between RV time delay and global RV longitudinal strain was 
observed (r=-0.70, p<0.001) (Figure 2, panel B). 
DISCUSSION
The current study demonstrated the presence of a time delay in RV longitudinal myocardial 
deformation between the outlet and inlet components in healthy controls as well as in cToF patients. 
Two-dimensional speckle tracking analysis showed that longitudinal RV outlet deformation preceded 
RV inlet deformation in healthy controls, and this sequence was also observed in the RV of cToF 
patients. However, in cToF patients, the RV outlet was activated significantly later than in healthy 
controls, reducing the time delay between the inlet and outlet components of the RV. This abnormal 
temporal activation of the RV was related to a significant deterioration of RV performance. 
Temporal sequence of RV deformation in healthy subjects
The data of the present study show that longitudinal RV outlet deformation occurs prior to RV inlet 
deformation, which seems to conflict with the theory of a peristalsis-like contraction pattern of the 
RV segments. This peristalsis theory, postulating that the RV body contracts prior to the RV outflow 
tract, was originally derived from experimental animal data, using sonomicrometry to assess 
RV motion.(20-22) Data from these experiments do not uniformly point towards a peristalsis-
like pattern of RV contraction. Importantly, two directions of movement of the RV outflow tract 
have been explored: transversal and longitudinal. In individuals with a structurally normal right 
ventricle, a peristalsis-like pattern of RV contraction was observed in the transversal direction with 
contraction of the RV body followed by contraction of the RV outflow tract.(21,22) However, in the 
longitudinal direction, the peristalsis-like pattern was not observed.(21,22) These findings were 
recently confirmed by Matsui and co-workers.(7) The authors assessed longitudinal shortening 
at the RV free wall and at the RV outflow tract with two-dimensional tissue tracking in healthy 
volunteers. Time to peak longitudinal strain at the RV outflow tract occurred prior to that of the 
RV free wall. In addition, changes in the transverse diameter of the RV outflow tract were tracked 
in time. Measuring in this direction, a peristalsis-like sequence of RV activation was observed: the 
time to minimal diameter of the RV outflow tract was delayed as compared with the RV free wall. 
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Figure 2. Relation between RV time delay and RV performance
Scatter plots representing correlations between RV performance and RV time delay. Panel A: Correlation 
between RV time delay and TAPSE. Panel B: Correlation RV time delay and RV global strain. Abbreviations: RV: 
right ventricle, TAPSE: tricuspid annulus peak systolic excursion.
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In addition, Uebing et al. provided further evidence on the longitudinal activation sequence of the 
RV in a subgroup of healthy volunteers.(4)  Using tissue Doppler imaging, time to peak longitudinal 
velocity of the RV free wall and RV outflow tract were measured. This study showed that peak 
systolic longitudinal velocity of the RV outflow tract occurs prior to that of the RV free wall. In 
contrast, the study by Geva et al. assessed RV segmental volumes with echocardiography and MRI 
in healthy subjects and evaluated the activation sequence in the transverse direction.(8) In this 
direction, again, a peristalsis-like pattern of RV contraction was observed. 
Based on this evidence and the data of the current study, a hypothetical model of the sequence 
of normal segmental RV contraction can be postulated, with early longitudinal and late transverse 
movement of the RV outflow tract. Nevertheless, additional studies to confirm this model of RV 
sequential contraction are warranted. 
Delayed activation of RV outlet deformation in cToF patients
The RV outlet is involved in the surgical repair of tetralogy of Fallot to relieve pulmonary stenosis, 
by either infundibulectomy or RV outflow tract patch placement. The present study demonstrated 
that, similar to healthy patients, longitudinal RV outlet deformation in cToF patients occurs prior to 
RV inlet deformation. However, RV outlet deformation was significantly delayed in cToF patients, 
causing a reduced RV time delay. The longitudinal deformation of the RV outlet was even more 
delayed in patients that had undergone RV outflow tract or transannular patch placement. This 
effect after surgical repair in cToF patients confirms the findings of Uebing and colleagues.(4) In 
their study, the RV time delay observed in healthy subjects was reduced in cToF patients, which was 
mainly caused by a delayed longitudinal RV outlet motion. The presence of RV outflow tract damage 
due to a surgical patch or scar tissue presumably causes delayed RV outlet contraction. This finding 
confirms the importance of current surgical strategies, with an aim to preserve RV outflow tract 
integrity whenever possible. 
Relationship between electrical and mechanical RV delay and RV performance
In the current study, the observed delay between RV inlet and RV outlet deformation was only 
weakly related with QRS duration. QRS prolongation reflects temporal differences in electrical 
activation within the myocardium, and is currently used as a marker for dyssynchrony in trials 
on cardiac resynchronization therapy (CRT) for left ventricular (LV) failure.(23,24) However, 
the relationship between QRS prolongation and intra-ventricular mechanical delay is not 
straightforward.(25) Moreover, the current study demonstrated the presence of an average 
mechanical delay of 140 ms within the RV of healthy subjects with a narrow QRS duration. Future 
studies are needed to further characterize the deformation pattern of the RV inlet and outlet in 
various age groups and etiologies. 
The RV time delay was closely related with RV end-diastolic volume as assessed with CMR, 
as well as with degree of pulmonary regurgitation, indicating a relation between the observed 
mechanical abnormities and chronic volume overload. In addition, the RV mechanical time delay 
was significantly related with RV performance, as assessed with two-dimensional speckle 
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tracking and TAPSE. According to our data, disappearance of the RV time delay is associated 
with a deterioration of RV performance. Furthermore, the presence of a mechanical delay 
in the structurally normal RV has important clinical implications for future treatment of RV 
dysfunction, in particular with CRT. Importantly, the concept is in contrast with reported data 
on LV performance, where LV dyssynchronous contraction leads to LV systolic dysfunction. In 
case of LV failure, CRT improves LV function by restoring synchronous LV contraction pattern.
(26) However, based on the results of the present study, showing a mechanical time delay 
in longitudinal deformation of the healthy RV, these assumptions may not hold for RV motion 
patterns. The effects of CRT have been evaluated in patients with cToF and RV dysfunction.(27-
30) However, a better understanding of the RV mechanical activation patterns and the presence 
of a physiological RV time delay between longitudinal deformation of the RV inlet and outlet may 
be essential to maximize the benefits of CRT. 
Study limitations
Two-dimensional speckle tracking analysis is dependent on image quality and frame rate. In the 
present study, two-dimensional gray scale images were optimized to obtain the highest image 
quality at the highest frame rate possible to allow reliable analysis. In addition, assessment of 
exercise capacity was not performed in the current study. Additional studies investigating the 
relationship between the observed RV time delay and exercise capacity are warranted.
Conclusion
The presence of a mechanical time delay between the outlet and inlet components of the RV 
may be an important determinant of preserved RV function. Longitudinal deformation of the RV 
outlet precedes longitudinal deformation of the RV inlet in individuals with structurally normal 
right ventricles. In cToF patients, this mechanical sequence is also observed, however, RV outlet 
deformation is significantly delayed causing a reduction of RV time delay which is subsequently 
related to impairment in RV performance. 
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ABSTRACT
Background: In patients with corrected tetralogy of Fallot (cToF), left ventricular (LV) dysfunction 
is closely related to right ventricular (RV) dysfunction, indicating adverse ventricular-ventricular 
interactions. However, the mechanism that links RV dysfunction to LV dysfunction remains unclear.
 
Methods: In this prospective study, 32 cToF patients and 19 controls were enrolled. With cardiac 
magnetic resonance imaging (CMR), biventricular ejection fractions were assessed. Using two-
dimensional speckle tracking, global and regional RV and LV strain and LV twist were assessed. 
To detect and characterize ventricular-ventricular interaction, the relation between global and 
regional RV mechanics and global and regional LV mechanics was assessed. 
Results: Global RV strain, global LV strain and LV twist were decreased in cToF patients. Global RV 
strain correlated with global LV strain (r = 0.66, p < 0.001) and LV twist (r = -0.72, p < 0.001) indicating 
the presence of adverse ventricular-ventricular interaction. Furthermore, close relations were 
observed between apical RV strain and apical LV strain (r = 0.62, p < 0.001) and apical LV rotation 
(r = -0.67, p < 0.001). 
Conclusions: RV strain was significantly related to LV strain and LV twist in cToF patients and 
controls. Furthermore, apical RV strain correlated with apical LV strain and apical LV rotation, 
indicating adverse apical ventricular-ventricular interactions.
2.4
Relation of left ventricular twist and global strain 
with right ventricular dysfunction in patients after 
correction of tetralogy of Fallot
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INTRODUCTION
Current surgical techniques have improved the clinical outcome of patients with tetralogy of 
Fallot.(1) However, after the third postoperative decade, the risk of death increases dramatically.
(2) Recent studies have demonstrated that reduced left ventricular (LV) ejection fraction and 
right ventricular (RV) ejection fraction and older age at correction of tetralogy of Fallot (cToF) 
are strong independent determinants of poor clinical outcome in cToF patients.(3,4) In addition, 
several studies have demonstrated a close relationship between RV and LV ejection fraction in cToF 
patients(3,5) indicating the potential pathophysiologic role of ventricular-ventricular interactions 
that lead to clinical deterioration late after cToF. However, these ventricular-ventricular 
interactions have not been completely elucidated and, more importantly, the mechanism that links 
RV dysfunction to impairment of LV function remains unclear. Two-dimensional speckle tracking 
echocardiography has enabled assessment of multidirectional myocardial mechanics, providing 
information on complex RV and LV motion patterns. This imaging modality has demonstrated to be 
useful to detect subclinical cardiac dysfunction in several clinical conditions.(6,7) In the present 
study, two-dimensional speckle tracking echocardiography and cardiac magnetic resonance (CMR) 
were used to comprehensively characterize global and regional RV and LV performance in cToF 
patients and in healthy subjects. In addition, global and regional RV mechanics were related to 
global and regional LV mechanics to detect and characterize ventricular-ventricular interaction. 
METHODS
Thirty-two consecutive cToF patients undergoing clinical CMR evaluation between July 2008 and 
July 2009 (age range 8-18 years) were prospectively recruited from an ongoing registry (Center 
for Congenital Heart Disease Amsterdam-Leiden). Exclusion criteria were previous pulmonary 
valve replacement and any contraindications for CMR, such as claustrophobia, cardiac devices 
or arrhythmia.  In addition, 19 healthy subjects, matched by age and body surface area, without 
structural heart disease underwent echocardiography and CMR evaluation within the same time 
frame. Individuals with history of cardiomyopathy, valvular heart disease or arrhythmic disorders 
were excluded.  CMR and transthoracic echocardiography were performed to study LV and RV 
performance and to assess ventricular-ventricular interactions. RV ejection fraction (EF), RV end-
diastolic and end-systolic volume, LVEF and LV end-diastolic and end-systolic volume were assessed 
with CMR. RV and LV longitudinal strain and LV twist were evaluated with two-dimensional speckle 
tracking. Ventricular-ventricular interaction was studied by assessing the relationships between 
RV and LV strain and LV rotation. The study protocol was approved by the institutional review board 
and all subjects gave written, informed consent.
CMR was performed on a 1.5-Tesla pulsar gradient system (Intera, release 11; Philips Medical 
Systems, Best, the Netherlands) with 33 mT/m amplitude, 100 mT/m/ms slew rate, and 0.33 ms rise 
time. A five-element cardiac coil was used for signal reception. After acquiring a series of localizing 
thoracic scout images, multi-section transversal(8) cine imaging was performed. A stack of slices 
was planned in the transversal plane, covering both ventricles throughout the cardiac cycle. Images 
were acquired with a steady-state free precession sequence during breath hold at end-expiration 
with the settings: repetition time 3.9 ms, echo time 1.5 ms, flip angle 50°, slice thickness 8 mm, 
matrix 160 x 256, field-of-view 350 mm and temporal resolution 25 ms. 
Images were analyzed using the MASS (Medis, Leiden, The Netherlands) software package.(9) LV 
and RV volumes were calculated by manually tracing the endocardial borders at end-systole and 
end-diastole in all slices and multiplying the area with slice thickness. Subsequently, LV and RV 
ejection fractions were automatically calculated by MASS. LV and RV volumes were indexed for 
body surface area.
All subjects were imaged in the left lateral decubitus position with a commercially available system 
(Vingmed Vivid 7, General Electrics Medical Systems, Milwaukee, Wisconsin, USA) equipped with 
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Table 1. Patient and control characteristics
Abbreviations: AP: arteria pulmonalis; BSA: body surface area, BMI: body mass index, CMR: cardiac magnetic 
resonance, LV-EDV: left ventricular end-diastolic volume, LVEF: left ventricular ejection fraction, LV-ESV: left 
ventricular end-diastolic volume, NA: not applicable, RV-EDV: right ventricular end-systolic volume, RV-ESV: right 
ventricular end-systolic volume, RVEF: right ventricular ejection fraction; RVOT: right ventricular outflow tract.
between RV time delay and TAPSE. 
 Variable Patients (n=32)    Controls (n=19)                     p-value
Age (years) 13.2 ± 2.9 14.1± 2.4 0.228
Male/female 19/13 12/7 0.693
Age at surgery (years) 0.9 ± 0.6 ..
Type of surgery 
    Infundibulectomy 5 (15% ..
    RVOT patch 4 (13%) ..
    Transannular patch 20 (63%) ..
    AP patch 3 (9%) ..
QRS (ms) 134 ± 19 94 ± 8 <0.001
BSA (m²) 1.4 ± 0.3 1.6 ± 0.3 0.113
BMI (kg/m²) 18.5 ± 4 19.4 ± 3 0.368
Pulmonary regurgitation 
    Mild 8 (25%) ..
    Moderate 13 (41%) ..
    Severe 11 (34%) ..
CMR parameters
RV-EDV (ml/m²) 131± 30 98 ± 13 <0.001
RV-ESV (ml/m²) 110 ± 66 59 ± 46 <0.001
RVEF (%) 50 ± 5 53 ± 4 0.016
LV-EDV (ml/m²) 88 ± 20 95 ± 10 0.196
LV-ESV (ml/m²) 40 ± 13 42 ± 7 0.266
LVEF (%) 56 ± 5 56 ± 3 0.724
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a 3.5 MHz transducer. Standard two-dimensional images, Doppler and color Doppler data were 
acquired from the parasternal and apical views and digitally stored in cine-loop format. Analyses 
were performed off-line using EchoPac version 108.1.5 (General Electric Medical Systems). 
For speckle tracking analysis, standard two-dimensional gray-scale images with a frame rate 
≥40 frames/s were used. Three cardiac cycles were obtained and stored in cine-loop format for 
offline analysis. All echocardiographic measurements were averaged from three cardiac cycles. 
The presence of pulmonary regurgitation was systematically evaluated with continuous-wave 
Doppler echocardiography, by measuring duration of pulmonary regurgitation, and color Doppler 
echocardiography, by measuring width of regurgitant jet, as previously described by Li et al.(10) 
Global longitudinal RV strain was assessed with two-dimensional speckle tracking analysis in 
the apical 4-chamber view, measuring the longitudinal peak systolic strain of the RV free wall, as 
described previously (Figure 1A).(11) The weighted average of the 3 regional values of the RV free 
wall (basal, mid and apical segments) provided the value of global longitudinal RV strain. Regional 
longitudinal peak systolic strain of the RV was assessed at the basal, mid and apical components 
of the RV free wall. Intra- and inter-observer reproducibility for RV strain measurement have 
been previously reported showing small bias and no significant trend (-0.2 ± 3.6% and 0.6 ± 3.8%, 
respectively).(12)
Global longitudinal LV strain was measured at the apical long axis, 2- and 4-chamber views using 
automated function imaging, a novel two-dimensional speckle tracking algorithm.(13,14) The end-
systolic frame is defined in the apical long-axis view. Closure of the aortic valve is marked and the 
software measures the time interval between the R-wave and aortic valve closure. This interval is 
used as a reference for the apical 2- and 4-chamber views. After defining the mitral annulus and 
the LV apex with three index points at the end-systolic frame in each apical view, the automated 
algorithm places the region of interest including the entire myocardial wall. The tracking algorithm 
follows the endocardium from this single frame throughout the cardiac cycle and allows for 
manual adjustment of the region of interest. The LV is divided into 6 segments in each view and the 
tracking quality is manually validated for each segment. The algorithm displays regional and global 
longitudinal LV peak strain in a 17-segment model “bull’s eye” plot, with the average values of peak 
longitudinal strain for each view and the averaged global peak longitudinal strain for the entire 
LV (Figure 1B). Regional longitudinal LV strain was evaluated at the basal, mid and apical level by 
calculating the average strain values of the basal, mid and apical segments of the apical long axis, 
2- and 4-chamber views. Intra- and inter-observer reproducibility for automated function imaging 
measurements have been previously reported with small bias and no significant trend (-0.3 ± 0.6% 
and -0.2 ± 2.6%, respectively).(13) 
LV rotation was measured at the apical and basal level in the parasternal short-axis view using two-
dimensional speckle tracking. The basal plane was identified by the presence of the mitral valve. 
The apical plane was defined as the smallest cavity during systole below the papillary muscles. Off-
line, the endocardial border was traced at an end-systolic frame and the region of interest was 
placed to fit the entire myocardium. Subsequently, LV rotation of both apical and basal planes was 
automatically calculated. Counterclockwise rotation provided a positive value, whereas clockwise 
rotation provided a negative value, as viewed from the apex. LV twist was defined as the maximal 
net difference in rotation between the LV apex and base at isochronal time points (Figure 1C).(15) 
Statistical analysis
Continuous variables are expressed as means ± standard deviations. Comparisons between patients 
and controls were analyzed using a Mann-Whitney U-test. Categorical variables are presented as 
numbers and percentages and were compared with Fisher’s exact test. The relations between LVEF, 
RVEF and global LV and RV strain, and between RV end-diastolic volume, RV end systolic volume 
and global RV strain were evaluated with linear regression. Differences in RV apical strain between 
controls and subgroups of cToF patients with mild, moderate and severe pulmonary regurgitation 
were assessed with the Kruskal-Wallis test. Furthermore, linear regression analysis was used to 
assess the relationship between global RV strain and global LV strain and LV twist. In addition, 
regional ventricular-ventricular interaction was studied, by evaluating the relation between RV 
strain and LV strain and rotation at the basal and apical level with linear regression. To analyze 
whether surgical technique could determine RV and LV strain or LV rotational mechanics, univariate 
regression analysis was performed. A p-value of <0.05 was considered statistically significant. 
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Table 2. Global and regional right ventricular and left ventricular longitudinal peak systolic 
Abbreviations: 2D: two-dimensional, LPSS:  longitudinal peak systolic LV: left ventricle, RV: right ventricle.
Patients (n=32) Controls (n=19) p-value
2D speckle tracking parameters
Global RV LPSS (%) -20.5 ± 4.2 -30.7 ± 3.3 <0.001
Regional RV LPSS (%)
    basal -21.9 ± 6.2 -28.0 ± 5.5  0.001
    mid -23.8 ± 3.7 -30.4 ± 4.2 <0.001
    apical -20.7 ± 6.9 -32.6 ± 4.7 <0.001
Global LV LPSS (%) -17.2 ± 1.3 -20.4 ± 1.3 <0.001
Regional LV LPSS (%)
    basal -18.6 ± 2.5 -19.2 ± 2.4  0.519
    mid -18.1 ± 2.1 -19.7 ± 2.7  0.014
    apical -15.9 ± 2.8 -22.1 ± 3.4 <0.001
LV twist (o) 8.8 ± 3.3 14.8 ± 3.2 <0.001
    apical rotation (o) 5.6 ± 2.4 10.0 ± 2.0 <0.001
    basal rotation (o) -4.1 ± 2.0 -5.3 ± 2.3  0.073
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Figure 2. Global and regional left ventricular longitudinal strain and left ventricular twist
Panel A: Bar-graph presenting the global left ventricular longitudinal strain and regional left ventricular longitudi-
nal strain at the basal, mid and apical levels in corrected tetralogy of Fallot patients and controls. A significantly 
decreased global strain is observed in the patients, mainly caused by a significantly reduced strain at the apical 
and mid level of the left ventricle.*p < 0.0001 vs. controls; †p = 0.014 vs. controls. Panel B: Bar-graph presenting 
left ventricular basal and apical rotation and left ventricular twist in corrected tetralogy of Fallot patients and 
controls. Rotation at the basal level is clockwise and expressed as a negative value, whereas apical rotation is 
counterclockwise and expressed as a positive value. In the patients, left ventricular twist is significantly reduced, 
mainly because of a significantly decreased rotation at the apical level. * p < 0.0001 vs. controls. 
Abbreviations: cToF: corrected tetralogy of Fallot, LV: left ventricle.
Figure 1. Two-dimensional speckle tracking echocardiography for right ventricular longitudinal 
strain, left ventricular longitudinal strain and left ventricular twist analysis
Panel A. Example of two-dimensional speckle tracking of right ventricular longitudinal strain in a corrected 
tetralogy of Fallot patient. Global and segmental strain curves are automatically calculated providing global 
and regional peak systolic longitudinal strain. Global right ventricular strain: white dotted curve, apical right 
ventricular strain: green curve, mid right ventricular strain: blue curve, basal right ventricular strain: yellow curve. 
Panel B. Example of “bull’s eye” plot of left ventricular longitudinal strain of a corrected tetralogy of Fallot 
patient. Longitudinal strain is most reduced at the apical level. 
Panel C. Example of apical and basal rotation and left ventricular twist of a corrected tetralogy of Fallot 
patient. Left ventricular twist is reduced, mainly due to reduced apical rotation. Basal rotation: purple curve, 
apical rotation: blue curve, left ventricular twist: white curve. Abbreviations: A2C: apical 2-chamber view, A4C: 
apical 4-chamber view, AFI: automated functional imaging, AVC_AUTO: aortic valve closure detected automa-
tically, AVC_MEAS: aortic valve closure detected manually, Avg: average peak strain of the LV, cToF: corrected 
tetralogy of Fallot, GLPS: global longitudinal peak strain, LAX: apical long axis view, LV: left ventricle HR_ApLAX: 
heart rate during acquisition of the apical long axis view, RV: right ventricle.
A
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RESULTS
Characteristics of cToF patients and healthy subjects are displayed in Table 1. All patients were 
in New York Heart Association functional class I. Baseline characteristics were not significantly 
different between cToF patients and healthy controls with the exception of QRS duration (patients: 
134 ± 19 ms vs. controls: 94 ± 8 ms, p < 0.001). RV end-diastolic volume and RV end-systolic volume 
were larger in cToF patients and RVEF was significantly reduced. LV dimensions and LVEF did not 
differ in cToF patients as compared to controls.
The assessment of RV function with two-dimensional speckle tracking demonstrated significantly 
reduced global longitudinal RV strain in cToF patients (-20.5 ± 4.2% vs. -30.7 ± 3.3%, p < 0.001) as 
compared to controls (Table 2). When assessing regional longitudinal RV strain, cToF patients had 
significantly reduced strain in all segments of the RV free wall (basal, mid and apical) (Table 2). In 
addition, RV apical longitudinal strain was significantly different in controls and in cToF patients 
with mild, moderate and severe pulmonary regurgitation (-32.6 ± 4.7 %, -20.2 ± 9.6 %, -23.6 ± 6 % 
and -18.0 ± 5.3 %, respectively; p < 0.001).
Two-dimensional speckle tracking analysis demonstrated a significant impairment in global 
longitudinal LV strain in cToF patients (-17.2 ± 1.3% vs. -20.4 ± 1.3%, p < 0.001) (Table 2 and Figure 2A). 
Assessment of regional longitudinal LV strain revealed that in cToF patients strain was significantly 
reduced at the mid level (-18.1 ± 2.1 vs. -19.7 ± 2.7, p = 0.014) and apical level (-15.9 ± 2.8% vs. -19.8 
± 2.9, p < 0.001). In contrast, longitudinal LV strain at the basal level was not significantly different 
(Table 2, Figure 2A). 
The assessment of LV rotation and twist demonstrated a significantly reduced LV apical rotation in 
cToF patients as compared to controls (5.6 ± 2.4o vs. 10.0 ± 2.0o, p < 0.001) whereas no differences 
were observed in LV basal rotation (-4.1 ± 2.0o vs. -5.3 ± 2.3o, p = 0.073) (Table 2). This resulted in 
a significantly reduced LV twist in cToF patients (8.8 ± 3.3o vs. 14.8 ± 3.2o, p < 0.001) (Figure 2B). 
In addition, the influence of the surgical technique (the use of an RVOT patch or transannular patch) 
on RV and LV performance was evaluated by univariate regression analysis. Surgical technique 
did not determine RV or LV performance (RV global longitudinal strain: r = 0.14; p = 0.458, RV 
apical longitudinal strain: r = 0.26; p = 0.159, LV global longitudinal strain: r = 0.15; p = 0.425, LV 
apical longitudinal strain: r = 0.01; p = 0.959, LV twist: r = 0.16; p = 0.379, LV apical rotation: r = 0. 
21; p = 0.251). 
The assessment of global ventricular-ventricular interaction showed that LVEF and RVEF were 
closely related (r = 0.63, p<0.001). In addition, global longitudinal RV strain correlated significantly 
with global longitudinal LV strain (r = 0.66, p < 0.001) and with LV twist (r = -0.72, p < 0.001) (Figure 
3A). Evaluation of regional ventricular-ventricular interaction revealed that apical longitudinal RV 
strain was significantly correlated with apical longitudinal LV strain (r = 0.62, p < 0.001) and with 
apical LV rotation (r = -0.67, p < 0.001) (Figure 3B). In contrast, no significant correlations were found 
between the basal longitudinal RV strain and basal longitudinal LV strain (r = 0.13, p = 0.394) and 
basal LV rotation (r = 0.23, p = 0.116). 
DISCUSSION
The present study demonstrated that cToF patients in the first post-operative decades have a 
significantly reduced RVEF and preserved LVEF, as assessed with CMR. However, the evaluation 
of myocardial deformation with two-dimensional speckle tracking confirmed the RV dysfunction 
observed with CMR and revealed the presence of LV subclinical dysfunction, with impairment in 
global longitudinal LV strain and LV twist. In addition, regional analysis with two-dimensional speckle 
tracking revealed a homogeneous reduction of longitudinal RV strain in all segments, whereas the 
LV showed a significant impairment in longitudinal strain and rotational mechanics only at the mid 
and apical levels. More important, a close relationship was observed between global RV and LV 
mechanics, demonstrated with both CMR and two-dimensional speckle tracking. When assessing 
regional performance, this close relationship was most pronounced at the apical levels of the 
RV and LV. These findings indicate the presence of adverse ventricular-ventricular interactions 
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Figure 3. Ventricular-ventricular interactions
Scatter-plots presenting correlations between right ventricular global strain and left ventricular global strain nd 
left ventricular twist (Panel A). Panel B presents the correlation between right ventricular apical strain and left 
ventricular apical strain, and between right ventricular apical strain and left ventricular apical rotation. 
Abbreviations:  cToF: corrected tetralogy of Fallot: LV: left ventricle, RV: right ventricle. 
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and provide new insights into the pathophysiological mechanisms that link RV dysfunction to LV 
dysfunction.  Evaluation of global and regional RV performance in cToF patients may be challenging 
with two-dimensional echocardiography. Currently, CMR is the gold standard for evaluation of RV 
dimensions and ejection fraction.(16) In addition, recent CMR volumetric analyses of the different 
components of the RV (inlet, apical trabecular and outlet) have provided meaningful insight into the 
adaptive response of the RV to volume overload.(17) This adaptive response relied mostly on the 
RV apical trabecular component that accounted for the largest increase in volume.(17) In addition, a 
close relationship between the function of the apical trabecular component and global RV function 
(r2 = 0.69) was observed, whereas no relationship was found between the function of the RV inlet 
and outlet and global RV function.(17) This indicates that global RV performance strongly depends 
on the function of the RV apical component. With the use of two-dimensional speckle tracking, the 
present study confirmed and extended previous findings. Although a homogeneous reduction in 
strain at the three different RV levels was observed, only the deterioration of RV apical strain was 
related to impairment in LV mechanics, indicating an adverse ventricular-ventricular interaction 
at this level. The assessment of LV systolic dysfunction in cToF patients is crucial as it is the 
strongest determinant of poor clinical outcome in these patients.(3,4) LV systolic dysfunction is 
usually observed late after surgical correction and is related to RV dysfunction.(3) However, there 
is a paucity of data on the time course of LV dysfunction in cToF patients and whether this could 
be detected at an early age with more sensitive methods than LVEF.(18-20) The present study 
demonstrated that in cToF patients with preserved LVEF, a significantly impaired global longitudinal 
LV strain was observed. Therefore, subclinical LV systolic dysfunction is already present in the first 
post-operative decades. In addition, two-dimensional speckle tracking echocardiography enables 
assessment of LV torsional mechanics by evaluating LV apical and basal rotation. LV twist is a 
comprehensive index of LV performance and takes into account the complex helical disposition 
of the myofibers. At present, LV torsional mechanics in cToF patients have not been extensively 
studied. The present study provides new insights into this field. In cToF patients with preserved 
LVEF, LV twist was significantly reduced. This reduction was secondary to a significant reduction in 
LV apical rotation, whereas LV basal rotation was preserved. These results indicate that impairment 
in LV performance may start at the apical level. 
Finally, LV twist and LV apical rotation were closely related to global and apical RV strain, 
demonstrating the presence of adverse ventricular-ventricular interactions. As previously indicated, 
changes in the geometry of the RV apical trabecular component as a consequence of volume overload 
may induce alterations in the apical LV geometry that could lead to reduced apical LV performance. 
Sheehan et al. studied the geometric changes of the RV caused by chronic volume overload in cToF 
patients and observed that the RV cross-sectional area was only significantly enlarged at the apical 
level.(21) This apical RV dilatation may lead to distortion of the apical LV geometry and altered fiber 
orientation at the apex of the heart. Consequently, regional strain and rotation at the LV apex may 
decrease at an earlier stage than the LV basal segments. In addition, at a late stage of the disease, 
changes in myofiber orientation of the interventricular septum may further decrease RV and LV 
performance, especially in patients with increased pulmonary vascular resistance.(22)
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The relatively small sample size of the study may constitute a limitation. Furthermore, objective 
assessment of exercise capacity was not performed. Finally, RV myocardial fibrosis and its potential 
influence on RV performance were not evaluated. Additional studies relating the location and extent 
of RV fibrosis to RV performance as assessed with myocardial deformation imaging are warranted. 
The findings of the current study have important clinical implications. In cToF patients with 
significant pulmonary regurgitation, an early detection of RV and LV dysfunction by means of 
myocardial strain and LV torsional mechanics may indicate the need of pulmonary valve replacement 
in order to reverse RV and LV dysfunction and to improve late clinical outcome. Additional studies 
investigating the prognostic value of these RV and LV mechanical parameters are warranted.
Proefschrift2708.indd   78-79 27-08-11   13:06
80 81
REFERENCE LIST
1  Bacha EA, Scheule AM, Zurakowski D, et al. Long-term results after early primary repair of tetralogy of 
Fallot. J Thorac Cardiovasc Surg 2001;122:154-61.
2   Nollert G, Fischlein T, Bouterwek S, et al. Long-term survival in patients with repair of tetralogy of 
Fallot: 36-year follow-up of 490 survivors of the first year after surgical repair. J Am Coll Cardiol 
1997;30:1374-83.
3   Geva T, Sandweiss BM, Gauvreau K, et al. Factors associated with impaired clinical status in long-term 
survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 
2004;43:1068-74.
4  Ghai A, Silversides C, Harris L, et al. Left ventricular dysfunction is a risk factor for sudden cardiac death 
in adults late after repair of tetralogy of Fallot. J Am Coll Cardiol 2002;40:1675-80.
5   Tzemos N, Harris L, Carasso S, et al. Adverse left ventricular mechanics in adults with repaired tetralogy 
of Fallot. Am J Cardiol 2009;103:420-5.
6   Delgado V, Tops LF, van Bommel RJ, et al. Strain analysis in patients with severe aortic stenosis and pre-
served left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J 2009.
7   Hare JL, Brown JK, Marwick TH. Association of myocardial strain with left ventricular geometry and 
progression of hypertensive heart disease. Am J Cardiol 2008;102:87-91.
8   Fratz S, Schuhbaeck A, Buchner C, et al. Comparison of accuracy of axial slices versus short-axis slices 
for measuring ventricular volumes by cardiac magnetic resonance in patients with corrected tetralogy 
of fallot. Am J Cardiol 2009;103:1764-9.
9   van der Geest RJ, Buller VG, Jansen E, et al. Comparison between manual and semiautomated anal-
ysis of left ventricular volume parameters from short-axis MR images. J Comput Assist Tomogr 
1997;21:756-65.
10   Li W, Davlouros PA, Kilner PJ, et al. Doppler-echocardiographic assessment of pulmonary regurgitation 
in adults with repaired tetralogy of Fallot: comparison with cardiovascular magnetic resonance imaging. 
Am Heart J 2004;147:165-72.
11   Knirsch W, Dodge-Khatami A, Kadner A, et al. Assessment of myocardial function in pediatric patients 
with operated tetralogy of Fallot: preliminary results with 2D strain echocardiography. Pediatr Cardiol 
2008;29:718-25.
12   van RJ, Mollema SA, Delgado V, et al. Relation of immediate decrease in ventricular septal strain after 
alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ven-
tricular outflow tract pressure gradient. Am J Cardiol 2009;103:1592-7.
13   Delgado V, Mollema SA, Ypenburg C, et al. Relation between global left ventricular longitudinal strain 
assessed with novel automated function imaging and biplane left ventricular ejection fraction in 
patients with coronary artery disease. J Am Soc Echocardiogr 2008;21:1244-50.
14   Reisner SA, Lysyansky P, Agmon Y, et al. Global longitudinal strain: a novel index of left ventricular 
systolic function. J Am Soc Echocardiogr 2004;17:630-3.
15   Bertini M, Nucifora G, Marsan NA, et al. Left ventricular rotational mechanics in acute myocardial infarc-
tion and in chronic (ischemic and nonischemic) heart failure patients. Am J Cardiol 2009;103:1506-12.
16   Lai WW, Gauvreau K, Rivera ES, et al. Accuracy of guideline recommendations for two-dimensional quan-
tification of the right ventricle by echocardiography. Int J Cardiovasc Imaging 2008;24:691-8.
17   Bodhey NK, Beerbaum P, Sarikouch S, et al. Functional analysis of the components of the right ventricle 
in the setting of tetralogy of Fallot. Circ Cardiovasc Imaging 2008;1:141-7.
18   Abd El Rahman MY, Abdul-Khaliq H, Vogel M, et al. Relation between right ventricular enlargement, QRS 
duration, and right ventricular function in patients with tetralogy of Fallot and pulmonary regurgitation 
after surgical repair. Heart 2000;84:416-20.
19   Schamberger MS, Hurwitz RA. Course of right and left ventricular function in patients with pulmonary 
insufficiency after repair of Tetralogy of Fallot. Pediatr Cardiol 2000;21:244-8.
20   Weidemann F, Eyskens B, Mertens L, et al. Quantification of regional right and left ventricular func-
tion by ultrasonic strain rate and strain indexes after surgical repair of tetralogy of Fallot. Am J Cardiol 
2002;90:133-8.
21   Sheehan FH, Ge S, Vick GW, III, et al. Three-dimensional shape analysis of right ventricular remodeling in 
repaired tetralogy of Fallot. Am J Cardiol 2008;101:107-13.
22   Buckberg GD. The ventricular septum: the lion of right ventricular function, and its impact on right 
ventricular restoration. Eur J Cardiothorac Surg 2006;29 Suppl 1:S272-S278
Right ventricular imaging: echocardiography2 2.4
Proefschrift2708.indd   80-81 27-08-11   13:06
82 83
ABSTRACT
Background: Accurate assessment of right ventricular (RV) function and dimensions has important 
prognostic implications in patients with repaired tetralogy of Fallot (ToF). 3-dimensional imaging is 
the preferred methodology to evaluate RV function. Novel post-processing software applications 
to evaluate 3-dimensional data have provided insight into RV function and dimensions by analyzing 
the various RV components (inlet, apical trabecular, outlet). The present study aimed to characterize 
regional RV function and dimensions with real-time 3-dimensional echocardiography (RT3DE) in 
repaired ToF patients. 
Methods: Forty-one repaired ToF patients (age range 8-18 years) and 20 control subjects were 
enrolled. Global and segmental RV volumes and ejection fraction (EF) were assessed with RT3DE 
and compared between repaired ToF patients and controls.
Results: RT3DE segmental analysis demonstrated that the apical trabecular region was the most 
remodeled RV component in repaired ToF patients, with significantly increased end-diastolic 
volume and end-systolic volume as compared to controls (59 ± 19 ml vs. 41 ± 16 and 36 ± 13 ml vs. 
24 ± 8 ml, respectively; p=0.001 for both). However, EF was preserved at that region. In contrast, 
EF was reduced at the RV inlet and outlet: (inlet: 53 ± 6% vs. 58 ± 7%, p=0.003, outlet: 44 ± 16% vs. 
52 ± 10, p=0.032).
Conclusions: Repaired ToF patients show characteristic RV remodeling as assessed with RT3DE. 
At the apical trabecular part the largest volumes were observed as compared with control patients, 
whereas EF at the inlet and outlet components was significantly impaired. RT3DE may facilitate 
future studies on segmental RV volumes and function in repaired ToF patients.
2.5
Real-time three-dimensional echocardiography: 
segmental analysis of the right ventricle in patients 
with tetralogy of Fallot
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INTRODUCTION
Right ventricular (RV) dilatation and subsequent RV failure in patients with repaired tetralogy of 
Fallot (ToF) are associated with poor clinical outcome.1 The clinical management of these patients 
is highly determined by RV dimensions and function.1-3 Evaluation of RV volumes using conventional 
2-dimensional echocardiography is hampered by the complex geometry of the RV.4 Recently, 
real-time 3-dimensional echocardiography (RT3DE) has overcome some of the limitations of 
2-dimensional echocardiography to assess RV volumes and function.5-9 The feasibility and accuracy 
of RT3DE for RV volume assessment have been demonstrated in several studies including repaired 
ToF patients.5-9 
From an embryological and anatomical perspective, the RV can be divided into three sections; the 
inlet, the apical trabecular part, and the outlet.10, 11 Recent studies in repaired ToF patients using 
magnetic resonance imaging have shown that the three different components of the RV show a 
different volumetric and functional response to volume overload.12, 13 The performance of RT3DE to 
assess the various RV components has not been evaluated so far. Accordingly, the objective of the 
current study was to evaluate the feasibility of a novel semi-automated software algorithm based 
on RT3DE to assess the dimensions and function of the various components of the RV. Furthermore, 
the contribution of the various RV components to the global RV volume and function was evaluated 
in repaired ToF patients and compared with a group of control subjects. 
METHODS
Study population and protocol
A total of 41 consecutive repaired ToF patients (mean age 13.1 ± 2.8 years, 56% male) and 20 
healthy controls, matched for age, gender and body surface area, were prospectively enrolled 
in the present study. All patients and controls were evaluated with standard two-dimensional 
echocardiography and RT3DE. Particularly, global and segmental RV volumes and ejection fraction 
were assessed with RT3DE. Using dedicated software, RT3DE RV data were segmented off-line 
in three different functional regions: inlet, apical trabecular and outlet. The contribution of each 
functional component to global RV volume and function was compared between repaired ToF 
patients and healthy controls. The study protocol was approved by the institutional review board 
and all subjects gave written, informed consent.
RT3DE image acquisition and analysis
Transthoracic RT3DE images of the RV were acquired by a single experienced sonographer using 
a commercially available system equipped with a 3V phased array transducer (Vivid-7.0.0, GE 
Vingmed Ultrasound AS, Horten, Norway). Patients and control subjects were imaged in the left 
lateral decubitus position. To encompass the full RV volume into the dataset, six ECG-gated sub-
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volumes were acquired to form a larger pyramidal volume including the entire RV. Images were 
acquired during a single breath-hold in end-expiration to avoid translational motion. Compression 
and gain settings were adjusted to optimize image quality and subsequent endocardial border 
visualization. RT3DE RV datasets were stored digitally and quantitative analysis of the 
3-dimensional RV volumes was performed offline using commercially available semi-automated 
software (TomTec Imaging Systems, Unterschleissheim, Germany). 
Global assessment of RV volumes and function 
From the RT3DE RV full-volume datasets, first, the software algorithm automatically displayed 
the RV volume in three imaging planes (4-chamber, sagittal and coronal plane; Figure 1). In these 
planes, manual identification of three anatomic landmarks (center of the tricuspid annulus, center 
of the mitral valve annulus, left ventricular apex) was performed. Subsequently, the endocardial 
RV border was manually traced at end-systole and end-diastole in the 4-chamber, sagittal and 
coronal planes. During contour tracing, the apical trabeculae were included in the chamber volume. 
The automated algorithm tracked the endocardial borders frame-by-frame throughout the cardiac 
cycle. After automated endocardial border tracking, the algorithm displayed the frame-by-frame 
endocardial contour position in a cine-loop. The dynamic change of the endocardial border and 
the apical trabeculae could be appreciated in this cine loop, and the contours were adjusted when 
necessary. Finally, the software automatically calculated RV end-diastolic volume (EDV), RV end-
systolic volume (ESV) and RV ejection fraction (EF). 
Regional assessment of RV volumes and function
The algorithm for segmental analysis of the RV is displayed in Figure 2. After manual tracing of 
the endocardial borders of the full RV volume in the 4-chamber view, sagittal RV view and coronal 
RV view, the software identified three anatomical landmarks (lateral wall of the tricuspid annulus, 
lateral wall of the pulmonary annulus and apex). On the basis of these anatomical landmarks 
defined by the observer, three surface landmarks were subsequently identified mathematically 
by the automated software (landmark A to landmark C, Figure 2) Landmark A was defined as the 
region at 50 percent of the distance between the tricuspid valve border (lateral wall of tricuspid 
annulus) and the apex. Landmark B was defined as the region at 50 percent of the distance between 
the pulmonary valve border (lateral wall of pulmonary valve annulus) and the apex. Landmark C 
was defined as the as the region at 50 percent of the distance between the tricuspid valve border 
and the pulmonary valve border. From these surface landmarks, the three RV regions (inlet, apical 
trabecular and outlet) were automatically identified. Subsequently, the software provided volume 
computations for the three sub-volumes in every time-frame, from which EDV (largest volume), 
ESV (smallest volume) and EF ([ESV/EDV] *100%) were derived for each RV functional component.
Statistical analysis
Continuous variables are expressed as mean ± standard deviation. Categorical variables are 
presented as numbers and percentages. Differences between repaired ToF patients and controls 
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Table 1. Patient and control characteristics
Abbreviations: BSA: body surface area, EDV: end diastolic volume, EF: ejection fraction, ESV: end systolic 
volume, PA: pulmonary artery, RT3DE : real-time 3-dimensional echocardiography, RV: right ventricle, RVOT: right 
ventricular outflow tract. * information about type of surgery was not available in one patient. 
Table 2. RT3DE RV segmental analysis
Abbreviations: EDV: end diastolic volume, EF: ejection fraction, ESV: end systolic volume, RV: right ventricle, 
RT3DE: real-time 3-dimensional echocardiography.
Figure 1. RT3DE analysis of the RV
Example of RT3DE image analysis of the full RV volume showing the final step of the software algorithm. 
Panel A: sagittal view of the RV at three levels (basal, mid ventricular and apical). Panel B: 4-chamber view of the 
RV. Panel C: coronal view of the RV. The observer can scroll through the reconstructed 3D surface contours by 
moving the sagittal imaging planes in the apical-to-basal direction (light blue, dark blue and green dotted lines), 
and by rotating the coronal plane and 4-chamber plane (yellow dotted lines). Manual correction of the endocar-
dial contour position can be performed when needed in any view and any phase of the cardiac cycle. Finally, the 
software automatically displays the reconstructed full RV volume (center) and the volumes and ejection fraction 
are automatically displayed (not shown). 
Abbreviations: (1): inlet, (2) apical trabecular, (3) outlet, RT3DE: real-time 3-dimensional echocardiography, RV: 
right ventricle. 
Figure 2. Identification of the RV functional segments with automated software.
Identification of the RV functional segments with the automated software. After manual tracing of the endo-
cardial borders of the full RV volume in the 4-chamber view, sagittal RV view and coronal RV view, the soft-
ware automatically identifies 3 surface landmarks (landmark A to landmark C) on the 3-dimensional RV volume. 
Landmark A is defined as the region at 50 percent of the distance between the tricuspid valve border (lateral wall 
of tricuspid annulus) and the apex. Landmark B is defined as the region at 50 percent of the distance between 
the pulmonary valve border (lateral wall of pulmonary valve annulus) and the apex. Landmark C is defined as the 
as the region at 50 percent of the distance between the tricuspid valve border and the pulmonary valve border. 
Subsequently, the three RV regions, (inlet, apical trabecular and outlet) are identified in the 3D volume by the 
algorithm as indicated in the figure. 
cToF patients (n=41) controls (n=20) p-value 
age (y) 13.1 ± 2.8 13.8 ± 2.5 0.202
male/female n (%) 23/18 (56/44) 13/7 (65/35) 0.507
BSA (ml/m²) 1.4 ± 0.3 1.5 ± 0.3 0.129
QRS (ms) 134 ± 19 94 ± 8 <0.001
Type of surgery*
    transannular patch 26 (65) ..
    infundibulectomy 8 (20) ..
    RVOT or PA patch 6 (15) ..
Pulmonary regurgitation
    none/mild 12 (29) ..
    moderate 11 (27) ..
    severe 18 (44) ..
RT3DE
   RV EDV (ml) 164 ± 48 133 ± 50 0.026
   RV ESV (ml) 89 ± 26 64 ± 24 0.001
   RV EF (%) 46 ± 8 52 ± 5 0.007
 repaired ToF patients (n=41) controls (n=20) p-value
RV inlet
   EDV (ml) 67 ± 25 63 ± 27 0.546
   ESV (ml) 31 ± 10 26 ±12 0.098
   EF (%) 53 ± 6 58 ± 7 0.003
RV apical trabecular
   EDV (ml) 59 ± 19 41 ± 16 0.001
   ESV (ml) 36 ± 13 24 ± 8 0.001
   EF (%) 39 ± 12 39 ± 12 0.916
RV outlet
   EDV (ml) 38 ± 13 36 ± 21 0.728
   ESV (ml) 21 ± 9 17 ± 9 0.099
   EF (%) 44 ± 16 52 ± 10 0.032
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Proefschrift2708.indd   86-87 27-08-11   13:06
88 89
were analyzed using the unpaired t-test. Categorical data were analyzed with the Chi-square 
test. To assess the inter-observer agreement of RT3DE, Bland-Altman analysis was performed. 
Furthermore, the coefficient of variation was calculated (the absolute difference between the 
observers in percentage of the study population average). Data were analyzed using the SPSS 17.0 
software (SPSS Inc, Chicago, Illinois). A p-value of <0.05 was considered statistically significant. 
RESULTS
Study population
Table 1 summarizes the clinical and echocardiographic characteristics of patients and controls, 
and the surgical details of the repaired ToF patients. In all patients, surgical repair was performed 
through an atrial incision. An additional commisurotomy or valvotomy of the pulmonary valve was 
performed in two patients who received a RVOT or pulmonary artery patch. None of the patients 
showed a hemodynamically significant residual ventricular septum defect at the time of inclusion. 
By definition, there were no significant differences between patients and controls in terms of age, 
gender and body surface area. QRS duration was significantly increased in repaired ToF patients 
(134 ± 19 ms vs. 94 ± 8 ms, p<0.001). In repaired ToF patients, global RV volumes as assessed with 
RT3DE were significantly increased (RV EDV: 164 ± 48 ml vs. 133 ± 50 ml, p=0.026, RV ESV: 89 ± 
26 ml vs. 64 ± 24 ml p=0.001) and global RV EF was significantly reduced (46 ± 8% vs. 52 ± 5 %, 
p=0.007) as compared to control subjects. None of the included repaired ToF patients showed an 
aneurysmatic RVOT. 
Segmental analysis of RV volumes with RT3DE
Table 2 outlines the segmental analysis of the RV in repaired ToF patients and control subjects. 
At the RV inlet, the EDV and ESV were not different between repaired ToF patients and controls. 
In contrast, EF at the RV inlet was significantly reduced in repaired ToF patients as compared to 
controls (53 ± 6% vs. 58 ± 7%, respectively; p=0.003). At the apical trabecular segment of the 
RV, repaired ToF patients had a larger EDV compared to healthy controls (59 ± 19 ml vs. 41 ± 16, 
respectively; p=0.001). In addition, the ESV was significantly larger at the apical trabecular segment 
(ESV apical trabecular: 36 ± 13 ml vs. 24 ± 8 ml, p=0.001) whereas the segmental EF was not 
different between patients and controls at this region (Table 2). Finally, at the RV outlet, segmental 
volumes were not significantly different between patients and controls (Table 2). However, the EF 
at the outflow tract was significantly reduced in repaired ToF patients compared to controls (44 ± 
16% vs. 52 ± 10, p=0.032).
Reproducibility
Measuring inter-observer agreement of RT3DE for full RV volume assessment with Bland Altman 
analysis, small differences and tight limits of agreement were observed (Figure 3). (EDV: -1.6 ± 20 
ml, ESV 2.6 ± 7 ml, EF: -3.5 ± 5 %). Furthermore, the inter-observer agreement of the assessment 
with Bland Altman analysis of the segmental RV volumes with RT3DE showed small differences 
Figure 3. Inter-observer agreement of RT3DE for RV full volume assessment
Panel A. Bland Altman plot showing average difference and limits of agreement for the assessment of RV EDV. 
Panel B. Bland Altman plot showing average difference and limits of agreement for the assessment of RV ESV. 
Panel C. Bland Altman plot showing average difference and limits of agreement for the assessment of RV EF. 
Abbreviations: EDV: end diastolic volume, ESV: end systolic volume, EF: ejection fraction. RV: right ventricle
Right ventricular imaging: echocardiography2 2.5
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Figure 4. Inter-observer agreement of RT3DE assessment of the RV inlet
Panel A. Bland Altman plot showing average difference and limits of agreement for the assessment of EDV at 
the RV inlet. Panel B. Bland Altman plot showing average difference and limits of agreement for the assessment 
of ESV at the RV inlet. Panel C. Bland Altman plot showing average difference and limits of agreement for the 
assessment of EF at the RV inlet. Abbreviations: EDV: end diastolic volume, ESV: end systolic volume, EF: ejection 
fraction. RV: right ventricle
Right ventricular imaging: echocardiography2
Figure 5. Inter-observer agreement of RT3DE assessment of the RV apical trabecular segment
Panel A. Bland Altman plot showing average difference and limits of agreement for the assessment of EDV at the 
apical trabecular segment. Panel B. Bland Altman plot showing average difference and limits of agreement for 
the assessment of ESV at the apical trabecular segment. Panel C. Bland Altman plot showing average difference 
and limits of agreement for the assessment of EF at the apical trabecular segment. Abbreviations: EDV: end 
diastolic volume, ESV: end systolic volume, EF: ejection fraction. RV: right ventricle
2.5
Proefschrift2708.indd   90-91 27-08-11   13:06
92 93
Right ventricular imaging: echocardiography2
with fair limits of agreement: (Figure 4, Figure 5 and Figure 6) (RV inlet: EDV: 2.2 ± 33 ml, ESV: -0.2 
± 13 ml, EF: 0.5 ± 11%; RV apical trabecular: EDV: 1.6 ± 23 ml, ESV: 3.3 ± 14 ml, EF: -4.6 ± 12%; RV 
outlet: EDV: -4.7 ± 12 ml, ESV: -0.4 ± 6 ml , EF: -5.2 ± 18%).
In addition, the coefficients of variation for the RT3DE measurements were: EDV: 11 ± 7%; ESV: 
7 ± 7%; EF: 9 ± 8%. Furthermore, the coefficient of variation calculations of the assessment of 
segmental RV volumes with RT3DE yielded the following: RV inlet: EDV: 20 ± 17%, ESV: 21 ± 15%, 
EF: 8 ± 5%; RV apical trabecular: 18 ± 17%, ESV: 22 ± 16 %, EF: 15 ± 16%; RV outlet: EDV 16 ± 16%, 
ESV: 11 ± 11%, EF: 15 ± 16 %.
DISCUSSION
The present investigation demonstrated the feasibility of a novel semi-automated software 
based on RT3DE to assess volumes and function of the inlet, apical trabecular and outlet regions 
of the RV in healthy subjects and in repaired ToF patients. In repaired ToF patients, the various 
RV components showed different contributions to the global RV volumes and EF. Specifically, the 
apical trabecular part was significantly more dilated as compared to the other regions while EF 
was preserved. In contrast, at the RV inlet and outlet, volume dilatation was limited whereas the 
segmental EF was significantly impaired. 
RT3DE of the RV
Reliable assessment of RV volumes during follow-up of congenital heart disease patients has 
clinical and prognostic significance.1-3, 14, 15 Magnetic resonance imaging is currently the reference 
standard to asses RV volumes and function.16 A recent study by Sheehan et al. introduced a fast and 
accurate magnetic resonance imaging-based algorithm to analyze the volume and shape of the RV.17 
The algorithm uses a database with data on RV shape variations in healthy volunteers and patients. 
Nevertheless, magnetic resonance image acquisition is a time-consuming and expensive imaging 
technique. Moreover, as a result of the long acquisition time, sedation is required during magnetic 
resonance imaging in young congenital heart disease patients. Echocardiography is fast, safe and 
readily available for repeated assessment of ventricular function during routine clinical follow-
up. However, the complex morphology of the RV hampers reliable evaluation of RV volumes and 
function with 2-dimensional echocardiography.4 Novel RT3DE has enabled accurate assessment 
of RV volumes and function with few geometric assumptions.5-9 RT3DE has been validated against 
magnetic resonance imaging to measure global RV volumes and function in patients with various 
pathologies, including repaired ToF.6-9 For example, van der Zwaan et al. performed a direct 
comparison between RT3DE and magnetic resonance imaging to assess RV volumes and ejection 
fraction in patients with congenital heart disease.18 RT3DE provided a fast and reproducible 
assessment of RV volumes with a fair to good accuracy as compared to magnetic resonance imaging. 
Furthermore, the authors demonstrated a good test-retest variability of RT3DE in a subsequent 
study including patients with congenital heart disease and healthy subjects.19 In addition, Grewal 
et al. showed strong correlations and good agreement between RT3DE and magnetic resonance 
2.5
Figure 6. Inter-observer agreement of RT3DE assessment of the RV outlet
Panel A. Bland Altman plot showing average difference and limits of agreement for the assessment of EDV at the 
RV outlet. Panel B. Bland Altman plot showing average difference and limits of agreement for the assessment of 
ESV at the RV outlet. Panel C. Bland Altman plot showing average difference and limits of agreement for the as-
sessment of EF at the RV outlet. Abbreviations: EDV: end diastolic volume, ESV: end systolic volume, EF: ejection 
fraction. RV: right ventricle
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imaging to assess RV volumes in patients with repaired ToF.20 The current investigation showed a 
good inter-observer reproducibility of RT3DE for the assessment of global RV volumes in repaired 
ToF patients and control subjects. In addition, similar to previous studies, the present investigation 
demonstrated that repaired ToF patients had significant larger global RV volumes and reduced 
EF compared with healthy controls.21 Therefore, RT3DE may be a valuable imaging technique to 
accurately evaluate repaired ToF patients and facilitate clinical decision-making.
RT3DE segmental analysis of the RV
The adaptive response of the RV to chronic overload remains incompletely understood. In a recent 
magnetic resonance imaging investigation, Sheehan and colleagues have shown that the remodeled 
RV exhibits significant changes in geometry and 3-dimensional shape.13 The cross-sectional RV 
shape was analyzed from apex to base in repaired ToF patients with RV dilation. Specifically, 
repaired ToF patients showed dilatation of the apex, bulging at the base, and significant shape 
change (from crescent to rectangular shape).13 Accordingly, comprehensive evaluation of the 
various RV components may yield a better understanding of RV dilatation and dysfunction. Based on 
embryological and functional observations, the segmental approach of the RV identifies the inlet, 
apical trabecular and outlet components as separate entities within the RV.10 This approach was 
initially applied to comprehensively describe congenital malformed ventricles.10 Recently, Bodhey 
and colleagues demonstrated the role of this segmental analysis in the clinical assessment of RV 
dilatation in repaired ToF patients.12 Using magnetic resonance imaging, marked differences among 
the RV components were observed, with the apical trabecular part as the most dilated component 
in repaired ToF patients with volume overload.12 In the present study, the inlet, apical trabecular 
and outlet components of the RV were analyzed by novel RT3DE software in repaired ToF patients 
and controls. The identification of true anatomical structures that define the various RV segments, 
such as the parietal band, conal septum, septal band, moderator band and the papillary muscle 
insertions is not always feasible with echocardiography. Therefore, in the present study we applied 
a standardized automated software algorithm to identify the various RV segments, as opposed to a 
manual identification of the segments which may lead to significant error when anatomical landmarks 
are not correctly identified. The results indicate that RT3DE segmental analysis of the RV is feasible 
and has fair to good reproducibility. Furthermore, similar to the observations by Bodhey and co-
workers12, the most pronounced volume increase was observed at the apical trabecular part of the RV, 
whereas segmental EF was preserved. Accordingly, the apical trabecular part seems to play a central 
role in the adaptive response to volume overload in repaired ToF patients. Furthermore, despite the 
preserved EF at the apical trabecular segment, the altered apical geometry may distort regional fiber 
orientation, which could ultimately have a deleterious effect on systolic performance of the RV.22-24 
At the inlet and outlet components of the RV, a limited contribution to the RV dilatation was 
observed. This observation is in agreement with a previous investigation.12 The RV inlet and RV 
outlet components have a close anatomical relationship with the fibrous tricuspid and pulmonary 
annuli as well as with the left ventricle. Consequently, the amount of remodeling may be limited due 
the narrow configuration of the inlet and outlet components as compared to the apical trabecular 
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segment of the RV.12 Finally, the RT3DE segmental analysis showed an impaired EF at the inlet and 
outlet components. Both RV segments are involved in the surgical repair of ToF patients (closure of 
the ventricular septum defect at the inlet, relief of pulmonary stenosis at the outlet). The clinical 
implications of systolic dysfunction at the RV outlet have been the focus of extensive research in 
repaired ToF patients. Functional abnormalities of the RV outlet relate to surgical scarring and patch 
placement at that level, and have been shown to relate with outcome in repaired ToF patients.25, 26 
Study limitations 
The present study has several limitations. RV endocardial border detection in patients with a dilated 
RV is challenging, as the endocardial border may be blurred due to the increased distance from 
the transducer to the RV wall.8 Furthermore, the feasibility of the software algorithm to assess 
the dimensions and function of the various components of the RV was not previously validated 
against a reference method. Therefore, the results of the present study may not be comparable 
when different and larger populations are evaluated. Nevertheless, the results are in agreement 
with previous studies12, 25, 26, confirming thus the reliability of the methodology. However, we 
acknowledge that the present results should be extended and confirmed in larger populations. 
Furthermore, the inter-observer reproducibility of the algorithm in terms of segmental analysis 
is not optimal. Technological developments with accurate definition of anatomical landmarks may 
help to overcome this limitation.  
Conclusion 
Patients with repaired ToF show a characteristic RV remodeling as assessed with RT3DE. The 
apical trabecular part showed the largest volumes as compared with control patients. However, the 
function of the inlet and outlet components were significantly impaired. RT3DE can facilitate future 
studies on segmental RV volumes and function in patients with repaired ToF. However, additional 
studies are needed in order to validate current RT3DE based algorithms. 
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ABSTRACT
The survival of patients with congenital heart disease (CHD) has greatly improved over the 
last decades. Nevertheless, lifelong follow-up is required in postoperative CHD patients, and 
noninvasive imaging plays an important role during follow-up. Cardiac magnetic resonance (CMR) 
imaging enables comprehensive imaging of cardiac function and anatomy, and helps to detect 
patients who need re-intervention and to predict clinical outcome. Postoperative CHD patients who 
are frequently referred for CMR evaluation include those with coarctation of the aorta, tetralogy of 
Fallot, transposition of the great arteries and single ventricle patients after the Fontan procedure. 
This article reviews the current clinical role of CMR in these various subgroups of postoperative 
CHD patients. Furthermore, an overview of novel CMR applications and their clinical value in CHD 
patients is provided. 
Right ventricular imaging: cardiac magnetic resonance3
INTRODUCTION
Advances in diagnostic, surgical and peri-operative knowledge have greatly improved the survival 
of patients with congenital heart disease (CHD). As a result, the population with CHD has doubled 
over the last decades.(1) In addition, the age distribution of the CHD patients is changing with an 
increasing number of patients aging into adulthood.(1,2) However, surgical intervention may not 
lead to complete correction of CHD and re-interventions are frequently needed, especially in 
patients with complex CHD.(3) Therefore, extensive life-long follow-up is required in CHD patients 
to monitor ventricular, valvar and electrophysiological function and to detect any cardiovascular or 
non-cardiovascular sequelae.(4)
Cardiac magnetic resonance imaging (CMR) is a non-invasive imaging technique that plays an 
important role during clinical follow-up of postoperative CHD patients.(5) CMR is not hampered 
by geometrical assumptions or by the acoustic window, which may limit echocardiographic imaging 
in postoperative CHD patients as a result of abnormal cardiac anatomy or scar tissue. Moreover, 
as no ionizing radiation is needed, the application of CMR is safe and can be used for repeated 
evaluation of CHD patients during long-term follow-up. CMR provides various acquisition schemes 
such as black-blood spin echo (BBSE), bright-blood gradient echo (GRE) imaging, phase-encoded 
flow imaging, three-dimensional contrast-enhanced angiography (3D-MRA) and late gadolinium-
enhanced imaging. The various schemes make CMR a versatile imaging technique for a wide range 
of cardiovascular indications. 
In postoperative CHD patients, MRI can provide valuable information on cardiac anatomy, 
ventricular function, valvar function and on the presence and location of myocardial scar tissue. 
Within the population of postoperative CHD patients, the diagnostic subgroups most frequently 
referred for CMR evaluation include those with coarctation of the aorta, tetralogy of Fallot (ToF), 
transposition of the great arteries and single ventricle patients after the Fontan procedure.
(6,7) This article provides an overview of the role of CMR during follow-up of postoperative CHD 
patients. The various CMR acquisition schemes and their applications in postoperative CHD 
patients are reviewed, with specific attention to the most frequently referred subgroups of CHD 
patients.  Finally, we provide a concise overview of novel CMR applications and their clinical value 
in postoperative CHD patients.
TECHNICAL ASPECTS
Several technical aspects and acquisition schemes apply to CMR imaging. First, specific technical 
adaptations are needed with regard to cardiac and respiratory motion during image acquisition. In 
addition, a range of CMR-specific pulse sequences are used to image the various aspects of the 
heart that are of use in clinical practice. 
During CMR assessment, motion synchronization is needed to avoid respiratory and cardiac motion 
artifacts. To compensate for respiratory motion, various strategies (signal averaging, breath 
3.1
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holding, respiratory gating or single shot imaging) can be applied. To compensate for cardiac 
motion, the ECG signal is used. Typically, the R-wave of the ECG at the beginning of the cardiac 
cycle is used as reference point. ECG-synchronized MR imaging may be performed prospectively 
(i.e. ECG-triggering; the pulse events needed for data acquisition start at a fixed time after the 
R-wave), or retrospectively (i.e. ECG-gating; continuous data acquisition throughout multiple 
cardiac cycles with subsequent retrospective sorting of the obtained data based on its relative 
position within the cardiac cycle).
Although many acquisition schemes may be applied for the clinical evaluation of postoperative 
CHD patients, most clinical imaging protocols are commonly composed from the following range of 
techniques: BBSE imaging, bright-blood GRE cine imaging, phase-encoded flow imaging, 3D-MRA, 
and late gadolinium-enhanced imaging.(8-10)
Black-blood spin echo (BBSE)
BBSE in postoperative CHD patients is mostly performed to evaluate cardiac anatomy. For this 
purpose, static T1 weighted images are obtained with short echo times. BBSE images have high 
tissue-to-blood contrast, with intense signal from cardiac tissue (appearing grey-to-white) and 
no signal from the moving blood pool (appearing black). Currently, the most commonly used pulse 
sequence for BBSE imaging combines a black-blood double inversion preparation sequence with 
a turbo or fast spin echo acquisition. The double inversion preparation sequence nulls the signal 
from the blood in the imaged slice, improving contrast in the image, whereas the turbo or fast 
spin echo sequence shortens the acquisition time.(11) In CHD patients, multi-slice BBSE anatomic 
imaging is routinely used to characterize cardiac and extra-cardiac anatomy (Figure 1), although 
it is increasingly being replaced by bright-blood GRE imaging. BBSE is particularly useful to 
evaluate the spatial relationships between airways and blood vessels, such as in CHD patients 
with anomalies of the aortic vessels (eg. coarctation, right sided aorta, double aortic arch) or 
pulmonary vessels (anomalous pulmonary venous connection, Fontan circulation).(12) In the 
presence of intra-cardiac metal devices such as sternal wires or intravascular stents, BBSE is less 
affected by metallic artifacts than bright-blood GRE.(11)
Bright-blood gradient echo cine imaging 
Bright blood GRE imaging yields T1 weighted images, with blood appearing white, hence the 
name “bright blood”. In current clinical practice, bright-blood GRE image acquisition is essentially 
obtained by the ‘balanced steady state free precession’ (balanced SSFP) technique. Balanced 
SSFP is a fast gradient echo technique providing images with high spatial and temporal resolution.
(13) Contrast in balanced SSFP images is generated by the differences in T1/T2 ratio in the imaged 
tissues. Balanced SSFP imaging yields a high signal from blood or fat (which have a short T1 time), 
hence appearing white in the reconstructed images, whereas other tissues, such as myocardium, 
will appear gray. Like BBSE, balanced SSFP allows imaging of cardiac anatomy. Moreover, balanced 
SSFP is specifically useful for the assessment of ventricular function(14,15). With whole-heart 
multi-slice balanced SSFP cine images, ventricular volumes (end-diastolic volume, end-systolic 
volume, stroke volume), ejection fraction and ventricular mass can be reliably assessed (Figure 
2).(14,15) Since multiple contiguous parallel slices covering the entire ventricle are obtained, 
geometrical assumptions of ventricular shape are avoided. This is particularly important for 
the assessment of reliable ventricular volumes and ejection fraction in CHD patients, as these 
patients may have an abnormal ventricular shape.(14) The analysis of left ventricular (LV) volumes 
and function is preferably performed in balanced SSFP cine images acquired in the short axis, but 
may also be derived from axial images. In contrast, the RV has a more complex ventricular shape 
and coarse endocardial trabeculations, which complicates the identification of the endocardial 
border in the short axis during image analysis. Therefore, CMR assessment of volume and function 
of the RV may be more reliable when imaged in the axial plane (Figure 2).(16) Moreover, imaging in 
the axial plane provides additional valuable information regarding spatial relationships between 
the heart and its surrounding structures, as well as diagnostic information of the surrounding 
structures (e.g. pulmonary artery stenosis, conduit obstruction, pleura effusion).  Finally, with 
bright-blood GRE cine acquisition, the presence of turbulent flow may be identified. Turbulent 
flow causes local signal loss during GRE acquisition, resulting in a black ‘flow void’ in the image. 
Figure 1. Example of black blood spin echo image
Repaired tetralogy of Fallot. BBSE images in a 36-year old male. Axial images with view from below showing the 
spatial relationships between the heart, large vessels, and airways. Right aortic arch (a) and right descending 
aorta (b-f). Normal diameter of left pulmonary artery (b), but relatively small caliber right pulmonary artery (c), 
as complication after Waterston shunt in the past. Dilated right ventricular outflow tract (d) and dilated right 
ventricle with some right ventricular hypertrophy (e,f). Note that this is accompanied with slight ventral displa-
cement of the left thoracic chest wall (c-e). The left ventricle was also enlarged (f). Patient had moderate-to-
severe pulmonary regurgitation of 45%.
Right ventricular imaging: cardiac magnetic resonance3 3.1
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Figure 2. Assessment of biventricular volumes and function with balanced steady state free 
precession
Schematic representation of assessment of volumes and function of right ventricle with axial balanced SSFP 
cine imaging in a 15 year old patient with tetralogy of Fallot. The right ventricle is dilated and ejection fraction 
is impaired. Multiple cines with contiguous parallel slices covering the whole heart are obtained. Five axial sli-
ces are displayed from inferior (top) to superior (bottom). Right ventricular volumes are obtained by manually 
tracing the endocardial borders at end-diastole (left panels) and end-systole (right panels) on all axial slices and 
multiplying the area by the slice thickness (Simpson’s rule). Subsequently, stroke volumes and ejection fraction 
can be calculated.
Accordingly, valvar regurgitation, stenosis, or turbulent flow over a ventricular septum defect may 
be identified with GRE cine imaging. However, the balanced SSFP technique is less sensitive for the 
identification of turbulent flow as compared to the conventional GRE techniques. Furthermore, to 
obtain quantitative flow measures, phase-encoded imaging is required.
Phase-encoded flow imaging
In contrast with BBSE and bright-blood GRE imaging, which rely on signal intensity for image 
reconstruction, flow imaging encodes the phase of moving spins in the structures of interest 
linearly to the velocity of their movement. Intravascular protons that flow along a magnetic 
gradient obtain phase-shifts that are proportional to their flow velocity. Therefore, after the 
application of a magnetic gradient along the flow direction, the flow velocity of the blood can be 
derived by analyzing the phase-shifts at a plane of interest.(17) 
Phase-encoded flow imaging is used to measure flow volumes, regurgitation fraction and peak flow 
velocities. Phase-encoded flow imaging can be performed in any arbitrary direction, perpendicular 
to an acquisition plane (i.e. through-plane encoding), or in a combination of directions (i.e., 2D in-
plane encoding or 3D encoding).
Through-plane phase-encoded flow imaging enables the assessment of flow volumes across 
cardiac valves and vessels. For this purpose, the imaging plane is positioned perpendicular to 
the flow at the level of the valve or vessel of interest. Data acquisition with retrospective ECG-
gating results in a time series of reconstructed phase-encoded images covering the full cardiac 
cycle. From these images, flow velocity curves are reconstructed from which flow volumes and 
regurgitation volumes can be derived (Figure 3). In CHD patients, through-plane flow imaging 
can furthermore be used to quantify shunt volumes, measuring the ratio between pulmonary flow 
volume (Qp) and aortic flow volume (Qs).(18) In the absence of a shunt, the aortic flow volume should 
equal the pulmonary flow volume, and the Qp/Qs ration is equal to 1. In general, a Qp/Qs ratio over 
1.5 represents a large left-to-right shunt that indicates the need for (re)intervention. Similarly, 
the relative flow volume to each lung can be measured to assess the hemodynamic significance of 
branch pulmonary artery stenosis.(19,20)
3D gadolinium-enhanced angiography (3D-MRA)
3D-MRA provides three-dimensional images of the pulmonary and aortic vessels. 3D-MRA images 
are obtained by a T1-weighted sequence applied shortly after intravenous administration of a 
gadolinium-based contrast agent. The intravascular gadolinium-chelate shortens the T1 time of the 
surrounding tissue (blood) resulting in increased signal intensity, delineating bright blood against 
virtually no background tissue signal (Figure 4). 3D-MRA provides images with high resolution 
and is suitable for characterization of complex intravascular anatomy of the aorta and pulmonary 
vessels. In CHD patients, 3D-MRA is of great value to detect vascular anomalies, such as major 
aorta-to-pulmonary collateral arteries (MAPCAs).(21) Furthermore, during long-term follow-up 
of postoperative CHD patients, 3D-MRA is an important imaging tool for the evaluation of (re)
stenosis, aneurysms, or for the evaluation of surgical shunts.(22,23)
Right ventricular imaging: cardiac magnetic resonance3 3.1
Proefschrift2708.indd   104-105 27-08-11   13:06
106 107
Late gadolinium-enhanced imaging
Following 3D-MRA, late gadolinium-enhanced imaging may be performed. Images are acquired 
approximately ten minutes after intravenous gadolinium-chelate contrast agent administration. 
Late gadolinium-enhanced imaging enables the detection and quantification of myocardial fibrosis 
or scar tissue. The imaging sequence takes advantage of the T1 shortening effect of gadolinium and 
of the differences in ‘wash-out’ kinetics of the gadolinium-chelate between viable and non-viable 
myocardium. To obtain the late gadolinium-enhanced images, an inversion-recovery, T1 weighted 
GRE image is acquired. Myocardial fibrotic regions or scar tissue have a delayed wash-out of the 
contrast agent and appear bright; i.e. “late enhancement”, whereas contrast agent in normal and/
or viable tissue has been washed out (no enhancement).(24) Although limited data are available at 
present in CHD patients, late gadolinium-enhanced myocardial viability imaging may be of use in 
various postoperative CHD patients to quantify scar tissue.(25,26) 
CMR IN POSTOPERATIVE CHD PATIENTS 
The subgroups of postoperative CHD patients most frequently referred for CMR evaluation include 
those with coarctation of the aorta, ToF patients, patients after correction of transposition of the 
great arteries and single ventricle patients after the Fontan procedure.(6,7) The various subgroups 
require specific CMR imaging protocols based on postoperative anatomy and the specific clinical 
problems that may be encountered during follow-up.
Coarctation of the aorta
Coarctation of the aorta is characterized by stenosis of the aortic lumen. The stenotic region is 
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typically located just distal to the left subclavian artery at the insertion of the ductus arteriosus 
(Figure 5). Coarctation severity may vary from a mild focal stenosis (presenting in young adults 
with hypertension) to a severe obstruction with an additional hypoplastic aortic arch (presenting 
in infants with severe systemic hypo-perfusion at the time of the physiologic closure of the 
ductus arteriosus). Coarctation of the aorta is associated with cardiac and vascular anomalies, 
of which a bicuspid aortic valve is the most common anomaly (75%).(27) Even in the absence of 
symptoms, relief of a significant hemodynamic coarctation (as indicated by a pressure gradient 
over the coarctation >20 mmHg, as assessed by catheterization) is indicated due to a high incidence 
of complications (including congestive heart failure, aortic rupture and infective endocarditis) 
if left untreated.(28) Relief of the obstruction may be performed surgically by resection of the 
stenotic region followed by end-to-end anastomosis or, less frequently, by the use of prosthetic 
material or a subclavian flap.(27,29) Alternatively, in older patients, an endovascular approach 
may be used with transcatheter stenting or balloon angioplasty.(27,30,31) Common problems in 
postoperative coarctation patients include aneurysm formation at the surgical site, re-coarctation 
with hypertension and subsequent LV dysfunction and collateral artery formation.(30,31)
During long term follow-up of postoperative coarctation patients, CMR imaging of the aortic arch 
should be routinely performed to detect aneurysm formation or re-coarcation.(5,32) Aneurysm 
formation at the region of coarctation correction is observed in up to 30% of postoperative 
patients, with the highest incidence after the use of prosthetic material.(33) To appreciate aortic 
aneurysms or re-coarctation, anatomical BBSE images may be obtained by planning a stack 
of slices in the oblique sagittal plane through the aortic arch. However, when the coarctation 
3.1
Figure 4. 3D-MRA in repaired tetralogy of Fallot
Gadolinium-contrast agent enhanced 3D-MRA in a 36-year old male (same patient as in Figure 1). 3D frontal 
view, oblique from below, showing the pulmonary trunk and pulmonary arteries. Note the small diameter of the 
right pulmonary artery as complication after Waterston shunt in the past (i.e. connection between the ascending 
aorta and right pulmonary artery), compare with the left pulmonary artery. Note that the intravascular anatomy 
is better delineated by 3D-MRA than by BBSE imaging (compare with Figure 1).
Figure 3. Phase-encoded flow imaging
Schematic representation of phase-encoded flow imaging across the pulmonary artery. The imaging plane is 
positioned perpendicular to the pulmonary artery, midway between the PV and the bifurcation at end diastole. 
Velocity is encoded in one direction during free breathing. Consecutive modulus (anatomic) images (left panel) 
and phase-encoded images (middle) are obtained, covering the full cardiac cycle. The inner border of the pul-
monary artery is traced (red trace) during every phase in the modulus image and copied to the corresponding 
phase-encoded images. Time - flow velocity curves (right panel) can be reconstructed, from which the following 
parameters can be calculated: Right ventricular stroke volume, regurgitation volume, and regurgitation fraction 
across the pulmonary valve. 
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tissue is thin or membranous, it may not be projected on BBSE images due to partial volume 
effects. Alternatively, bright-blood GRE cine imaging may yield a turbulent flow void at the 
site of obstruction. In case of re-coarctation, quantification of the hemodynamic severity is 
necessary to investigate the need for intervention. Although cardiac catheterization is currently 
the reference standard to quantify hemodynamic severity, it is an invasive procedure requiring 
ionizing radiation. Alternatively, for initial assessment of the hemodynamic significance of 
re-coarctation, CMR may be used (Figure 6). CMR has various approaches to non-invasively 
characterize coarctation severity. With 3D-MRA, the exact diameter, length, and location of 
the (re-)coarctation is visualized and can be measured. In addition, with 3D-MRA, the presence 
of collateral arteries is shown. In the presence of collateral arteries coarctation severity can 
be assessed by measuring collateral flow volume with the use of phase-contrast flow imaging. 
For this purpose, the aortic flow volume just proximal to the coarctation region is measured 
and compared with the flow volume in the descending aorta at the level of the diaphragm. In the 
presence of collaterals, the flow volume is increased at the distal aorta. The percent increase 
in volume provides a quantitative measurement of (re-)coarctation severity.(34) In addition, 
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Figure 6. Aortic coarctation severity by flow measures
MR images in a 13-year old female, same patient as in figure 5. 3D-MRA showing the locations for flow measu-
rements with resulting flow volumes through the aorta. Flow was measured by velocity encoded imaging, imme-
diately proximal to the coarctation, half-way below the coarctation, and at the level of the diaphragm. Note that 
the aortic flow increases from proximal to distal that indicates retrograde collateral flow towards the aorta. At 
the level of the diaphragm approximately 90% of flow through the aorta is due to collateral retrograde flow via 
chest-wall- and intercostal arteries. Output at the level of the aortic valve was 5.6 L/min.
Figure 7. Transposition of the great arteries after arterial switch
CMR images in a 12-year old male with transposition of the great arteries after arterial switch. Axial black blood 
image with view from below (a) and MRA (e) showing the spatial relationships between the pulmonary trunk and 
ascending aorta. Lecompte maneuver locates the pulmonary trunk in front of the ascending aorta with the pul-
monary arteries on either side of the aorta (a-c, e). Left pulmonary artery is partially obstructed due to the po-
sition of the main pulmonary artery in relation to the aorta. Axial GRE cine end-diastolic (b) and end-systolic (c) 
images showing the dynamic character of obstruction within the cardiac cycle. The neo-aortic root in this child 
was enlarged to 39 mm (d). 
3.1
Figure 5. Aortic coarctation
CMR images in a 13-year old female with recently discovered coarctation. BBSE images in axial orientation with 
view from below (a-c) and sagittal image with left lateral view showing the aortic arch with mildly hypoplastic 
descending aortic arch (a) and the aorta at the narrowest part of the coarctation (arrow in b, d) at the classic 
location distal from the origin of the left subclavian artery (SA, in d). Descending aorta distal from the coarcta-
tion (arrow, c). MRA showing the coarctation in original 2.8 mm slice image (e) and in thick 29 mm 3D maximum 
intensity projection image (f). Note the enlarged intercostal arteries and enlarged mammary artery that serve as 
collateral arteries as to bypass the coarctation (f).
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another study validated CMR against catheterization to assess re-coarctation severity in 31 
patients.(35) 3D-MRA was used to assess the diameter of the narrowest coarctation segment. 
Additionally, with phase-encoded flow MRI at the thoracic descending aorta, the deceleration 
velocity of flow was obtained as a quantitative measure of flow obstruction. Using this combined 
approach, CMR could differentiate between a transcatheter pressure gradient >20 mmHg or 
below 20 mmHg with high sensitivity (95%) and specificity (82%).(35)
Tetralogy of Fallot
Tetralogy of Fallot (ToF) is the most common complex congenital heart disease with an incidence of 
420 per million live births.(36) In ToF patients, an anterior displacement of the RV outflow septum 
causes a ventricular septum defect, overriding of the aorta, pulmonary stenosis, and subsequent 
RV hypertrophy. Surgical repair of ToF involves closure of the ventricular septum defect and relief 
of the pulmonary stenosis by infundibular resection, valvulotomy and/or patch placement. The 
long term survival after surgical correction of ToF is excellent. Nevertheless, postoperative ToF 
patients may present with a range of functional and hemodynamic sequelae during follow-up. CMR 
plays an important role to assess these abnormalities.
After surgical relief of the pulmonary stenosis, pulmonary regurgitation is common in ToF patients.
(37) As a result of the pulmonary regurgitation, longstanding chronic volume overload may cause 
RV dilatation and subsequent RV dysfunction (Figure 1 and Figure 2).(38) Severe RV dilatation 
in postoperative ToF patients is associated with ventricular arrhythmia and sudden death.(37) 
Therefore, in postoperative ToF patients with moderate or severe pulmonary regurgitation fraction 
(≥25%) and severe right RV dilatation (RV end-diastolic volume >160-170 ml/m2 or RV end-systolic 
volume >82-85 ml/m2) or clinical symptoms, pulmonary valve replacement is recommended in order 
to improve clinical outcome.(39-41) CMR is currently the method of choice to quantify pulmonary 
regurgitation and to assess RV volumes and function. Sequential assessment of ventricular volumes 
and function with bright blood GRE cine images and assessment of pulmonary regurgitation with 
phase-encoded images is therefore crucial for clinical decision-making with regard to pulmonary 
valve replacement in postoperative ToF patients. 
Furthermore, during CMR imaging of postoperative ToF patients, specific attention should be 
paid to the right ventricular outflow tract (RVOT). As a result of regional surgical manipulation, 
regional wall motion abnormalities at the RVOT are observed in more than 50% of patients and are 
independently related with RV dilatation.(42) RVOT akinesia or dyskinesia may be assessed with 
bright blood GRE cine imaging in the oblique sagittal plane through the RVOT or in the midventricular 
short axis.(25,42,43) In addition, several studies have demonstrated the presence of fibrotic or scar 
tissue at the RVOT, as indicated by late enhancement imaging.(25,43,44) Recently, two independent 
imaging studies on postoperative ToF patients illustrated that both regional RVOT dysfunction 
and late RVOT enhancement independently relate to global RV function, exercise capacity and 
ventricular arrhythmia.(43,44) These findings emphasize the importance of comprehensive 
RVOT imaging using bright blood GRE cine images and late gadolinium-enhanced imaging. RVOT 
imaging is furthermore important for the selection of ToF patients suitable for percutaneous valve 
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replacement.(45) Currently, this transcatheter technique to replace the pulmonary valve may be 
performed in patients without a transannular patch who previously underwent surgical pulmonary 
valve replacement.(46) The percutaneously placed pulmonary valve needs safe anchoring at the 
RVOT and therefore, specific anatomic properties of the RVOT are required. Schievano et al. have 
shown that morphological characterization of the RVOT, as assessed by 3D-MRA, greatly aids in 
selecting patients for percutaneous pulmonary valve replacement.(45) 
In addition, progressive aortic regurgitation, aortic dilatation and LV dysfunction may occur in ToF 
patients. Accordingly, LV function and aortic root dimensions need a comprehensive evaluation 
during CMR imaging of ToF patients.(47) Grotenhuis et al. demonstrated an association between 
aortic regurgitation and a reduced aortic elasticity in cToF patients.(47) Ultimately, reduced aortic 
elasticity and regurgitation may lead to LV dysfunction in ToF patients.(47) Furthermore, recent 
trials on LV dysfunction in postoperative ToF patients have demonstrated a close correlation 
between RV and LV performance, especially at the apical level. These results indicate an important 
role of ventricular-ventricular interaction in the pathophysiological mechanism leading to LV 
dysfunction in ToF patients.(48,49) Finally, stenotic lesions, such as conduit obstruction or 
stenosis at the main or branch pulmonary arteries are frequently encountered in postoperative 
ToF patients. These lesions may aggravate pulmonary regurgitation or cause asymmetric lung 
perfusion and reduced exercise capacity.(50) BBSE and 3D-MRA provide an anatomic evaluation 
of the pulmonary arteries (Figure 1 and Figure 4). Furthermore, phase-contrast flow imaging of 
the pulmonary arteries has been validated against perfusion scintigraphy to accurately assess 
differential lung flow over both branch pulmonary arteries.(20)
Transposition of the great arteries
The population of postoperative patients with transposition of the great arteries consist of 
three subgroups of patients: those with D-transposition of the great arteries who underwent 
arterial switch operation, D-transposition patients after atrial switch operation (Mustard or 
Senning procedure), and patients with “congenitally corrected” transposition of the great arteries 
(L-transposition). The latter two subgroups have the morphological RV sustaining the systemic 
circulation, which largely determines the role of CMR during follow-up in these patients. 
D-transposition of the great arteries after arterial switch
Patients with D-transposition of the great arteries have a discordant ventriculo-arterial 
connection. In these patients, the aorta arises from the morphological RV and the pulmonary 
artery arises from the morphological LV. The ‘D’ refers to the (normal) dextro-position of the 
embryonic bulboventricular loop (i.e. the morphological RV is on the right side). In patients with 
D-transposition, the atrial situs and the atrio-ventricular connections are normal. Common 
associated cardiac lesions include a ventricular septum defect and pulmonary outflow obstruction. 
In the absence of a sufficient shunt between the pulmonary and systemic circulation (such as a 
patent ductus arteriosus, a ventricular septum defect or an atrial septum defect), neonates with 
D-transposition present with severe cyanosis at the time of the physiological closure of the ductus 
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arteriosus. In these patients, atrial balloon septostomy (Rashkind procedure) may be performed 
to create or enlarge an atrial septum defect.(51) Currently, the arterial switch operation is the 
surgical procedure of choice to anatomically correct patients with D-transposition of the great 
arteries. During this procedure, both arteries are transected above the sinuses and subsequently 
switched and re-anastomosed to the correct ventricle  (Figure 7).(52) Subsequently, the coronary 
arteries are re-implanted in the neo-aorta.(52) 
Survival is excellent after the arterial switch operation.(53) However, during long term follow-up, 
several complications may be encountered, including RVOT obstruction or supra-valvar pulmonary 
stenosis, dilatation of the neo-aortic root, neo-aortic regurgitation, and coronary artery stenosis.
(53) As a result of these complications, re-interventions are frequently performed during follow-
up.(53) The most common indications for re-intervention after arterial switch operation are RVOT 
obstruction and supra-valvar pulmonary stenosis, accounting for 40% of all reoperations.(54) 
Two types of pulmonary artery obstruction may be observed. First, a circumferential narrowing at 
the suture line of the pulmonary artery anastomosis may develop. Second, as a result of surgical 
manipulation, tension and flattening of pulmonary arteries may cause obstruction. Furthermore, 
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Figure 8. Transposition of the great arteries after atrial switch
MR images in 36-year old female with transposition of the great arteries after Senning repair, axial black blood 
images with view from below. The aorta (Ao) is located above the right ventricle (RV) that sustains the systemic 
circulation. The pulmonary artery (PA) is located above the left ventricle (LV) that sustains the pulmonary circu-
lation. Blood from the superior vena cava (SVC) and inferior vena cava (IVC) is directed to the systemic venous 
atrium (SVA), that is connected to the LV. Blood from the pulmonary veins (PV) is directed to the pulmonary 
venous atrium (PVA), that is connected to the RV. Note RV hypertrophy caused by systemic pressure. PVA and 
right ventricle are enlarged due to longstanding tricuspid regurgitation. Br: bronchus
aortic dilatation and regurgitation during follow-up may be caused by abnormalities of the neo-aortic 
root in postoperative D-transposition (Figure 7, panel D).(55) After the arterial switch operation, the 
native pulmonary trunk and native pulmonary valve (neo-aortic root and valve) are functioning in 
the systemic circulation. The smooth muscle in the vessel wall of the pulmonary root is structurally 
different from that of the aortic root.(56) In addition, a diminished amount of collagen in the arterial 
wall of both great arteries of patients with D-transposition has been demonstrated.(56) As a result, 
the compliance of the pulmonary trunk in patients with D-transposition may be reduced. Accordingly, 
even in the absence of significant pulmonary artery stenosis, increased peak flow velocities in the 
pulmonary trunk have been demonstrated in patients after arterial switch operation.(57)
To appreciate possible pulmonary or RVOT stenosis and neo-aortic dilatation during CMR evaluation 
of postoperative D-transposition patients, specific attention should be paid to the LV and RV outflow 
tracts. Oblique sagittal and oblique coronal bright-blood GRE cines through the LV outflow tract 
and RVOT enable assessment of the regional diameters and geometry.(58,59) Furthermore, multi-
slice axial bright-blood GRE cines from the diaphragm up to the transverse aorta permits dynamic 
imaging of the supra-valvar aortic and pulmonary artery regions as well as assessment of ventricular 
volumes and function. In addition, with the use of 3D-MRA, more distal (branch) pulmonary artery 
stenosis can be identified. Finally, aortic and pulmonary valve competence and velocity can be 
quantified by phase-encoded flow imaging.(59)
Finally, stenosis of the coronary arteries at the site of the surgical anastomosis may occur after 
arterial switch operation.(60) Although those patients are often asymptomatic, they may be at 
risk for ischemia during follow-up.(61,62) CMR enables various approaches for the detection of 
coronary artery disease, including late enhancement MRI, stress MRI (by supine bycicle ergometry 
or dobutamine infusion), contrast-enhanced myocardial perfusion MRI, coronary angiography MRI 
and coronary flow MRI.(5) Various authors have demonstrated the feasibility of these imaging 
techniques to detect coronary stenosis in young asymptomatic patients after the arterial switch 
operation. As a result, these imaging protocols are increasingly being incorporated into the 
CMR protocols of patients after arterial switch operation.(5) However, at present, the clinical 
implications of the detection of coronary obstruction with CMR in asymptomatic patients after 
arterial switch operation remains under investigation.(62-64)
D-transposition of the great arteries after atrial switch
Before the introduction of the arterial switch operation, which was first performed by Jatene in 
1975(52), D-transposition of the great arteries was surgically corrected at the atrial level. During 
atrial correction of D-transposition, a surgical baffle is constructed within the atria, redirecting the 
systemic venous blood to the LV and the pulmonary venous blood to the RV (Figure 8). The atrial 
baffle may be constructed with synthetic or pericardial tissue (Mustard procedure), or, alternatively, 
native atrial tissue is used (Senning procedure). In patients with D-transposition after atrial switch, 
the RV is supporting the systemic circulation. Consequently, the RV functions as a high pressure 
pump with increased oxygen demand, making it vulnerable for failure and/or ischemia.(65) In a 
follow-up study including 91 patients with D-transposition after the Mustard procedure, over 50% 
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of patients presented with systemic RV failure after 25 years follow-up.(66) Other common clinical 
problems after atrial switch include tricuspid regurgitation, baffle obstruction, baffle leakage, and 
pulmonary venous or systemic venous obstruction. 
L-transposition of the great arteries
L-transposition of the great arteries is a rare congenital cardiac anomaly, comprising less than 1% 
of all patients with CHD. L-transposition is characterized by atrio-ventricular and ventriculo-arterial 
discordance: the right atrium is connected the morphological LV, which is connected to the pulmonary 
artery, and the left atrium is coupled with the morphological RV, which is connected to the aorta. 
The ‘L’ refers to the levo-position of the embryonic bulboventricular loop (i.e. the morphological RV 
is on the left side). In L-transposition patients, the morphological RV is supporting the systemic 
circulation. Associated cardiac anomalies are very common in L-transposition and include tricuspid 
valve abnormalities (90%), ventricular septal defects (70%) and pulmonary stenosis (40%).(67) 
The clinical presentation and outcome of patients with L-transposition is largely determined by the 
nature and hemodynamic consequences of the associated lesions.(68) 
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Figure 9. Example of pulse wave velocity assessment with CMR
From: Grotenhuis et al. J. Magn. Reson. Imaging 2009;30:521–526. Copyright by Wiley-Blackwell.
Analysis of pulse wave velocity with CMR. a: Oblique sagittal image covering the full course of the aorta, indica-
ting the sites for the through-plane velocity-encoded pulse wave velocity assessments: the ascending aorta (1), 
the proximal descending aorta just distal to the aortic arch (2), and the most distal level of the abdominal aorta 
depicted in the oblique sagittal scout (3). Determination of the onset of the three systolic flow waves for pulse 
wave velocity at the measurement sites are depicted in b, The distance between these sites and the transit time 
between the individual onsets of the systolic flow waves determine the pulse wave velocity.
Surgical management may be performed to improve outcome in patients with significant associated 
cardiac lesions. Most commonly, surgical repair for L-transposition of the great arteries includes 
closure of a ventricular septum defect, and/or tricuspid valve surgery or replacement. Alternatively, 
repair may be performed by means of the double switch procedure. The double switch procedure 
combines atrial rerouting (Senning or Mustard procedure) with the arterial switch. Hence, after the 
double switch operation, the morphological LV supports the systemic circulation. Currently, the 
double switch procedure is gaining ground in the surgical treatment of patients with L-transposition.
During long term follow-up of L-transposition patients with a systemic RV, ventricular dysfunction 
and tricuspid regurgitation are common.(69) In a multi-center study by Graham and colleagues 
on 132 L-transposition patients with various associated cardiac lesions, 67% presented with 
systemic RV failure at the age of 45.(69) 
CMR imaging plays an important prognostic role in the clinical follow-up of both patient subgroups 
with a systemic RV. Assessment of function and condition of the systemic RV can be studied in 
detail with various CMR techniques. CMR bright-blood GRE cines should be obtained to assess 
volumes and function of the systemic RV, as well as qualitative assessment of the presence of 
tricuspid regurgitation.(5) In systemic RV patients with progressive RV failure and significant 
tricuspid regurgitation, tricuspid valve replacement may be performed. The importance of close 
clinical follow-up of RV ejection fraction is underlined by the results of a study of Van Son et al., 
who observed increased mortality in systemic RV patients after tricuspid replacement when pre-
operative ejection fraction was below 44%.(70) Image post-processing of the cine images requires 
special attention in systemic RV patients. During systemic RV analysis, hypertrophy of the RV 
myocardium may complicate identification of the endocardial border. When the hypertrophied 
RV trabeculations are included in the myocardial blood pool, RV volumes are may be significantly 
overestimated.(71) A recent investigation showed that delineation of endocardial contours outside 
the trabeculations yields more reproducible and probably more accurate measurements.(71) 
Furthermore, stress MRI is of prognostic value in patients with a systemic RV. Winter et al. 
demonstrated that the inability of the systemic RV to increase ejection fraction and to reduce RV 
end-systolic volume upon exertion is significantly related to adverse outcome.(72) In addition, 
late enhancement imaging enables further prognostic classification of patients with a systemic 
RV. Areas of late enhancement in the systemic RV have been associated with RV dysfunction, poor 
exercise tolerance, arrhythmia, and progressive clinical deterioration.(73)
Finally, in D-transposition patients after the atrial switch operation and in L-transposition 
patients after the double switch procedure, another important goal of CMR imaging is the detailed 
assessment of baffle function and morphology. Obstruction of the intra-atrial baffle is frequently 
encountered during follow-up. Furthermore, baffle leaks may occur, causing left-to-right or right-
to-left shunting at the atrial level. Baffle leaks may be quantified with phase-encoded flow imaging, 
by comparing aorta and pulmonary artery flow volumes (Qp/Qs). To delineate baffle obstruction, 
contiguous slices in the axial plane obtained by BBSE or bright-blood GRE cine imaging at the atrial 
level can be used.(74) Fogel et al. demonstrated that a 3D image display of the obtained contiguous 
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Figure 10. Post processing of 3D time-resolved fl ow images for volumetric assessment
From: van der Hulst et al. Radiology 2010; 256: 724-734. Copyright by RSNA. 
Post processing of 3D time-resolved fl ow images for volumetric assessment of the tricuspid valve. Retrospective 
tracking of the tricuspid valve is performed by positioning a plane of interest on the tricuspid valve perpendicular 
to the fl ow in every cardiac phase in a four-chamber (a) and two-chamber (b) view (cine images: repetition time 
(TR) 3.9 ms, echo time (TE) 1.5 ms, fl ip angle 50°). Velocity-encoded images from three orthogonal directions 
(TR/TE 7.5 ms/4.3 ms, fl ip angle 10°) (c-e), reconstructed from the position of the valve determined with re-
trospective valve tracking based on the two-chamber (b) and four-chamber (a) views. Through-plane velocity-
encoded images (f) are obtained by reformatting of the center valvular plane in each cardiac phase. The inner 
border of the tricuspid annulus is traced for fl ow analysis. A region within the free wall of the right ventricle 
is traced for background correction. Tricuspid fl ow velocity in time can be presented in a curve (g), from which 
fl ow volume can be calculated. Abbreviations: AP: anterior-posterior velocity-encoded, FH: feet-head velocity-
encoded, RL: right-left velocity-encoded.
3.1
Figure 11. Quantitative imaging of fl ow with 3D time resolved imaging
From: Hope et al. J. Magn. Reson. Imaging 2010;31:711–718. Copyright by Wiley-Blackwell.
Abnormal vortical fl ow in a postoperative coarctation patient. Minimal residual narrowing (top arrow) of the 
mid aortic arch demonstrated with 3D-MRA (a) and BBSE (b) images images. Streamlines are presented in mid 
(c) and late (d) systole. Disturbed fl ow is revealed (secondary fl ow features), with acceleration and signal drop 
out secondary to aliasing, as well as vortical-type fl ow (bottom arrow) downstream of the focal region of mild 
aortic narrowing.
Right ventricular imaging: cardiac magnetic resonance
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slices is useful for this purpose, as complex spatial relationships are more easily clarified.(74) 
Furthermore, 3D-MRA is a valuable technique for anatomic imaging of baffle morphology in 
patients with D-transposition after atrial switch.(74) 
Single ventricle patients after the Fontan procedure
The subgroup of CHD patients with a single ventricle is heterogeneous, with diverse complex 
cardiac anomalies. There may be a true ‘anatomic’ single ventricle, or, more commonly, there may be 
one ‘functional single ventricle’ (such as in hypoplastic left heart syndrome or tricuspid atresia). The 
single ventricle can be of RV or LV morphology and a range of additional cardiac abnormalities may 
be present. The treatment of choice in patients with a single ventricle is the surgical construction 
of the Fontan circulation, performed in a staged process requiring at least two separate surgical 
interventions.(75) After completion of the Fontan circulation, the systemic and pulmonary 
circulations are separated and the single ventricle sustains the systemic circulation. Both caval 
veins are directly connected to the pulmonary arteries without interposition of a sub-pulmonary 
ventricle. Direct connection of the systemic venous return to the pulmonary arteries is constructed 
via an intra-atrial tunnel or an extra-cardiac conduit.(76) A fenestration may be created between 
the systemic venous return and the pulmonary venous pathways which allows for shunting towards 
the pulmonary venous circulation in case of increased pulmonary vascular resistance. 
The Fontan procedure is a palliative procedure, although long term outcome is improving. In a recent 
report on 250 single ventricle patients who underwent the Fontan procedure, the 20-year survival 
after a successful Fontan procedure was 84%.(76) Failure of the Fontan circulation (defined as 
death, surgical ‘takedown’ of the Fontan, heart transplantation, or symptomatic heart failure in 
New York heart association (NYHA) functional class III or IV) was observed in 30% of patients 
after 20 years follow-up.(76) CMR evaluation can aid in the early recognition of single ventricle 
dysfunction. For this purpose, volumes, mass and ejection fraction can be studied by obtaining 
whole-heart bright blood GRE cines.(77) In addition to ventricular failure, other problems may 
complicate postoperative single ventricle with a Fontan circulation. Most commonly, obstruction 
of the pulmonary arteries or pulmonary veins occur, which can severely compromise the Fontan 
circulation. Flow obstruction to the pulmonary arteries may be due to anatomical narrowing or to 
increased pulmonary vascular resistance. Also, an enlarged right atrium or extra-cardiac conduit 
may compress the pulmonary veins.(78) Anatomic narrowing and obstruction in the pulmonary 
arterial and venous pathways can be visualized by static BBSE or bright-blood GRE cine acquisitions. 
Furthermore, obstruction can be revealed with the use of phase-encoded flow imaging by through-
plane measurement of flow velocities. Of note, in Fontan patients, the maximum velocity-encoding 
during image acquisition should be anticipated upon the low flow velocities at the systemic venous 
side of the Fontan circulation. Moreover, as a result of the low blood flow velocities, the BBSE 
images should be comprehensively reviewed to identify possible thrombi.
In addition to the BBSE images, bright blood GRE images and phase-encoded images, 3D-MRA can 
reveal possible obstruction of the pulmonary and venous pathways in Fontan patients. Furthermore, 
3D-MRA is helpful in delineating possible collateral arteries. The detection of the presence of 
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collateral arteries is of clinical importance in Fontan patients as collateral blood flow causes 
volume overload to the vulnerable single ventricle. Goo and co-workers recently evaluated time-
resolved 3D-MRA for the assessment of flow dynamics in Fontan patients. In 15 young patients 
(median age 10 years), time-resolved 3D-MRA yielded data on preferential lung flow and collateral 
arteries with high spatial resolution.(23) 
Finally, imaging of bilateral lung perfusion is of clinical importance in Fontan patients.(79) Currently, 
perfusion scintigraphy is the method of choice to assess lung perfusion. However, Fratz and co-
workers have demonstrated that in patients with a Fontan circulation, lung perfusion imaging with 
phase-encoded flow MRI is more accurate than perfusion scintigraphy.(79) 
NOVEL CMR IMAGING TECHNIQUES IN CHD PATIENTS
In addition to the ‘conventional’ imaging sequences that are used during routine clinical follow-
up, continuing research has provided several novel applications of CMR that have clinical value in 
postoperative CHD patients, including pulse wave velocity, 3D flow imaging, tissue velocity imaging 
and T1 mapping. 
Aortic pulse wave velocity
The aortic pulse wave velocity is a surrogate marker for aortic wall compliance. It is defined as the 
velocity of the systolic wave front propagating through the aorta. Aortic pulse wave velocity, as 
assessed with Doppler echocardiography, is a strong predictor of cardiovascular mortality.(80,81) 
In hypertensive patients, the aortic pulse-wave velocity, as assessed with CMR, has been shown to 
be associated with LV mass and lacunar brain infarcts.(82) With CMR, the aortic pulse wave velocity 
can be assessed at any site of the aorta even in the presence of a tortuous aortic vessel. To obtain the 
aortic pulse wave velocity with CMR, ‘conventional’ phase-encoded flow images at various regions 
of the aorta are acquired (usually at the ascending aorta, descending aorta and at the abdominal 
aorta just proximal to the iliac bifurcation).(83) From the time-flow curves at each aortic region, 
the timing of the onset of the systolic flow wave can be obtained. (Figure 9) Subsequently, the time 
difference between the onset of flow between two aortic regions (transit time) is calculated. Finally, 
the pulse-wave velocity is obtained by dividing the distance measured between the two regions by 
the transit time. This CMR approach to assess the aortic pulse wave velocity was recently validated 
against intra-arterial pressure measurements during catheterization, and good agreement and high 
reproducibility were reported.(83) 
The application of CMR to assess the aortic pulse wave velocity has been performed in postoperative 
CHD patients. Grotenhuis and colleagues assessed the aortic pulse wave velocity of the aortic arch 
in 15 D-transposition patients after arterial switch operation.(58) A reduced elasticity, reflected by 
an increased pulse wave velocity, was observed in the patients as compared with 15 age-matched 
controls (patients: 5.1 ± 1.2 m/s, controls: 3.9 ± 0.7 m/s, p=0.004).(58) Another study reported the 
aortic pulse wave velocity of 16 ToF patients after pulmonary valve replacement. The pulse wave 
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velocity at the aortic arch was increased in the ToF patients as compared with 16 healthy control 
subjects (5.5 ± 1.2 m/s vs. 4.6 ±  0.9 m/s, p=0.04).(47) Finally, Voges et al. assessed the aortic pulse 
wave velocity in 40 patients with a hypoplastic left heart syndrome and a Fontan circulation. In their 
study, the aortic pulse wave velocity was not significantly different in patients as compared with 
healthy controls.(84) 
Current clinical research aims at further improvement of the assessment of the pulse wave velocity 
with CMR. Westenberg et al. recently validated the assessment of aortic pulse wave velocity by 
in-plane two-directional phase-encoded imaging of the aortic arch.(85) With this method, the 
entire aortic arch was depicted in three two-directional phase-encoded slices, which enabled the 
assessment of pulse-wave velocity among any two regions in the aorta.(85) The in-plane method 
was compared with the through-plane method and showed a better agreement with intra-arterial 
pressure measurement and an improved reproducibility.(85) Future follow-up studies using pulse 
wave velocity assessment with CMR are needed to reveal its prognostic value in CHD patients.
3D time-resolved flow imaging
Three-dimensional three-directional phase-encoded flow imaging (3D time-resolved flow 
imaging) enables quantification of valve flow as well as visualization of complex flow patterns.
(86-90) Quantification of valve flow with conventional phase-encoded (two-dimensional) flow 
imaging is hampered by cardiac motion, since the acquisition plane is fixed throughout the 
cardiac cycle. Indeed, it has been shown that two-dimensional flow assessment of atrioventricular 
valve flow can lead to significant overestimation of flow volumes.(90) 3D time-resolved flow 
imaging solves the problem of valve motion by scanning a 3D volume with phase-encoding in 
three orthogonal directions.(87,90,91) This approach allows for ‘retrospective valve tracking’ 
during post-processing, a method that enables manual adjustment of the imaging plane in the 
3D volume at any phase according to the angle and position of the valve of interest (Figure 10).
(87,90) Furthermore, 3D time-resolved flow imaging allows simultaneous assessment of flow 
over all four valves, resulting in decreased scan time.(87) In postoperative ToF patients, 3D 
time-resolved flow has been validated against planimetry for the assessment of pulmonary and 
tricuspid flow.(89) As compared with two-dimensional flow MRI, 3D time-resolved flow imaging 
yielded better agreement with stroke volumes as assessed by SSFP planimetry.(89) Furthermore, 
the simultaneous assessment of flow over several valves enables evaluation of diastolic function 
of the RV in ToF patients with pulmonary regurgitation.(89) In the presence of pulmonary 
regurgitation, the flow pattern over the tricuspid valve does not reflect RV filling, since RV filling 
occurs also from the pulmonary regurgitation. Summation of the 3D time-resolved diastolic flow 
curves of the pulmonary valve and tricuspid valve allows the reconstruction of RV time-volume 
curves.(89) The RV time-volume curve represents RV filling and can be used to detect diastolic 
impairment in ToF patients.(89) 
In addition to flow quantification, complex flow patterns can be visualized with 3D time resolved 
flow images.(86,88) This can be performed by particle tracing visualization in the 3D phase-
encoded dataset. Particle tracing simulates the path taken in time by an imaginary particle (e.g. 
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an erythrocyte in the vessel of interest). Particle tracing allows comprehensive visualization of 
complex flow pathways, for instance in patients with a Fontan circulation.(88) Furthermore, flow 
patterns can be characterized in static images with the use of so-called streamlines. Streamlines 
provide a snapshot of the instantaneous blood flow pattern in an image. In streamline images, 
laminar flow can be differentiated from ‘secondary flow features’ (e.g. vortices or helices) (Figure 
11). Hope and colleagues performed 3D time-resolved systolic streamline imaging of the aorta in 
26 coarctation patients and in eight healthy subjects. All healthy subjects showed laminar aortic 
flow patterns. However, vortical and helical flow patterns were observed in the descending aorta 
of 14 postoperative coarctation patients (54%).(86) Future studies are warranted to assess the 
clinical implications of flow visualization in postoperative CHD patients. 
Tissue-velocity imaging
The echocardiographic assessment of peak systolic velocities with tissue Doppler imaging 
has shown to be of incremental value to conventional echocardiography to assess ventricular 
performance in various clinical conditions.(92-94) In addition, the assessment of the temporal 
occurrence of peak systolic velocities permits evaluation of mechanical dyssynchrony, which aids 
in the selection of heart failure patients that may benefit from cardiac resynchronization therapy.
(95) With CMR, myocardial velocity (tissue-velocity) can be measured with phase-encoded imaging.
(96-98) With tissue-velocity imaging, the maximum velocity is set at a lower threshold as compared 
to flow imaging (for example at 20 cm/s) which enables the assessment of myocardial motion 
velocity in time. Velocity can be encoded into any desired direction (usually along the longitudinal 
axis of the heart) and subsequently, regional time-velocity curves can be obtained. Tissue-velocity 
imaging with CMR has been validated against tissue Doppler imaging with echocardiography for 
the assessment of myocardial velocities and timings of myocardial velocities.(99-102) A recent 
study on tissue-velocity imaging of the RV with CMR in 33 ToF patients demonstrated significantly 
reduced peak systolic velocities at the RVFW and at the RVOT as compared with 19 healthy 
controls (RVFW: 8.2 cm/s (inter-quartile range 6.4-9.7) vs. 12.4 cm/s (10.8-13.8), p<0.01, RVOT: 
4.7 cm/s (4.1-7.2) vs. 10.2 cm/s ( 8.7-11.2), p<0.01.(99) Furthermore, the mechanical activation 
pattern of the RV was evaluated and a significant time-delay within the healthy RV was observed, 
which was reduced in ToF patients.(99) Insight into RV mechanics may have clinical implications for 
future studies on pacing strategies in RV failure. In future trials, tissue-velocity MRI can provide 
detailed insight into myocardial performance, myocardial mechanics and possible dyssynchrony in 
postoperative CHD patients.
T1 mapping
The novel CMR application of clinical T1 mapping enables quantification of myocardial interstitial 
fibrosis. Interstitial fibrosis has been demonstrated within the myocardium of CHD patients(103) 
and may be an important substrate leading to heart failure. Currently, late enhancement imaging 
is the reference standard to image myocardial fibrosis or scar tissue.(5) However, with late 
enhancement imaging, diffuse myocardial fibrosis is not revealed, as the selected inversion time to 
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obtain late enhancement images is deliberately chosen to null ‘normal’ myocardium. Hence, with late 
enhancement imaging, only macroscopic scarring can be visualized. By the use of contrast-enhanced 
T1 mapping (regional assessment of T1 time throughout the myocardium of interest), diffuse 
interstitial fibrosis may be quantified. Recently, various methods to obtain T1 maps in clinical 
practice have been proposed.(104,105) In a heterogeneous group of adult CHD patients, Broberg 
et al. performed T1 mapping of the LV.(106) The authors assessed the ratio of T1 in the blood pool 
and in the LV myocardium before and after gadolinium-chelate administration with a multi-phase 
inversion recovery GRE sequence (Look-Locker sequence). In the presence of myocardial fibrosis, 
the gadolinium has a delayed wash-out from the extracellular matrix of the myocardium, altering 
the T1 ratio of the surrounding blood and myocardium. With this technique, the authors observed 
significantly more interstitial fibrosis in CHD patients as compared to healthy controls.(106) T1 
mapping may be of great value in future research on the pathophysiology and treatment of heart 
failure in CHD patients.
CONCLUSION AND FUTURE PERSPECTIVE
Post-operative CHD patients constitute a heterogeneous group of patients that require life-long 
follow-up. In current clinical practice, noninvasive cardiac imaging with CMR plays an important role 
during follow-up of postoperative CHD patients, especially in those with complex CHD. CMR imaging 
yields 3D datasets that provide a comprehensive characterization of complex cardiac anatomy and 
reliable imaging of cardiac function. In addition, continuing clinical research on novel CMR techniques 
aims at providing new imaging parameters that may further improve clinical-decision making with 
regard to re-intervention and follow-up protocols in the growing CHD population.
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Direct comparison between tissue Doppler imaging 
and velocity-encoded magnetic resonance imaging 
for the assessment of performance and temporal 
activation of the right ventricle in corrected  
tetralogy of Fallot patients
Radiology 2011; 260: 88-97










Purpose: To compare velocity-encoded magnetic resonance imaging (VE-MRI) with tissue Doppler 
imaging (TDI) to assess right ventricular (RV) peak systolic velocities and timings in patients with 
corrected tetralogy of Fallot (cToF) and healthy subjects. 
Materials and Methods: Local institutional review board approval was obtained, and patients or 
their parents gave informed consent. Thirty-three patients (20 male, 13 female; median age 12 
years (11-15) [inter-quartile range]; range 8-18 years) and 19 controls (12 male, 7 female, median 
age 14 years (12-16), range 8-18 years) underwent VE-MRI and TDI. Peak systolic velocity and time 
to peak systolic velocity (expressed as percentage of cardiac cycle) were assessed at the RV free 
wall (RVFW) and RV outflow tract (RVOT). Data were analyzed using linear regression, paired and 
unpaired tests and Bland-Altman plots.
Results: Good correlation and agreement between the two techniques were observed. Peak systolic 
velocities: RVFW: r=0.95, mean difference -0.4cm/s, p<0.01, RVOT: r=0.95, mean difference -0.4
cm/s p=0.02. Timings: RVFW r=0.94, mean difference -0.2%, p=0.44, RVOT: r=0.89, mean difference 
-0.5%, p=0.01. Peak systolic velocities were reduced in cToF patients (RVFW: 8.2cm/s (6.4-9.7) 
vs. 12.4cm/s (10.8-13.8), p<0.01, RVOT: 4.7cm/s (4.1-7.2) vs. 10.2cm/s (8.7-11.2), p<0.01). A time 
delay between the RVFW and RVOT was observed, which was significantly shorter in cToF patients 
(5.9% (4.9-7.4) vs. 8.4% (6.6-12.4), p<0.01). 
Conclusions: VE-MRI and TDI enable assessment of RV systolic performance and timing of 
velocities at the RVFW and RVOT in cToF patients. Both techniques can be used interchangeably to 
clinically assess velocities and timings of the RV.
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INTRODUCTION
In patients after surgical correction of Tetralogy of Fallot (cToF), right ventricular (RV) dimensions 
and ejection fraction are important determinants of long-term outcome (1-3). However, these 
parameters evaluate RV function at a global level. In contrast, assessment of myocardial velocities 
with echocardiographic tissue Doppler imaging (TDI) permits evaluation of regional RV systolic 
function and characterization of the RV mechanical activation sequence by timing of peak systolic 
velocities. Previous studies have shown that assessment of RV myocardial velocities enables reliable 
quantification of RV performance in various clinical conditions (4-8). In cToF patients, abnormalities in 
timings of systolic events of the RV free wall (RVFW) and right ventricular outflow tract (RVOT) have 
been observed, which may contribute to RV failure in cToF patients (9,10). Therefore, comprehensive 
assessment of velocities and timings of the RVFW and RVOT may provide better understanding of 
RV failure in cToF patients. Cardiac magnetic resonance imaging (MRI) is the method of reference 
to assess RV dimensions and function in cToF patients (11). Recently, velocity- encoded MRI (VE-
MRI) has been introduced to assess myocardial velocities. In the left ventricle (LV), VE-MRI has 
been validated against TDI for the assessment of myocardial velocities and timings of peak systolic 
velocities (12-15). In patients with cToF, the use of VE-MRI to assess myocardial velocities is of 
interest as it enables comprehensive assessment of RV function in cToF patients during a single 
integrated MRI examination. Thus far, the application of VE-MRI and TDI to assess RV velocities and 
timings in different regions of the RV has not been directly compared to our knowledge. 
Accordingly, the aim of our study was to compare velocity-encoded magnetic resonance imaging with 
tissue Doppler imaging to assess peak systolic velocities and timings within the right ventricle in 
patients with a corrected tetralogy of Fallot and in healthy subjects. 
MATERIALS AND METHODS
Study population
All participants or their parents gave written informed consent. Thirty-three patients with corrected 
tetralogy of Fallot (cToF) (mean age 13 years ± 3 [standard deviation]) were prospectively recruited. 
In addition, 19 healthy controls with a similar age range were enrolled in the study. All cToF patients 
and healthy controls underwent transthoracic echocardiography (including TDI) and MRI (including 
VE-MRI) on the same day. TDI and VE-MRI were performed to assess peak systolic velocities as 
well as the timing of peak systolic velocities at the RVFW and at the RVOT. The VE-MRI data and the 
TDI data were analyzed by A.E.v.d.H. (with 3 years experience in cardiac MRI and echocardiography). 
Inter-observer assessment of VE-MRI data was performed by A.A.W.R. (with 12 years experience in 
cardiac MRI). Correlation and agreement between TDI and VE-MRI measurements were assessed 
in the entire study cohort. Furthermore, the VE-MRI derived peak systolic velocities and the time 
difference between peak systolic velocities at the RVWF and RVOT were compared between cToF 
patients and controls. 
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Tissue Doppler imaging
Transthoracic echocardiography images were acquired by a single experienced sonographer (8 years 
experience in echocardiography) using a commercially available system equipped with a 3.5 MHz 
transducer (Vivid-7.0.0, GE Vingmed Ultrasound AS, Horten, Norway). Subjects were in the left lateral 
decubitus position during image acquisition. Acquisition of TDI images was performed with adjusted 
sector width and angle to align the ultrasound beam with the direction of the myocardial motion. 
The color frame rate was ≥120 frames/s, yielding a temporal resolution <8.3ms, and at least three 
consecutive beats were recorded. Analyses were performed off-line using EchoPac version 108.1.5 
(General Electric Medical Systems). Longitudinal myocardial velocity curves were obtained by placing 
regions of interest (ROI) at the basal RVFW in the 4-chamber view (Figure 1, a and c) and at the lateral 
RVOT in a dedicated apical RVOT view (Figure 1, b and d), as previously reported (10). Semi-automated 
tissue tracking was used to maintain the sample area within the ROI throughout the cardiac cycle. 
Peak systolic velocity was measured at the RVFW (Figure 1c) and at the RVOT (Figure 1d).
In addition, time from R-wave of the ECG to peak systolic velocity was measured at both segments 
(Figure 1, c and d) and expressed as percentage of the RR interval to ensure accurate comparison 
of timings between the two techniques. Finally, the time difference between peak systolic 
velocity at the RVFW and peak systolic velocity at the RVOT was calculated in each cToF patient 
and control subject.
Magnetic resonance imaging
MRI was performed on a 1.5-Tesla pulsar gradient system (Intera, release 12; Philips Medical 
Systems, Best, the Netherlands) with 33 mT/m amplitude, 100 mT/m/ms slew rate, and 0.33 ms 
rise time. A five-element cardiac coil was used for signal reception. Multi-section transverse (16) 
cine imaging was performed to assess ventricular volumes and ejection fraction. A stack of slices 
was planned in the transversal plane, covering both ventricles throughout the cardiac cycle. Multi-
section cine-images were acquired with a steady-state free precession sequence during breath hold 
at end-expiration, with scan parameters: repetition time (TR) 3.9ms, echo time (TE) 1.5ms, field of 
view 350mm; slice thickness 8mm; flip angle 50°; 1.8×2.0×8.0mm acquisition voxel reconstructed 
into a 1.4×1.4×8.0mm voxel; one signal acquired, 30 phases reconstructed, retrospective gating 
with 10% acceptance window.  
VE-MRI was performed in a 4-chamber orientation for the assessment of longitudinal velocity data 
at the RVFW (Figure 2, a and c), and in a double oblique RVOT view for the assessment of longitudinal 
velocities at the RVOT (Figure 2, b and d). Imaging parameters for VE-MRI acquisition were: 
repetition time 5.4ms, echo time 3.4ms, flip angle 10°, slice thickness 8mm, matrix 128×128, field-
of-view 370mm, actual temporal resolution 10.8ms. Retrospective triggering was used and data 
acquisition was performed during free breathing. Four signal averages were acquired to increase 
signal-to-noise ratio. Maximum velocity was set at 20cm/s to assess myocardial velocities. The 
maximum number of phases was reconstructed, yielding an effective temporal resolution in the 
velocity graph of approximately 10ms.
3.2
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Magnetic resonance image analysis
All MRI data were analyzed using the MASS software package (Leiden University, Leiden, The 
Netherlands) (17). LV and RV end-systolic and end-diastolic volumes were calculated by summation of 
discs after manual tracing of the endocardial borders at end-systole and end-diastole in all transverse 
slices. RV and LV ejection fractions were then automatically calculated by the MASS software. For 
assessment of myocardial velocities, a ROI was placed in the VE-MRI images at the basal RVFW 
(Figure 2c) and the lateral wall of the RVOT (Figure 2d) in all phases. Manual positioning of the ROI 
was performed throughout the cardiac cycle to ensure data sampling within the myocardial wall. 
The average velocity within the ROI was recorded in every cardiac phase. Time-velocity graphs were 
constructed from the RVFW (Figure 2c) and lateral RVOT segments (Figure 2d). From these graphs, 
peak systolic velocity and time to peak systolic velocity were derived. Timings are expressed as 
percentage of the RR interval. In addition, the time difference between peak systolic velocity at the 
RVFW and peak systolic velocity at the RVOT was calculated in each cToF patient and control subject. 
Finally, intra-observer and inter-observer agreement for the VE-MRI measurements were assessed 
in a blinded manner, by re-measuring peak velocities and timings at the RVFW and RVOT in 15 
randomly chosen individuals. Intra-observer agreement was evaluated by repeating measurements 
within one week interval.
Statistical analysis
Continuous variables were tested for normal ditriubution with the Kolmogorov-Smirnov test. 
Continuous variables with a normal distribution are expressed as mean ± standard deviation 
whereas those variables without normal distribution are expressed as median and IQR. Categorical 
variables are presented as numbers and percentages. Comparisons between cToF patients and 
controls were analyzed using the Mann-Whitney U-test for continuous data and the Fisher’s exact 
test for categorical data. Comparisons between TDI and VE-MRI in the full population were analyzed 
using the paired t-test for normal distributed variables and with the Wilcoxon singed rank test for 
variables without a normal distribution. Linear regression analysis was used to evaluate the relation 
between TDI and VE-MRI. Logarithmic transformation was performed before linear regression 
analysis when variables were not normally distributed. Bland-Altman analysis was performed to 
assess the agreement between the two techniques. Intra-observer and inter-observer agreement of 
VE-MRI measurements was assessed using the intra-class correlation coefficient (ICC) for absolute 
agreement. Data were analyzed using the SPSS 17.0 software (SPSS Inc, Chicago, Illinois). A p-value 
of <0.05 was considered statistically significant and 95% confidence intervals (CI) were calculated.
RESULTS
Study population
Baseline characteristics of the cToF patients and controls are displayed in Table 1. cToF patients 
had significantly increased RV end-diastolic and RV end-systolic volumes (Table 1). Furthermore, 
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Table 1. Baseline characteristics
Abbreviations: BSA: body surface area, EDV: end-diastolic volume, EF: ejection fraction, ESV: end-systolic vo-
lume, LV: left ventricle, PA: pulmonary artery, RV right ventricle, RVOT: right ventricular outflow tract. *median 
and inter-quartile range
RV ejection fraction was lower in cToF patients than in controls (median 48%, IQR: 47 to 53% vs. 
median 53% IQR 50 to 55%, p=0.01). All measurements at the RVFW and RVOT were feasible in 
each patient and control subject for both imaging techniques.
TDI versus VE-MRI: peak systolic velocities
Table 2 and Figure 3 summarize the relationship between TDI and VE-MRI to assess peak 
systolic velocities at the RVFW and RVOT. At the RVFW, a small difference between the 
techniques was observed. (Table 2) An excellent correlation between both techniques was 
observed in the full population (r=0.95, p<0.01) (Figure 3a). In addition, when the population 
was divided in cToF patients and controls, excellent correlations were observed between 
the two techniques (cToF patients r=0.91, p<0.01, controls r=0.90, p<0.01). Bland-Altman 
analysis showed limits of agreement of -2.3 to 1.5cm/s (Figure 3b). Finally, intra- and 
inter-observer agreement of VE-MRI assessment of peak systolic velocities at the RVFW 
yielded an intra-observer ICC of 0.97 (p<0.01) and an inter-observer ICC of 0.96 (p<0.01). 
At the RVOT, the assessment of peak systolic velocities yielded a small difference between the 
two techniques in the full population (Table 2). Furthermore, a strong correlation between TDI and 
VE-MRI was observed in the full population (r=0.95, p<0.01) (Figure 3c), as well as after dividing 
 cToF patient (n=33) control (n=19) p-value
Age (y)* 12 (11-15) 14 (12-16) 0.16
Gender male/female n (%) 20/13 (60/40) 12/7 (63/37) 0.55
QRS duration (ms)* 132 (120-150) 96 (90-100) <0.01
Cardiac cycle (ms) 796 ± 127 848 ± 120 0.16
BSA (m²)* 1.4 (1.2-1.7) 1.5 (1.4-1.7) 0.09
Age at corrective surgery (y)* 0.7 (0.5 - 1.1) ..
Type of corrective surgery n (%)
    Infundibulectomy 7 (21) ..
    Transannular patch 20 (61) ..
    RVOT patch 3 (9) ..
    PA patch 3 (9) ..
MRI
    LV-EDV (mL)* 117 (96-150) 141 (126-167) 0.03
    LV-ESV (mL)* 52 (40-69) 62 (54-78) 0.05
    LV-EF (%)* 57 (51-60) 55 (53-59) 0.89
    RV-EDV (mL)* 171 (152-205) 149 (128-175) 0.03
    RV-ESV (mL)* 90 (75-106) 72 (59-82) 0.02
    RV-EF (%)* 48 (47-53) 53 (50-55) 0.01
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Table 2. Relationship between TDI and VE-MRI
Timings are expressed as percentage of the RR interval. Abbreviations: CI: confidence interval, RVFW: right ven-
tricular free wall, RVOT: right ventricular outflow tract, TDI: tissue Doppler imaging, VE-MRI: velocity encoded 
magnetic resonance imaging. *median and inter-quartile range
the population in cToF patients and controls (cToF patients r=0.92, p<0.01, controls r=0.87, p<0.01). 
Figure 3d shows the Bland-Altman plots for VE-MRI and TDI agreement. Finally, good intra-
observer and inter-observer agreement was noted for the assessment of peak systolic velocities 
at the RVOT (intra-observer ICC: 0.99, p<0.01, inter-observer ICC 0.97, p<0.01).
TDI versus VE-MRI: timing of peak systolic velocitis
Table 2 and Figure 4 show the relationship between TDI and VE-MRI to measure time to peak 
systolic velocity corrected by the RR interval. At the RVFW, no significant difference between 
the techniques was observed (Table 2). In addition, an excellent correlation between TDI and VE-
MRI measurements at the RVFW was observed in the full population (r=0.94, p<0.01) (Figure 4a). 
Furthermore, good correlations between TDI and VE-MRI measurements were noted when the 
population was divided in cToF patients and controls (cToF patients r=0.86, p<0.01, controls r=0.92, 
p<0.01). Bland-Altman analysis showed narrow limits of agreement (-3.2 to 2.9%) (Figure 4b). 
Finally, intra-observer analysis of time to peak systolic velocity at the RVFW yielded an ICC of 0.96 
(p<0.01). Assessment of inter-observer agreement of time to peak systolic velocity at the RVFW 
showed an ICC of 0.92 (p<0.01).
At the RVOT, a small difference between TDI and VE-MRI for time to peak systolic velocity at the 
RVOT was observed (Table 2). A strong correlation was observed between TDI and VE-MRI (r=0.89, 
p<0.01) (Figure 4c). After dividing the population in cToF patients and controls, good correlations 
between TDI and VE-MRI measurements were observed (cToF patients r=0.91, p<0.01, controls 
r=0.73, p<0.01). Bland-Altman analysis of agreement between VE-MRI and TDI to assess time to 
peak systolic velocity at the RVOT is displayed in Figure 4d. In addition, intra-observer agreement 
analysis of time to peak systolic velocity at the RVOT yielded an ICC of 0.89 (p<0.01). Inter-observer 
agreement of time to peak systolic velocity at the RVOT was 0.84 (p<0.01).
Right ventricular imaging: cardiac magnetic resonance3 3.2
Figure 1.
Image analysis of tissue Doppler images. (a): Echocardiographic 4-chamber view of a cToF patient. Red region of 
interest indicates RVFW myocardial segment where TDI measurements were performed. (b): Echocardiographic 
apical view of the RVOT of a cToF patient. Red region of interest indicates myocardial RVOT segment where TDI 
measurements were performed. (c): Example of TDI assessment of peak systolic velocity and time to peak systolic 
velocity at the RVFW in a cToF patient. Peak systolic velocity can be derived from the time-velocity curve (vertical 
arrow). Time to peak systolic velocity can be measured by calculating time from R to peak systolic velocity (hori-
zontal arrow). (d): Example of TDI assessment of peak systolic velocity and time to peak systolic velocity at the 
RVOT in a cToF patient. Peak systolic velocity can be derived from the time-velocity curve (vertical arrow). Time 
to peak systolic velocity can be measured by calculating time from R to peak systolic velocity (horizontal arrow). 
Abbreviations: Ao: aorta, LV: left ventricle, RA: right atrium, RV: right ventricle, RVOT: right ventricular outflow tract.
 TDI VE-MRI mean dif-
ference
95% CI of 
difference
p-value paired samples 
coefficient
Peak systolic velocity
RVFW (cm/s) 9.1 ± 2.5 9.6 ± 3.0 -0.4 ± 1 -0.7 to -0.2 <0.01 0.95
RVOT (cm/s)* 6.4 (4.6-9.4) 6.6 (4.4-9.9) -0.4 ± 1 .. 0.02 0.95
Time to peak 
systolic velocity
RVFW (%) 14.5 ± 4.3 14.7 ± 4.4 -0.2 ± 1.6 -0.6 to 0.3 0.44 0.94
RVOT (%) 6.7 ± 2.2 7.2 ± 2.4 -0.5 ± 1.1 -0.8 to -0.2 0.01 0.89
Time difference
RVFW - RVOT (%)* 7.2 (5.1-10.1) 6.8 (5.3-9.2) -0.4 ± 2 .. 0.22 0.79
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Finally, the time difference between time to peak systolic velocity at the RVFW and at the RVOT 
was calculated and compared between TDI and VE-MRI. The difference between the two techniques 
was not statistically significant (Table 2). An excellent correlation was observed between the two 
techniques for the overall population (r=0.79, p<0.01) and after dividing the population in patients 
and controls (cToF patient: r=0.75, p<0.01, control r=0.76, p<0.01). Finally, Bland-Altman analysis 
yielded narrow limits of agreement (-3.6 to 4.4%).
Patients versus controls: VE-MRI peak systolic velocities and timing of velocitiess
The VE-MRI derived peak systolic velocities and time differences between the RVWF and RVOT 
were compared between cToF patients and controls. The peak systolic velocity at the RVFW was 
significantly reduced in cToF patients (median: 8.2cm/s, IQR: 6.4 to 9.7cm/s vs. median 12.4cm/s, 
IQR 10.8 to 13.8cm/s, p<0.01). Similarly, at the RVOT, the peak systolic velocity was reduced in 
cToF patients (median 4.7cm/s, IQR: 4.1 to 7.2, vs. median 10.2cm/s, IQR: 8.7 to 11.2cm/s, p<0.01). 
Finally, the time difference between peak systolic velocity at the RVFW and the RVOT was 
significantly shorter in cToF patients as compared with controls (median 5.9%, IQR: 4.9 to 7.4%, vs. 
median 8.4%, IQR: 6.6 to 12.4%, p<0.01).
DISCUSSION
Our study provides a direct comparison of tissue Doppler imaging and velocity-encoded magnetic 
resonance imaging to assess peak systolic velocities and timings of the right ventricular free wall 
and right ventricular outflow tract in patients with a corrected tetralogy of Fallot and in healthy 
subjects. The main findings of the present study are: 1) velocity-encoded magnetic resonance 
imaging and tissue Doppler imaging have a strong correlation and a good agreement for the 
assessment of peak systolic velocities and timings at the right ventricular free wall and right 
ventricular outflow tract in patients with corrected tetralogy of Fallot as well as in healthy 
subjects 2) both velocity-encoded magnetic resonance imaging and tissue Doppler imaging 
showed reduced peak systolic velocities in patients with corrected tetralogy of Fallot at the right 
ventricular free wall as well as at the right ventricular outflow tract 3) velocity-encoded magnetic 
resonance imaging showed that the time difference between peak systolic velocity at the right 
ventricular free wall and the right ventricular outflow tract was significantly reduced in patients with 
corrected tetralogy of Fallot. 
VE-MRI: peak systolic velocities
Evaluation of peak myocardial systolic velocities enables quantitative assessment of RV performance. 
Meluzin and co-workers demonstrated a close relationship between peak systolic velocity at the 
tricuspid valve annulus and RV ejection fraction in healthy subjects as well as in patients with LV 
failure (7). In addition, in patients with inferior myocardial infarction, Alam et al. demonstrated that 
measurement of tricuspid valve annular velocities with TDI enabled differentiation between patients 
Figure 2. 
Image analysis of velocity-encoded MRI images. (a): Example of anatomic location of myocardial RVFW segment 
where measurements were performed. Cine image of 4-chamber view (repetition time (TR) 3.9 ms, echo time (TE) 
1.5 ms, flip angle 50°). Red region of interest indicates myocardial segment where velocity-encoded measure-
ments were performed. (b): Example of anatomic location of myocardial RVOT segment where measurements 
were performed. Cine image of double oblique RVOT view, red region of interest indicates myocardial segment 
where velocity-encoded measurements were performed. (c): Velocity-encoded image of 4-chamber view. (TR: 5.4 
ms, TE: 3.4 ms, flip angle 10°) Velocity is encoded in longitudinal direction. A region of interest (red) is positioned 
at the basal RVFW in all cardiac phases. The average velocity at the region of interest is calculated in every phase, 
and can be displayed in a time-velocity curve, from which peak systolic velocity at the RVFW and time to peak sys-
tolic velocity at the RVFW can be derived. (d): Velocity-encoded image of RVOT. Velocity is encoded in longitudinal 
direction. A region of interest (red) is positioned at the lateral wall of the RVOT in all cardiac phases. The average 
velocity at the region of interest is calculated in every phase, and can be displayed in a time-velocity curve, from 
which peak systolic velocity at the RVOT and time to peak systolic velocity at the RVOT can be derived.
Abbreviations: Ao: Aorta, LA: left atrium, LV: left ventricle, PA: pulmonary artery, RA: right atrium, RV: right ven-
tricle, RVFW: right ventricular free wall, RVOT: right ventricular outflow tract.
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Figure 4. 
Correlation and agreement between TDI and VE-MRI for the assessment of time to peak velocity at the RVFW 
and at the RVOT. (a): Correlation between TDI and VE-MRI for the assessment of time to peak systolic velocity 
at the RVFW. (b): Agreement between TDI and VE-MRI for the assessment of time to peak systolic velocity at the 
RVFW. (c): Correlation between TDI and VE-MRI for the assessment of time to peak systolic velocity at the RV 
outflow tract. (d): Agreement between TDI and VE-MRI for the assessment of time to peak systolic velocity at 
the RV outflow tract. Timings are expressed as percentage of the RR interval. Triangles: cToF patients, squares: 
controls. Abbreviations: RVFW: right ventricular free wall, RVOT: right ventricular outflow tract, TDI: tissue Dop-
pler imaging, Ts: time to peak systolic velocity, VE-MRI: velocity encoded magnetic resonance imaging.
Abbreviations: RVFW: right ventricular free wall, RVOT: right ventricular outflow tract.
Figure 3. 
Correlation and agreement between TDI and VE-MRI for the assessment of peak systolic velocities at the RVFW 
and RVOT. (a): Correlation between TDI and VE-MRI for the assessment of peak systolic velocity at the RVFW. 
(b): Agreement between TDI and VE-MRI for the assessment of peak systolic velocity at the RVFW. (c): Cor-
relation between log TDI and log VE-MRI for the assessment of peak systolic velocity at the RV outflow tract. 
(d): Agreement between TDI and VE-MRI for the assessment of peak systolic velocity at the RV outflow tract. 
Triangles: cToF patients, squares: controls. 
Abbreviations: RVFW: right ventricular free wall, RVOT: right ventricular outflow tract, TDI: tissue Doppler ima-
ging, VE-MRI: velocity-encoded magnetic resonance imaging.which peak systolic velocity at the RVOT and time 
to peak systolic velocity at the RVOT can be derived.
Abbreviations: RVFW: right ventricular free wall, RVOT: right ventricular outflow tract.
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with and without RV dysfunction (4). In cToF patients, RV dysfunction is commonly observed (1). 
Cardiac MRI currently is the reference standard to measure volumes and ejection fraction of the RV 
(11). However, this parameter of RV function may be influenced by pulmonary regurgitation, commonly 
observed in this group of patients (18). In contrast, assessment of myocardial velocities is much 
less affected by loading conditions (19) and, therefore, it may provide a more accurate and reliable 
quantification of RV performance. In addition, myocardial velocities can be assessed at the regional 
level, providing more detailed information on systolic performance of the different RV components. 
Recently, VE-MRI was evaluated against TDI to assess LV myocardial velocities (12-15). However, no 
studies on VE-MRI for the assessment of RV myocardial velocities are available, to our knowledge. 
Our study provides a comparison of VE-MRI and TDI in healthy subjects and in cToF patients to assess 
myocardial velocities at the RVFW as well as at the RVOT. Excellent correlations between the two 
techniques were observed. A small difference between TDI and VE-MRI was observed, with VE-MRI 
slightly exceeding TDI velocities at both RV regions. The small bias may be explained by acoustic 
window limitations of TDI, preventing optimal alignment of the ultrasound beam with the myocardial 
wall in some patients. This may result in an underestimation of peak velocity. Other possible sources 
of bias may be phase errors or partial volume effects by VE-MRI, or technical differences between TDI 
(acquiring real-time velocities) and VE-MRI (acquiring a retrospectively-reconstructed time-velocity 
graph, averaged over 2-3 minutes). However, the observed statistical bias was small (≤0.7cm/s) and 
unlikely to be of any clinical relevance.
VE-MRI: timing of peak systolic velocities
In addition to the evaluation of myocardial velocities, VE-MRI has been shown to be a reliable tool 
for the assessment of timings and dyssynchrony of the LV (13,15). The use of VE-MRI to assess RV 
timings and possible dyssynchrony has not been studied, to our knowledge. Our study compared 
VE-MRI with TDI to assess timings of the RVFW and RVOT in healthy controls as well as in cToF 
patients. VE-MRI showed close correlation and agreement with TDI at both RV regions. At the 
RVOT, a small difference between VE-MRI and TDI was observed (0.5%). However, with an average 
cardiac cycle length of 800ms in our subjects, this difference equals approximately to 4ms, which 
is smaller than the temporal resolution of either technique. Moreover, the assessment of a time 
difference between the RVFW and the RVOT was highly concordant between TDI and VE-MRI, 
without a significant difference between the two techniques. 
VE-MRI velocities and timings; cToF patients versus controls
In cToF patients, RV dysfunction is commonly observed as a result of volume overload due to 
pulmonary regurgitation (1,3). Although MRI derived RV end-diastolic volume and ejection fraction 
are important parameters for clinical decision making in these patients, the exact pathophysiological 
mechanisms leading to RV failure remain to be elucidated to our knowledge (20). The study of 
regional peak systolic velocities may contribute to a better understanding of RV failure. A recent 
study observed reduced velocities at the RVFW in 25 asymptomatic adult cToF patients as 
compared with 25 healthy controls (5). Our study confirms this finding in young cToF patients. In 
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addition, our study extends these findings by assessing myocardial velocities and timings at the 
RVOT. In tetralogy of Fallot patients, surgical correction involves relief of the pulmonary stenosis 
by transannular patching or infundibulectomy. As a result, functional abnormalities of the RVOT are 
often observed, which have been related to RV performance (10,21). In our study, a reduced peak 
systolic velocity was observed in cToF patients, providing further evidence of abnormal mechanical 
performance of the RVOT in these patients.
Finally, time differences between peak systolic velocities at the RVFW and RVOT were evaluated. 
Investigation of the mechanical activation of the RV may help improve the results of different 
pacing strategies. The detrimental effects of RV apical pacing have been extensively demonstrated 
(22-24). In addition, the benefits of cardiac resynchronization therapy (CRT) may be maximized if 
the mechanical activation sequence of the RV is fully understood. Currently, little is known about 
the mechanical activation pattern of the different RV regions in either healthy subjects or cToF 
patients. In our study, a time delay between peak systolic velocity at the RVFW and RVOT was 
observed both cToF patients and controls. This presence of a time delay within the healthy RV 
confirms the findings of previous authors (9,10,25). In addition, the time delay within the RV was 
significantly shortened in cToF patients. These findings may have important clinical implications, 
as the pathophysiological basis of CRT is restoration of a synchronous contraction pattern and 
possibly, this concept may not be applied to the RV. In future studies, VE-MRI and TDI should be 
employed to investigate the RV mechanical activation pattern and its relation with RV performance. 
Study limitations
The observed statistical differences in timings of peak systolic velocities at the RVFW and RVOT 
between VE-MRI and TDI could have resulted from a difference in temporal resolution between the 
techniques. Nevertheless, the difference in temporal resolution between the techniques was very 
small (2.5 ms) and therefore unlikely to be relevant in clinical practice.
In conclusion, VE-MRI and TDI can be used interchangeably for the clinical assessment of 
myocardial velocities and timings of the RV in healthy subjects as well as in cToF patients. Using 
VE-MRI, significant differences were detected in myocardial velocities as well as timings of the 
RVFW and RVOT between cToF patients and controls. The assessment of timings of peak velocities 
at the RVFW and RVOT can aid in future research on the mechanical activation pattern of the RV in 
healthy subjects and in cToF patients.
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Objectives: In patients with corrected tetralogy of Fallot (cToF), pulmonary regurgitation and 
subsequent increased right ventricular (RV) end-diastolic volume are diastolic parameters related 
to adverse outcome. In addition, abnormalities of the RV outflow tract (RVOT) independently 
promote RV dilatation in cToF patients. Tissue Doppler imaging (TDI) and tissue-velocity magnetic 
resonance imaging (TV-MRI) enable quantitative assessment of regional diastolic performance 
by measuring myocardial velocities. Assessment of regional diastolic velocities of the RV may 
provide insight into the relation between RVOT dysfunction and RV dilatation in cToF patients. 
The aim of the study was to perform a direct comparison of TV-MRI against TDI to assess regional 
RV diastolic velocities in cToF patients and control subjects. In addition, the relationship between 
regional RV diastolic velocities and RV dilatation was investigated. 
Materials and methods: Thirty-four cToF patients (8-18 years) and 19 controls were studied. Early 
(E’) and late (A’) peak diastolic velocity and E’/A’ were assessed with TDI and TV-MRI at the RV 
free wall (RVFW) and at the RVOT. RV volumes and pulmonary regurgitation were quantified with 
planimetric and three-dimensional flow MRI, respectively. 
Results: Good correlation and agreement were observed between TDI and TV-MRI at both regions 
of the RV (RVFW: E’: r=0.92, mean bias: 0.5 cm/s, A’: r=0.92, mean bias: 0.4 cm/s; RVOT: E’:  r=0.92, 
mean bias: -0.3 cm/s, A’: r=0.95, mean bias: 0.03 cm/s). With both imaging techniques, regional 
RV diastolic velocities were significantly reduced in cToF patients. The E’/A’ ratio at the RVOT 
(assessed with both TDI and TV-MRI) was related to RV end-diastolic volume, even after correction 
for pulmonary regurgitation (TDI: p<0.01, TV-MRI: p=0.05).
Conclusions: TDI and TV-MRI can be used interchangeably for the assessment of regional diastolic 
velocities and performance of the RV in cToF patients and in healthy controls. Regional diastolic 
velocities at the RVOT are reduced in cToF patients as compared with controls. In addition to 
pulmonary regurgitation, impaired diastolic performance at the RVOT is independently related 
to RV dilatation.
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INTRODUCTION
Tetralogy of Fallot (ToF) is the most common cyanotic congenital heart disease. Patients with ToF 
present with a ventricular septum defect (VSD), overriding of the aorta, pulmonary stenosis, and 
right ventricular hypertrophy. In current clinical practice, ToF patients are surgically corrected in 
the first year of life. Correction is performed by closure of the VSD and relief of the pulmonary 
stenosis by infundibulectomy and/or patch placement at the right ventricular outflow tract (RVOT). 
In ToF patients after surgical correction (cToF), pulmonary regurgitation is commonly observed.1 
During long-term follow-up of cToF patients, right ventricular (RV) dilatation is related to poor 
clinical outcome in cToF patients.1 Chronic volume overload due to pulmonary regurgitation is 
recognized as an important factor causing RV dilatation in cToF patients.1, 2 However, various studies 
have demonstrated that, in addition to pulmonary regurgitation, functional abnormalities of the 
RVOT after surgical repair independently promote RV dilatation in cToF patients.3-5In the presence 
of pulmonary regurgitation, the diastolic filling pattern of the RV is altered. Abnormalities of the RV 
diastolic function are commonly observed in cToF patients with pulmonary regurgitation. However, 
the clinical implications of global diastolic dysfunction, including a restrictive RV filling pattern, in 
cToF patients remain unclear.6-9 In addition, regional diastolic function of the RV and specifically, 
of the RVOT has not been investigated so far. Therefore, assessment of diastolic velocities at the 
level of the RVOT may provide further insight into the relation between RVOT dysfunction and RV 
dilatation in cToF patients with pulmonary regurgitation.
Novel imaging techniques, such as tissue Doppler imaging (TDI) and tissue-velocity magnetic 
resonance imaging (TV-MRI) enable quantitative assessment of diastolic performance by 
measuring myocardial velocities.10, 11 Regional diastolic myocardial velocities as assessed with 
TDI and TV-MRI have not been evaluated in cToF patients, to our knowledge. Accordingly, the 
aim of the current study was to perform a head-to-head comparison between TV-MRI and TDI to 
investigate the performance of these techniques to assess regional RV diastolic velocities at the 
RV free wall (RVFW) and at the RVOT in cToF patients and control subjects with structurally normal 
hearts. In addition, the relationship between regional RV diastolic velocities and RV dilatation was 
investigated.
METHODS
Patient population and data collection
Thirty-four cToF patients were prospectively enrolled in the current study. Patients after pulmonary 
valve replacement or any contraindications for cardiac MRI, such as claustrophobia, pacemaker 
devices and arrhythmia were excluded. In addition, 19 healthy controls with a similar age range 
were included in the study. Part of the population included in the present study formed part of 
the patient population of a previously published study.9 All cToF patients and healthy controls 
underwent transthoracic echocardiography (including TDI) and cardiac MRI (including planimetry, 
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TV-MRI and three-dimensional (3D) flow assessment) at the same day. With TDI and TV-MRI, early 
(E’) and late (A’) diastolic myocardial velocities and the E’/A’ ratio were measured at the RVFW and at 
the RVOT. RV dilatation and pulmonary regurgitation were detected and quantified by planimetric 
MRI and novel 3D flow MRI, respectively.9, 12
A head-to-head comparison between TDI and TV-MRI for the assessment of regional diastolic 
velocities of the RV was performed. In addition, regional diastolic velocities measured with both 
techniques were compared between cToF patients and controls. Finally, the relationship between 
regional diastolic velocities and indexed RV end-diastolic volume was investigated, taking into 
account the relationship between pulmonary regurgitation and RV dilatation. The study protocol 
was approved by the institutional review board, and all cToF patients and controls or their parents 
gave written informed consent. 
Echocardiography: tissue Doppler imaging
Transthoracic echocardiography images were acquired by a single experienced sonographer 
using a commercially available system equipped with a 3.5 MHz transducer (Vivid-7, GE Vingmed 
Ultrasound AS, Horten, Norway). Subjects were in the left lateral decubitus position during image 
acquisition. Standard two-dimensional gray-scale images were acquired from the parasternal 
(long- and short-axis) and apical views (2-, 4-chamber and long-axis) and digitally stored in cine-loop 
format. Acquisition of TDI images was performed in the apical 4-chamber view for the assessment 
of diastolic velocities at the basal RVFW, (Figure 1, panel A) and in a dedicated apical RVOT view 
for the assessment of diastolic velocities at the RVOT as previous reported (Figure 1, panel 
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Table 1. cToF patient and control characteristics
Abbreviations: BSA: body surface area, EDV: end-diastolic volume, EF: ejection fraction; ESV: end-systolic 
volume, PR: pulmonary regurgitation, PV: pulmonary valve, RV: right ventricular. *Surgical records about age at 
correction and type of surgery were unknown for one patient. 
 cToF patients controls p-value
Age (y) 13 ± 3 14 ± 2 0.254
Male/female n (%) 19/15 (60/40) 12/7 (63/37) 0.606
BSA (m²) 1.4 ± 0.3 1.6 ± 0.3 0.075
Age at surgical correction (y)* 0.8 ± 0.4 ..
Type of surgery n (%)*
  transannular patch 22 (67) ..
  Infundibulectomy 5 (15) ..
  RVOT or PA patch 6 (18) ..
RV-EDV (ml/m²) 135 ± 35 99 ± 14 <0.001
RV-ESV (ml/m²) 69 ± 21 47 ± 10 <0.001
RV-EF (%) 50 ± 6 53 ± 4 0.027
PV forward flow (ml) 96 ± 30 77 ± 18 0.013
End diastolic forward flow n (%) 14 (41) ..
PR fraction (%) 29 ± 15 0.2 ± 0.6 <0.001
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B).13, 14 The transducer was placed at the apex of the heart and then aligned with the longitudinal 
axis of the RVOT. A previous study published TDI data obtained from the apical RVOT view with 
good reproducibility.13 Sector width and angle were adjusted to align the ultrasound beam with 
the direction of the myocardial motion. Images were recorded during breath-hold to minimize 
translational motion. The color frame rate was ≥120 frames/s (temporal resolution 8.3 ms), and 
three consecutive beats were recorded. The acquisition time of the TDI images was approximately 
one minute per image.
Analysis of TDI images was performed off-line using EchoPac version 108.1.5 (General Electric 
Medical Systems, Horten, Norway). Longitudinal myocardial velocity curves were obtained by 
placing regions of interest (5 x 5 mm) at the basal RVFW in the apical 4-chamber view (Figure 1A, 
right panel) and at the lateral RVOT in the apical RVOT view (Figure 1B, right panel). The basal RVFW 
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Table 2. Comparisons of flow volumes between 2D VE-MRI, 3D VE-MRI and planimetry
Abbreviations: A’: peak late diastolic velocity, E’: peak early diastolic velocity, RVFW: right ventricular free wall, 
RVOT: right ventricular outflow tract, TDI: tissue Doppler imaging, TV-MRI: tissue-velocity magnetic resonance 
imaging. * data presented as median and inter-quartile range. 
Figure 1. TDI images of RVFW and RVOT in a cToF patient
Panel A: Left: gray-scale echocardiographic image of a 4-chamber view. Right: TDI image of a 4-chamber view. 
A yellow region of interest is indicated at the myocardial wall of the basal RVFW, from which the velocity curve 
is derived. Panel B: Left: gray-scale echocardiographic of dedicated RVOT view. Right: TDI image of RVOT view. 
A yellow region of interest is indicated at the myocardial wall of the lateral RVOT, from which the velocity curve is 
derived. Panel C: TDI derived velocity curve of the RVFW in a cToF patient. White arrows indicate E’ and A’.
Abbreviations: A’: peak late diastolic velocity, AO: Aorta, E’: peak early diastolic velocity, LA: left atrium, 
LV: left ventricle, PA: pulmonary artery, RA: right atrium, RV: right ventricle, RVOT: right ventricular outflow tract, 
TDI: tissue Doppler imaging.
 cToF patients controls p-value
RVFW    
 E’ (cm/s)    
       TDI           -9.9 ± 2.7 -12.6 ± 2.0 <0.001
       TV-MRI -10.2 ± 2.7 -13.3 ± 2.2 <0.001
A’ (cm/s)    
       TDI           -4.2 ± 1.5 -6.3 ± 1.4 <0.001
       TV-MRI   -4.6 ± 1.8 -6.7 ± 1.6 <0.001
E’/A’    
       TDI*          2.4 (2.0 – 3.1) 2.0 (1.7 – 2.4) 0.038
       TV-MRI*   2.3 (1.8 – 2.9) 1.9 (1.7 – 2.6) 0.095
RVOT    
E’ (cm/s)    
       TDI           -6.6 ± 2.1 -7.9 ± 1.8 0.041
       TV-MRI   -6.4 ± 2.1 -7.5 ± 2.1 0.071
A’ (cm/s)
       TDI -1.8 ± 1.3 -3.1 ± 1.1 0.002
       TV-MRI  -1.9 ± 1.3 -3.1 ± 1.1 0.002
E’/A’
       TDI* 4.0 (2.6 – 7.7) 2.9 (1.9 – 3.7) 0.015
       TV-MRI* 3.7 (2.5 – 5.8) 2.5 (1.9 – 3.3) 0.008
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was defined as the most basal region of the right ventricular free wall just apical to the tricuspid 
annulus in the 4-chamber view. The lateral RVOT was defined as the region of the RVOT opposite 
to the septum, just apical to the pulmonary valve annulus. The anatomical position of the ROI was 
identified at end-diastole. Semi-automated tissue tracking was used to maintain the sample area 
within the region of interest throughout the cardiac cycle. If needed, the sampling area was adjusted 
to fit within the region of interest. Myocardial velocity curves (Figure 1, panel C) were constructed 
by the software. From these curves, regional early diastolic velocity (E’) and regional late diastolic 
velocity (A’) were obtained at both RV regions. Finally, the ratio of E’ and A’ (E’/A’), was calculated for 
both regions of the RV. Previous authors have shown that an increased E’/A’ ratio indicates early 
impairment of diastolic function.15
Magnetic resonance imaging: TV-MRI 
MRI was performed on a 1.5-Tesla pulsar gradient system (Intera, release 12; Philips Medical 
Systems, Best, the Netherlands) with 33 mT/m amplitude, 100 mT/m/ms slew rate, and 0.33 ms 
rise time. A five-element cardiac coil was used for signal reception. TV-MRI was performed in 
a 4-chamber orientation to assess diastolic velocities at the RVFW (Figure 2, panel A), and in a 
double oblique coronal RVOT view, positioned along the longitudinal axis of the RVOT and through 
the pulmonary valve, for the assessment of diastolic velocities at the RVOT (Figure 2, panel B). 
Data acquisition was performed during free breathing and retrospective triggering was used. The 
acquisition time was approximately three minutes per TV-MRI image. The scan parameters were: 
repetition time (TR) 5.4 ms; echo time (TE): 3.4 ms; flip angle 10°; slice thickness 8 mm; field-of-
view 370 mm; 2.9×2.9×8.0 mm acquisition voxel reconstructed into a 1.4×1.4×8.0 mm voxel. To 
optimize signal-to-noise ratio, four signal averages were acquired. The maximum velocity was set 
at 20 cm/s. The maximum number of phases was reconstructed, yielding an effective temporal 
resolution in the velocity graph of approximately 10 ms (true temporal resolution, defined by the 
number of acquisitions for velocity encoding and the repetition time, equals 2×5.4 = 10.8 ms). 
Image analysis was performed by placing regions of interest (5 x 5 mm) in the myocardium at the 
basal RVFW (the most basal region of the right ventricular free wall just apical to the tricuspid 
annulus in the 4-chamber view) (Figure 2A, right panel) and at the lateral wall of the RVOT opposite 
the septum and just apical to the pulmonary annulus (Figure 2B, right panel). The anatomical 
position of the ROI was identified at end-diastole in the modulus image and then copied into the 
corresponding TV-MRI image. Manual re-positioning of the regions of interest was performed on 
a frame by frame visual evaluation throughout the cardiac cycle to ensure data sampling within the 
myocardial region of interest. If needed, the sampling area was adjusted to fit within the region of 
interest. The average myocardial velocity within the region of interest was recorded in every phase 
for both segments, from which velocity graphs were constructed (Figure 2, panel C). From these 
graphs, E’ (cm/s) and A’ (cm/s) were derived at both regions of the RV. Finally, E’/A’ was calculated 
at the RVFW and of the RVOT. 
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Figure 2. TV-MRI images of RVFW and RVOT in a cToF patient
Panel A: Left: Cine image of a 4-chamber view, anatomical example of how TV-MRI images were planned. Right: 
TV-MRI image in a 4-chamber orientation. Velocity is encoded in the longitudinal direction. A red region of 
interest is indicated at the myocardial wall of the basal RVWF, from which the velocity curve is derived. Pa-
nel B: Left: Cine image of a double oblique RVOT view, anatomic example of how TV-MRI images were planned. 
Right: TV-MRI image in a double oblique RVOT orientation. Velocity is encoded in the longitudinal direction. A red 
region of interest is indicated at the myocardial wall of the lateral RVOT, from which the velocity curve is derived. 
Panel C: TV-MRI derived velocity curve of the RVFW in a cToF patient. White arrows indicate E’ and A’. Abbreviations: 
A’: peak late diastolic velocity, AO: Aorta, E’: peak early diastolic velocity, LA: left atrium, LV: left ventricle, PA: 
pulmonary artery, RA: right atrium, RV: right ventricle, RVOT: right ventricular outflow tract, TV-MRI: tissue-
velocity magnetic resonance imaging.  
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Figure 3. Correlation and agreement between TDI and TV-MRI for the assessment of regional 
diastolic velocities at the RVFW
Panel A: Left: scatterplot depicting correlation between TDI and TV-MRI for the assessment of E’ at the RVFW. 
Right: Bland-Altman plot showing agreement between TDI and TV-MRI for the assessment of E’ at the RVFW. 
Panel B: Left: scatterplot depicting correlation between TDI and TV-MRI for the assessment of A’ at the RVFW. 
Right: Bland-Altman plot showing agreement between TDI and TV-MRI for the assessment of A’ at the RVFW. 
Abbreviations: A’: peak late diastolic velocity, E’: peak early diastolic velocity , RVFW: right ventricular free wall, 
TDI: tissue Doppler imaging, TV-MRI: tissue-velocity magnetic resonance imaging. 
Figure 4. Correlation and agreement between TDI and TV-MRI for the assessment of regional 
diastolic velocities at the RVOT
Panel A: Left: scatterplot depicting correlation between TDI and TV-MRI for the assessment of E’ at the RVOT. 
Right: Bland-Altman plot showing agreement between TDI and TV-MRI for the assessment of E’ at the RVOT. 
Panel B: Left: scatterplot depicting correlation between TDI and TV-MRI for the assessment of A’ at the RVOT. 
Right: Bland-Altman plot showing agreement between TDI and TV-MRI for the assessment of A’ at the RVOT. Ab-
breviations: A’: peak late diastolic velocity, E’: peak early diastolic velocity , RVFW: right ventricular free wall, TDI: 
tissue Doppler imaging, TV-MRI: tissue-velocity magnetic resonance imaging. 
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Magnetic resonance imaging: planimetry
RV volumes and ejection fraction were assessed with MRI planimetry. RV planimetry assessment 
was performed by transverse multi-section cine imaging. A stack of slices was planned in the 
transverse plane, covering the RV throughout the cardiac cycle. Cine images were acquired with a 
steady-state free precession sequence during breath hold at end-expiration. The scan parameters 
were: TR/TE: 3.9 ms/1.5 ms; flip angle 50°; slice thickness 8 mm; field of view 350 mm; 1.8×2.0×8.0 
mm acquisition voxel reconstructed into a 1.4×1.4×8.0 mm voxel; one signal acquired; 30 phases 
reconstructed; retrospective gating with 10% acceptance window.
Image analysis was performed with the MASS software (Leiden University Medical Center, Leiden, 
the Netherlands). RV end-diastolic volume and RV end-systolic volume were calculated by manually 
tracing the endocardial border at end-systole and end-diastole in all transverse slices in which 
myocardium was visible and multiplying the area by slice thickness. Tracing of the endocardial 
border was aided by visualization of the multiple phases in cine mode in every slice. The RVOT was 
included in the volume calculations of the RV.  From the obtained RV volumes, RV ejection fraction 
was automatically calculated. 
Magnetic resonance imaging: 3D flow 
Flow volume over the pulmonary valve was assessed with 3D velocity-encoded MRI. Detailed 
descriptions of the assessment of valvular flow and valvular function with 3D velocity-encoded 
MRI have been published recently.9, 11, 16 In short, two orthogonal guide views of the pulmonary 
valve were obtained (double oblique coronal view and double oblique sagittal view of the RV 
outflow tract). In addition, a 3D volume slab was localized at the base of the heart covering the 
pulmonary valve throughout the cardiac cycle. In the 3D volume slab, velocity was encoded in three 
orthogonal directions during free breathing. The scan parameters were: TR/TE 7.5 ms/4.3 ms; flip 
angle 10°; 3D volume imaging with 48 mm slab thickness reconstructed into 12×4 mm slices; field-
of-view 370 mm; 2.9×3.8×4.0 mm acquisition voxel reconstructed into a 1.4×1.4×4.0 mm voxel; 
one signal acquired; 30 phases reconstructed; retrospective gating with 10% acceptance window. 
A standard velocity-encoding of 150 cm/s was used in all three directions. Echo planar imaging 
was used with a factor of five. The acquisition time for 3D flow images was approximately five 
minutes.
For analysis of the 3D flow images of the pulmonary valve, first, the two orthogonal guide views 
of the pulmonary valve were used for ‘retrospective valve tracking’. In both views, a reformatting 
plane was marked perpendicular to the flow at the level of the valve annulus in every cardiac 
phase. The three-directional velocity data from the 3D volume slab were reformatted in this 
plane, yielding 30 through-plane velocity-encoded images at the level of the pulmonary valve. 
Second, in these reformatted images, the inner border of the pulmonary annulus was traced to 
obtain flow volumes. Background correction was performed to correct for through-plane motion 
and local phase offset. Finally, a flow velocity curve was obtained by multiplying the valve area 
in each time frame by its average flow velocity. From this curve, pulmonary forward flow volume 
(ml), pulmonary regurgitation fraction (%) and the presence of end diastolic forward flow (EDFF) 
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were derived. EDFF indicates a restrictive RV filling pattern, and is defined as the presence of late 
diastolic forward flow over the pulmonary valve that coincides with atrial contraction.6 
Statistical analysis
Variables were tested for normal distribution by the Kolmogorov-Smirnov test. Continuous variables 
with a normal distribution are expressed as mean ± standard deviation. Continuous data with no 
normal distribution are expressed as median and inter-quartile range (IQR). Categorical variables 
are presented as numbers and percentages. Differences between TDI and TV-MRI, and differences 
between cToF patients and controls, and between cToF patients with and without EDFF were 
analyzed using the paired or unpaired t-test where appropriate for normally distributed continuous 
data. For continuous data with no normal distribution, the Mann-Whitney U-test (unpaired data) 
or Wilcoxon signed rank test (paired data) were used. Categorical data were analyzed with the 
Chi-square test. Bland-Altman analysis was performed to assess the agreement between the 
two techniques. Linear regression analysis was used to evaluate the correlation between TDI and 
TV-MRI measurements. In addition, univariate and multivariate linear regression analyses were 
performed to investigate the effect of various clinical parameters, including regional diastolic 
velocities, on RV end-diastolic volume. Only significant univariate parameters were entered as 
variables in the multivariate analysis. Data were analyzed using the SPSS 17.0 software (SPSS Inc, 
Chicago, Illinois). A p-value of <0.05 was considered statistically significant. 
RESULTS
Study population
The characteristics of the patients and controls are summarized in Table 1. Age, gender and body 
surface area did not differ between cToF patients and controls. RV end-diastolic volume indexed 
for body surface area was significantly larger in cToF patients as compared with controls (135 ± 
35 ml/m² vs. 99 ± 14 ml/m², p<0.001). In cToF patients, the mean pulmonary regurgitation fraction 
was 29 ± 15%. A total of 14 patients showed EDFF over the pulmonary valve. None of the patients 
showed an aneurysmatic or dyskinetic RVOT. Satisfactory TDI and TV-MRI images of the RVFW and 
RVOT were obtained in all patients and control subjects. 
Diastolic velocities at the RVFW: TDI versus TV-MRI 
Early and late diastolic velocities at the RVFW were compared between TDI and TV-MRI. Figure 
3A shows a strong correlation between TDI and TV-MRI to measure E’ at the RVFW in the full 
population (Figure 3A, left panel). After dividing the population in cToF patients and controls, the 
correlations between TDI and TV-MRI to assess E’ at the RVFW were r=0.91 (p<0.001) and r=0.87 
(p<0.001), respectively. In addition, the Bland-Altman analysis showed a small bias between TDI 
and TV-MRI and tight limits of agreement in the full population (Figure 3A, right panel) Subgroup 
analysis yielded an average difference of 0.4 cm/s (limits of agreement of -1.9 to 2.6 cm/s) in cToF 
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patients and an average difference of 0.7 cm/s (-1.4 to 2.8 cm/s) in the control subjects. Similarly, 
for the assessment of A’ at the RVFW, TDI and TV-MRI showed a strong pooled correlation, as shown 
in Figure 3B (left panel). Assessing A’ at the RVFW in the subgroups of cToF patients and control 
subjects yielded correlations of r=0.9 (p<0.001) and r=0.85 (p<0.001), respectively. Furthermore, 
Bland-Altman analysis yielded small differences with narrow limits of agreement in the full 
population (Figure 3B right panel) as well as in the subgroups of cToF patients (average difference: 
0.4 cm/s, limits of agreement: -1.2 to 1.9 cm/s) and controls (0.4 cm/s, -1.3 to 2.12 cm/s). 
Diastolic velocities at the RVOT: TDI versus TV-MRI 
Figure 4A illustrates the correlation and agreement between TDI and TV-MRI-derived measurements 
of E’ at the RVOT in the full population. When dividing the population in cToF patients and controls, 
strong correlations were observed (cToF patients: r=0.94, p<0.001, controls r=0.87 p<0.001). The 
Bland-Altman analysis to assess E’ at the RVOT in the full population is shown in Figure 4A (right 
panel). Bland-Altman analysis in the subgroups of cToF patients and controls showed an average 
difference between TDI and TV-MRI of -0.3 cm/s in cToF patients (limits of agreement -1.7 to 1.1 
cm/s) and of -0.4 cm/s (-2.5 to 1.6 cm/s) in controls. 
Figure 4B shows the correlation and agreement between TDI and TV-MRI for the assessment 
of A’ at the RVOT in the full population. In the subgroups of cToF patients and controls, excellent 
correlations (cToF patients r=0.94, p<0.001, controls r=0.96, p<0.001) were observed, with small 
differences between the two techniques (cToF patients: average difference 0.05 cm/s, limits of 
agreement -0.9 to 1.0 cm/s, controls: 0.04 cm/s, -0.5 to 0.5 cm/s). 
RV regional diastolic velocities and performance: cToF patients versus controls
The regional diastolic velocities and the derived E’/A’ ratio, as assessed with both TDI and TV- MRI, 
were compared between cToF patients and controls (Table 2). 
At the RVFW, E’ was significantly reduced in cToF patients as compared to controls, as assessed with 
both TDI and TV-MRI (TDI: -9.9 ± 2.7 cm/s vs. -12.6 ± 2.0 cm/s, p<0.001, TV-MRI: -10.2 ± 2.7 cm/s vs. 
-13.3 ± 2.2 cm/s, p<0.001). Likewise, A’ at the RVFW was significantly decreased in cToF patients with 
both imaging techniques (Table 2). Finally, the E’/A’ at the RVFW was increased in cToF patients as 
compared with controls, although with TV-MRI, the difference did not reach statistical significance 
(TDI: 2.4 (2.0 – 3.1) vs. 2.0 (1.7 – 2.4), p=0.038, TV-MRI: 2.3 (1.8 – 2.9) vs. 1.8 (1.7 – 2.6), p=0.095). 
E’ at the RVOT, as assessed with TDI, was reduced in patients (-6.6 ± 2.1 cm/s vs. -7.9 ± 1.8 cm/s, 
p=0.041). With TV-MRI, the reduction of E’ in cToF patients was not statistically significant (-6.4 ± 
2.1 cm/s vs. -7.5 ± 2.1 cm/s, p=0.071 cm/s). In addition, A’ at the RVOT was significantly decreased 
in cToF patients as compared to controls with both TDI and TV-MRI (Table 2). Finally, the E’/A’ at the 
RVOT was significantly increased in cToF patients with both imaging techniques (TDI: 4.0 (2.6 – 7.7) 
vs. 2.9 (1.9 – 3.7), p=0.015, TV-MRI: 3.7 (2.5 – 5.8) vs. 2.5 (1.9 – 3.3), p=0.008). Comparing the cToF 
patients with and without a restrictive RV filling pattern, no differences in diastolic velocities and 
performance were observed at the RVFW (TDI RVFW E’: p=0.250, TV-MRI RVFW E’: p=0.491, TDI 
RVFW A’: p=0.101, TV-MRI A’: p=0.119, TDI RVFW E’/A’: p=0.299, TV-MRI RVFW E’/A’: p=0.248). In 
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addition, at the RVOT, no differences in diastolic velocity and performance were observed between 
patients with and without EDFF (TDI RVOT E’: p=0.394, TV-MRI RVOT E’: p=0.332, TDI RVOT A’: 
p=0.887, TV-MRI A’: p=0.985, TDI RVOT E’/A’: p=0.241, TV-MRI RVOT E’/A’: p=0.449).
Regional diastolic performance and RV dilatation
Univariate regression analysis was performed to investigate the relationship between various clin-
ical parameters, including the diastolic performance parameters, and indexed RV end-diastolic vol-
ume. No significant relation was observed between RV end diastolic volume and gender (p=0.186), 
age at surgical correction (p=0.107) or type of surgery (p=0.367). In contrast, pulmonary regurgita-
tion fraction was closely related to RV end-diastolic volume (r=0.71, p<0.01). Among the diastolic 
performance parameters at the RVFW, no significant relationship was observed between E’/A’ ratio 
and RV end-diastolic volume (TDI: r=0.18, p=0.20, TV-MRI: r=0.14, p=0.31). In contrast, at the RVOT, 
a significant relation between the E’/A’ ratio and RV end-diastolic volume was observed, with both 
TDI and TV-MRI (TDI: r=0.60, p<0.01, TV-MRI: r=0.48, p<0.01). 
Subsequently, multivariate regression analysis was performed to further investigate the observed 
relationship between diastolic velocities at the RVOT and the indexed RV end-diastolic volume. 
After correction for the pulmonary regurgitation fraction, E’/A’ ratio at the RVOT remained 
significantly related with indexed RV end-diastolic volume (TDI: p<0.01, TV-MRI: p=0.05).
DISCUSSION
The current study demonstrated that TDI and TV-MRI can be used interchangeably for the clinical 
assessment of regional diastolic velocities of the RV in cToF patients and in healthy controls. In ad-
dition, as assessed with both TDI and TV-MRI, regional diastolic velocities at the RVFW and RVOT 
are reduced in cToF patients as compared with healthy controls.
Finally, regional diastolic velocities at the RVOT were significantly related with RV end-diastolic 
volume, and this was independent of pulmonary regurgitation fraction.
Regional diastolic velocities of the RV
The assessment of diastolic velocities plays an essential role in the diagnosis of diastolic function in 
the left ventricle.17 In the RV, recent data have shown that reduced diastolic velocities (as assessed 
at the tricuspid annulus) may be an early sign of compromised RV function.18 However, no studies 
on the use of TV-MRI for the assessment of RV diastolic velocities are available. In addition, with 
both TDI and TV-MRI, the feasibility of the assessment of regional diastolic velocities of the RV 
has not been explored, to our knowledge. The current study provides a head-to-head comparison 
of TV-MRI and TDI in healthy subjects and in cToF patients to assess regional myocardial diastolic 
velocities at the RVFW and at the RVOT. Excellent correlations and a small bias between TDI and 
TV-MRI were observed at both RV regions. However, as the observed statistical difference was 
very small, it is unlikely to be relevant in clinical practice. Accordingly, for clinical purposes, both 
TDI and TV-MRI can be used interchangeably to assess regional RV diastolic velocities in healthy 
subjects and cToF patients.
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Regional velocities and performance: cToF patients versus controls
Increased RV end-diastolic volume and pulmonary regurgitation are diastolic parameters strongly 
related with adverse outcome in cToF patients.1, 2 Furthermore, global diastolic dysfunction as 
assessed with pulsed-waved Doppler recordings of the RV inflow, is commonly observed in cToF 
patients.6-9 However, the clinical implications of global diastolic dysfunction in cToF patients with 
pulmonary regurgitation remain unclear, as conflicting results have been published.6-9 
Previous studies have suggested that, in addition to pulmonary regurgitation, functional 
abnormalities of the RVOT may promote RV dilatation and RV dysfunction in cToF patients.3-5, 19, 20 
Therefore, comprehensive assessment of regional diastolic performance at the level of the RVOT 
in cToF patients may provide further insight into the pathophysiological mechanisms leading to 
RV dilatation in cToF patients with pulmonary regurgitation. In the current study, we observed 
significantly reduced early and late regional diastolic velocities at the RVFW and RVOT. The 
reduced diastolic velocities at the RVFW are in agreement with a recent study.21 Brili et al. assessed 
diastolic velocities at the RV tricuspid annulus with TDI in 25 asymptomatic cToF patients.21 
Diastolic velocities were significantly reduced as compared with healthy controls. The current 
study extends these observations with the finding of reduced diastolic velocities at the RVOT in 
cToF patients. Furthermore, E’/A’ ratio was evaluated in healthy controls and in cToF patients at 
both the RVFW and the RVOT. An increased E’/A’ ratio has been demonstrated to reflect impaired 
myocardial relaxation.15 In the present study, at both RV regions, E’/A’ ratio was increased in cToF 
patients, indicating impaired diastolic performance at both RV regions in cToF patients. Finally, a 
total of 40% of patients showed a restrictive filling RV filling pattern, as assessed with 3D flow. 
Conflicting results on the clinical consequences of the occurrence of RV restriction in cToF patients 
have been published.6, 8 In the present study, no differences were observed in diastolic myocardial 
velocities between patients with and without a restrictive RV filling pattern.
Relationship between diastolic performance and RV end-diastolic volume
In the current study, cToF patients showed significant pulmonary regurgitation and RV dilatation. A 
close relationship was observed between the pulmonary regurgitation and RV end-diastolic volume, 
which is in line with previous reports.1, 2 Furthermore, increased E’/A’ ratio at the RVOT, indicating 
impaired diastolic filling, was related to increased RV end-diastolic volume in the present analysis. 
This relationship between diastolic performance at the RVOT and indexed RV dilatation remained 
significant after correcting for pulmonary regurgitation and gender. At the RVFW, this relationship 
between diastolic performance and RV dilatation was not observed. These findings have important 
clinical implications, as RV dilatation in cToF patients is related with a poor clinical outcome. 
Furthermore, a recent study demonstrated that RV dilatation significantly increases over time in 
cToF patients.22 A significant dilatation of the RV in cToF patients with pulmonary regurgitation is 
an indication for pulmonary valve replacement in order to reduce RV volume and improve clinical 
outcome.23 However, various studies have demonstrated a lack of RV remodeling after pulmonary 
valve replacement in a substantial part of cToF patients.24-26 The observed independent relationship 
between diastolic performance at the RVOT and RV end-diastolic volume in cToF patients suggests 
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that RVOT dysfunction plays an additional role in the development of RV dilatation. This concept is 
supported by the results of a previous study by d’Udekem d’Acoz et al.4 A total of 189 cToF patients 
were compared to 44 patients with pulmonary regurgitation after commissurotomy for pulmonary 
stenosis. The authors demonstrated that despite equal amounts of pulmonary regurgitation, cToF 
patients had larger RV end-diastolic volumes as compared with the patients after correction of 
pulmonary stenosis.4 An important difference between surgical correction of tetralogy of Fallot 
and surgical correction of isolated pulmonary valve stenosis is the manipulation of the RVOT 
during tetralogy of Fallot correction. During surgical correction of tetralogy of Fallot, resection 
of infundibular muscle fibers or patch insertion at the RVOT is almost invariably needed to relieve 
the pulmonary stenosis. As a result, regional scar tissue may lead to functional abnormalities of 
the RVOT.5, 20 Several studies have shown a relationship between regional RVOT abnormalities and 
RV systolic dysfunction in cToF patients.13, 14, 20 The present study furthermore shows with two 
different imaging techniques that impaired RVOT diastolic performance is independently related 
to RV dilatation in cToF patients. Accordingly, in addition to pulmonary valve replacement, (surgical) 
treatment of cToF patients with pulmonary regurgitation and RV dilatation may need to target the 
RVOT. Additional studies to elucidate whether a targeted intervention on the RVOT in cToF patients 
undergoing pulmonary valve replacement may lead to improved outcomes are warranted.
Study limitations
The difference in temporal resolution between TDI and TV-MRI may have a small effect on the 
performance of peak diastolic velocity detection in the time-velocity graphs. However, as the 
difference in temporal resolution was very small (2.5 ms), this is unlikely to be relevant in clinical 
practice. Furthermore, myocardial velocity assessment with TDI and TV-MRI represents myocardial 
motion or displacement and does not image active myocardial deformation. Additional studies 
investigating regional diastolic myocardial deformation in cToF patients are needed. Finally, the 
manual repositioning of the regions of interest throughout the cardiac cycle may have introduced 
a small error in the velocity measurements, and furthermore the relatively small sampling area 
of the study may have influenced the results of the subgroup analyses. External validation of the 
observed diastolic myocardial velocities and the correlations and agreement between TDI and TV-
MRI to assess diastolic velocities at the RVFW and RVOT is warranted. 
Conclusions
TDI and TV-MRI can be used interchangeably for the clinical assessment of regional diastolic 
velocities of the RV in cToF patients and in healthy controls. Regional diastolic velocities and 
performance at the RVFW and RVOT are reduced in cToF patients as compared with healthy controls. 
The assessment of regional RV diastolic performance with TDI and TV-MRI provides further insight 
into the mechanism leading to RV dilatation in cToF patients, as regional diastolic performance at 
the RVOT was related to RV dilatation. 
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ABSTRACT
Purpose: To evaluate three-dimensional (3D) velocity-encoded (VE) magnetic resonance (MR) 
imaging, as compared with two-dimensional (2D) VE MR imaging, for assessment of pulmonary 
valve (PV) and tricuspid valve (TV) flow, with planimetry as the reference standard, and to evaluate 
diastolic function in patients with a corrected tetralogy of Fallot (TOF). 
Materials and Methods: Local institutional review board approval was obtained, and patients 
or their parents gave informed consent. Twenty-five patients with a corrected TOF (12 male, 13 
female; mean age, 13.1 years ± 2.7 [standard deviation]; age range, 8–18 years) and 19 control 
subjects (12 male, seven female; mean age, 14.1 years ± 2.4; age range, 8–18 years) underwent 
planimetric MR imaging, 2D VE MR imaging, and 3D VE MR imaging for TV and PV flow evaluation. 
For evaluation of diastolic function, PV and TV flow were summated. Data were analyzed by using 
linear regression analysis, paired and unpaired t testing, and Bland-Altman plots. 
Results: Strong correlations between the 2D VE MR and 3D VE MR measurements of PV flow (for 
forward flow: r = 0.87, P < .01; for backward flow: r = 0.97, P < .01) were observed. With PV effective 
flow as a reference, 3D TV effective flow measurements were more accurate than 2D TV effective 
flow measurements: In patients, the mean 2D TV effective flow versus 2D PV effective flow 
difference was 17.6 mL ± 11 (P < .001), and the mean 3D TV effective flow versus 3D PV effective flow 
difference was −1.2 mL ± 4.7 (P = .22). Diastolic functional impairment in patients could be detected 
at 3D VE MR imaging diastolic assessment. 
Conclusion: Three-dimensional VE MR imaging is accurate for PV flow assessment and is more 
accurate than 2D VE MR imaging for TV flow evaluation. Assessment of diastolic function with 3D VE 
MR imaging can facilitate ongoing research of diastolic dysfunction in patients with a corrected TOF. 
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imaging for ealuation of right ventricular valve flow 
and diastolic function in patients after correction
Radiology 2010; 256: 724-734
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INTRODUCTION
Tetralogy of Fallot (TOF) is one of the most common congenital heart diseases and consists of 
pulmonary stenosis, overriding of the aorta, ventricular septal defect, and right ventricular 
hypertrophy. Currently, surgical correction is performed in the first year of life by means of closure 
of the ventricular septal defect and relief of the pulmonary stenosis. After correction, pulmonary 
regurgitation is common. In a large multicenter study involving patients with corrected TOF, 54% 
of patients had at least moderate pulmonary regurgitation (1). Accurate assessment of pulmonary 
regurgitation is important, because this is a key determinant of the outcome of patients with a 
corrected TOF (1,2). In addition, right ventricular diastolic dysfunction is frequently observed (3-
5), with the estimated percentage of patients with a right ventricular restrictive filling pattern 
ranging from 35% to 66% (3,5-9). Conflicting results regarding the implications of diastolic 
dysfunction—the role of right ventricular restriction in particular—in terms of the long-term 
prognosis for patients with a corrected TOF have been published (3,5-9). This disparity can be 
attributed in part to technical difficulties in the assessment of right ventricular diastolic function. 
Echocardiography is a simple and widely available imaging modality for the assessment of right 
ventricular systolic and diastolic function. However, in patients with pulmonary regurgitation, 
right ventricular diastolic function does not correspond to Doppler echocardiographic tricuspid 
valve (TV) inflow patterns, because early diastolic filling of the right ventricle occurs from two 
sources: normal inflow through the TV and pathologic pulmonary regurgitation. 
In contrast, two-dimensional (2D) one-directional velocity-encoded magnetic resonance (MR) 
imaging enables evaluation of right ventricular diastolic function in the presence of pulmonary 
regurgitation by means of summation of the TV and pulmonary valve (PV) flow volumes obtained 
during two acquisitions (5,8). Currently, 2D velocity-encoded MR imaging is the method of choice 
for assessment of PV flow in clinical practice (10-13). However, 2D velocity-encoded MR evaluation 
of atrioventricular transvalvular flow is hampered by cardiac motion, because the acquisition 
plane is fixed throughout the cardiac cycle (14,15), whereas the TV may move up to 24 mm toward 
the apex during systole (16). As a result, correlations between atrioventricular transvalvular flow 
and aortic flow are only moderate (17). Moreover, it has been shown that 2D velocity-encoded 
MR imaging can lead to overestimations of TV flow volume of up to 25% (18). Finally, heart rate 
variability during separate flow acquisitions reduces the accuracy of the summation of TV and PV 
flow volumes in the assessment of diastolic function. 
Three-dimensional (3D) three-directional velocity-encoded MR imaging has been introduced 
for the assessment of transvalvular flow (17-19). The use of 3D velocity-encoded MR imaging 
resolves the problem of valvular annulus motion owing to retrospective valve tracking and 
velocity encoding in three orthogonal directions. In addition, 3D velocity-encoded MR imaging 
enables flow assessment through all cardiac valves during the same acquisition, eliminating 
the error that results from heart rate variability. Accordingly, the purpose of our study was to 
Right ventricular imaging: cardiac magnetic resonance3
evaluate 3D velocity-encoded MR imaging, as compared with 2D velocity-encoded MR imaging, 
for assessment of PV and TV flow, with planimetry as the reference standard, and to evaluate the 
diastolic function in patients with a corrected TOF. 
MATERIALS AND METHODS
Subjects
All participants or their parents gave written informed consent. Twenty-five patients who had a 
corrected TOF with pulmonary regurgitation (mean age, 13.1 years ± 2.7 [standard deviation]) and 
19 healthy control subjects (mean age, 14.1 years ± 2.4) underwent cardiac MR imaging, inclu-
ding MR planimetry (summation of disks from multisection 2D MR imaging) and both 2D velocity-
encoded MR imaging and 3D velocity-encoded MR imaging assessment of PV and TV flow. The 
image quality with all three MR imaging sequences was satisfactory in all subjects enrolled in the 
study. Patients with a corrected TOF were prospectively recruited from an ongoing registry of the 
Center of Congenital Heart Disease Amsterdam-Leiden (www.cahal.nl) when they were scheduled 
for cardiac MR imaging evaluation. Patients who had a corrected TOF with a residual ventricular 
septal defect were excluded. None of the patients with a corrected TOF had signs of marked tri-
cuspid regurgitation at echocardiographic assessment (20) performed on the same day as cardiac 
MR imaging. 
Cardiac MR Imaging
MR imaging was performed by using a 1.5-T pulsar gradient system (Intera, release 12; Philips Me-
dical Systems, Best, the Netherlands) with a 33 mT/m amplitude, a 100 (mT · m−1)/msec slew rate, 
and a 0.33-msec rise time. A five-element cardiac coil was used for signal reception. A series of 
localizing thoracic scout images were acquired for planning purposes. We assessed the ventricular 
volumes at multisection cine imaging by planning a stack of sections, in the transverse plane (21–
24), that encompassed both ventricles throughout the cardiac cycle. Cine images were acquired 
with a steady-state free precession sequence during breath holding at end expiration by using the 
following parameters: 3.9/1.5 (repetition time msec/echo time msec), a 350-mm field of view, an 
8-mm section thickness, a 50° flip angle, a 1.8 × 2.0 × 8.0-mm acquisition voxel reconstructed into 
a 1.4 × 1.4 × 8.0-mm voxel, one acquired signal, 30 phases reconstructed, and retrospective gating 
with a 10% acceptance window. 
For 2D TV flow mapping, right ventricular two-chamber and four-chamber cine views were ac-
quired. The 2D TV imaging plane was positioned at the valve at end systole, perpendicular to the 
inflow. For 2D PV flow mapping, a double-oblique coronal cine view and a double-oblique sagittal 
cine view of the right ventricular outflow tract were acquired. The 2D PV imaging plane was posi-
tioned perpendicular to the pulmonary artery, midway between the PV and the bifurcation at end 
diastole. Velocity was encoded in one direction during free breathing. Maximal velocity encoding 
of 150 cm/sec for PV flow and 100 cm/sec for TV flow was used. The velocity-encoded images 
3.4
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were reviewed immediately, and the maximal velocity was adjusted in cases of phase wrapping. 
Imaging parameters were as follows: 8.9/5.7, a 350-mm field of view, an 8-mm section thickness, a 
20° flip angle, a 2.7 × 3.4 × 8.0-mm acquisition voxel reconstructed into a 1.4 × 1.4 × 8.0-mm voxel, 
two acquired signals, a 495-mHz sampling bandwidth, 36 phases reconstructed, and retrospective 
gating with a 10% acceptance window. 
A detailed description of the 3D velocity-encoded MR imaging acquisition has been published re-
cently (18,19). In short, a 3D volume slab was localized at the base of the heart and encompassed 
both valves throughout the cardiac cycle (visually verified on the right ventricular four- and two-
chamber views and on the double-oblique coronal and sagittal views of the right ventricular out-
flow tract), in which the velocity was encoded in three orthogonal directions during free breathing. 
Imaging parameters were as follows: 7.5/4.3, a 370-mm field of view, 3D volume imaging with 48-
mm slab thickness reconstructed into 12 × 4-mm sections, a 10° flip angle, a 2.9 × 3.8 × 4.0-mm 
acquisition voxel reconstructed into a 1.4 × 1.4 × 4.0-mm voxel, one acquired signal, a 237-Hz sam-
pling bandwidth, retrospective gating with a 10% acceptance window, and 30 phases reconstruc-
ted. Standard velocity encoding of 150 cm/sec was used in all three directions. However, if the 2D 
velocity-encoded MR imaging PV acquisition required a higher maximal velocity, this velocity was 
also used with 3D velocity-encoded MR imaging in all three directions. Echo-planar imaging was 
performed with a factor of five, and the sampling bandwidth in the echo-planar imaging direction 
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Table 1. patient and control characteristics
BSA: body surface area, inf: infundibulectomy, LV-SV: left ventricular stroke volume, PA: pulmonary artery, 
PV: pulmonary valve, RVOT: right ventricular outflow tract, RV-SV right ventricular stroke volume, SD: standard 
deviation, TAP: transannular patch.
Table 2. Comparisons of flow volumes between 2D VE-MRI, 3D VE-MRI and planimetry 
Abbreviations: 2D: two-dimensional velocity-encoded MRI, 3D: three-dimensional velocity-encoded MRI, backw: 
backward, CI: confidence interval, diff: difference, effective: forward minus backward flow, forw: forward, PV: 







age (y) 13.1 ± 2.7 14.1 ± 2.4 0.22
male/female n (%) 12/13 (48/52) 12/7 (63/37) 0.3
heart rate (min-¹) 80 ± 14 78 ± 11 0.954
age at surgery 0.9 ± 0.5
type of surgery n (%)
    TAP 16 (72) na
    inf 2 (9) na
    RVOT patch 2 (9) na
    PA patch 2 (9) na
QRS (ms) 131 ± 19 94 ± 8 <0.001
BSA (m²) 1.4 ± 0.3 1.6 ± 0.3 0.11
Planimetry values
LV-SV 67 ± 20 82 ± 18 0.01
RV-SV (mL) 93 ± 28 81 ± 19 0.12





p-value 95% limits of  
agreement (mL)
2D PV forw / planimetry RV-SV patients 0.84 1.3 ± 15.6 0.69 -29.3 to 31.9
controls 0.96 5.6 ± 6.3 0.001 -6.7 to 17.9
3D PV forw  / planimetry RV-SV patients 0.87 1.5 ± 15.5 0.64 -28.9 to 31.9
controls 0.92 -4.7 ± 7.6 0.02 -19.6 to 10.2
2D PV forw / 3D PV forw patients 0.88 -0.3 ± 15.5 0.93 -30.7 to 30.1
controls 0.93 10.4 ± 6.6 <0.001 -2.5 to 23.3
2D PV backw / planimetry PV backw patients 0.83 11.0 ± 14.0 0.001 -16.4 to 38.4
3D PV backw / planimetry PV backw patients 0.84 3.2 ± 12.5 0.22 -21.3 to 27.7
2D PV backw / 3D PV backw patients 0.9 7.6 ± 6.7 <0.001 -5.5 to 20.7
2D TV effective / 2D PV effective patients 0.84 17.6 ± 11 <0.001 -4.0 to 39.1
controls 0.89 21.4 ± 12.8 <0.001 -3.7 to 46.5
3D TV effective/ 3D PV effective patients 0.97 -1.2 ± 4.7 0.22 -10.4 to 8.0
controls 0.95 2.0 ± 6.0 0.16 -9.8 to 13.8
2D TV forw / 3D TV forw patients 0.87 9.8 ± 9.8 <0.001 -9.4  to 29.0
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Diastolic Functional Data
Summation of the TV flow and PV flow (5) yielded right ventricular time-flow and time-volume 
curves (Fig 2) for 2D and 3D velocity-encoded MR imaging, at which diastolic functional data 
were calculated. The following measurements were derived from the time-flow curves (Fig 2, top 
panel): EPFR, in milliliters per second; deceleration time (expressed as a percentage of the R-R 
interval)—that is, the time from the early peak filling to the moment that an extrapolated de-
celeration-velocity line reaches 0 mL/sec; APFR, in milliliters per second; and EPFR/APFR ratio 
(EPFR divided by APFR). The following measurements were derived from the time-volume curves 
(Fig 2, bottom panel): early filling fraction (expressed as a percentage)—that is, the filling volume 
during the first one-third of diastole relative to the total filling volume—and atrial filling fraction 
(expressed as a percentage)—that is, the filling volume during atrial systole relative to the total 
filling volume. The patients who had a corrected TOF with end-diastolic forward flow (EDFF) were 
examined separately, because such patients are considered to have a restrictive right ventricular 
filling pattern (3). EDFF was defined as the presence of late-diastolic PV forward flow that coin-
Table 4 . Diastolic functional data in cToF patients and controls
* indicates statistical significant difference with control subject. Abbreviations: AFF: atrial filling fraction, 
APFR: peak atrial filling rate, DT: deceleration time, EDFF: end diastolic forward flow, EPFR: early peak filling 
rate, FF: early filling fraction.
Table 3. 3D VE-MRI and 2D VE-MRI diastolic functional data 
Comparsion of 2D VE-MRI with 3D VE-MRI data in all subjects (n=44)Abbreviations: AFF: atrial filling fraction, 
APFR: atrial peak filling rate, CI: confidence interval, DT: deceleration time, E/A: EPFR divided by APFR, EPFR: 
early peak filling rate, FF: early filling fraction, SD: standard deviation.
was 2.28 kHz. During image reconstruction, the local phase correction filter was switched on, and 
velocity offsets caused by Maxwell concomitant gradients were corrected. 
Image Analysis
Image postprocessing was performed with in-house–developed (Leiden University, Leiden, the Ne-
therlands) software packages: Flow (25) for 2D velocity-encoded MR imaging data and MR ana-
lytical software system (MASS) (26) for planimetric data. The 3D velocity-encoded MR imaging 
data were analyzed (A.E.v.d.H, J.J.M.W, L.J.M.K., 2, 14, and 13 years experience in cardiac MR ima-
ging, respectively) with MASS research software developed at our institution. Image readings were 
performed by a single researcher (A.E.v.d.H.) and were checked by the other two (J.J.M.W, L.J.M.K.). 
Differences were resolved by consensus. We evaluated ventricular volumes by manually tracing the 
endocardial border at end systole and end diastole on all transverse sections and multiplying the 
area by the section thickness. Right ventricular and left ventricular stroke volumes were automati-
cally calculated. The planimetric PV forward flow volume was assessed by using the right ventricu-
lar stroke volume. The planimetric PV backward flow volume was assessed by subtracting the left 
ventricular stroke volume from the right ventricular stroke volume (12). 
A detailed description of 3D velocity-encoded MR image postprocessing was published recently 
(18). In short, the two orthogonal guide views of the TV and PV were used for retrospective valve 
tracking. A reformatting plane (five parallel planes with 5-mm distance) was marked at the level 
of the valve annulus in every cardiac phase, perpendicular to the flow (Fig 1a and 1b). The 3D velo-
city data were reformatted in the center reformatted plane (Fig 1c-1e) to yield 30 through-plane 
velocity-encoded images (Fig 1f), with which the flow analysis was performed (Fig 1g). 
For both the 2D velocity-encoded images and the reformatted 3D velocity-encoded images, the 
inner border of the pulmonary or tricuspid annulus was traced during every phase. Two-dimensional 
velocity-encoded MR imaging contours were drawn on the corresponding modulus images and 
copied onto the velocity-encoded images (27). Background correction was performed on the 2D MR 
TV images and on the 3D MR PV and TV reformatted images to correct for through-plane motion 
and local phase offset (14,15,18). Through-plane motion correction was not possible for the 2D MR 
images of the PV, because no myocardium was present in the imaging plane. Background correction 
of the 3D MR TV images was performed by placing a region of interest at the center reformatted 
plane in the right ventricular free wall (Fig 1f). The background region of interest for 3D MR PV 
images was placed at the septum in the most caudal plane (at a 10-mm distance from the central 
plane) to warrant the presence of the myocardium for positioning the region of interest. Flow 
velocity curves were calculated by multiplying the valve area in each time frame by the average 
flow velocity to yield the following parameters, expressed as flow volumes in milliliters: PV forward 
flow volume, PV backward flow volume, PV effective flow volume (forward minus backward flow 
volume), TV forward flow volume, TV backward flow volume, and TV effective flow volume. The 
PV effective flow volume was used as a reference for evaluation of the TV effective flow volume, 
because these two values should be equal in the absence of intracardiac shunts. 
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 Control (n=19) EDFF (n=10) no EDFF (n=15)
EPFR (mL/s) 388 ± 104 521 ± 175* 398 ± 104
DT (%) 22 ± 5 25 ± 14 28 ± 8*
APFR (mL/s) 283 ± 101 306 ± 118 275  ± 126
E/A 1.9 ± 0.6 2.5 ± 1.1 2.0 ± 1
FF (%) 44 ± 14 47 ± 9 40  ± 11





p-value 95% CI of diff
EPFR (mL/s) 506 ± 132 423 ± 133 <0.001 58 to 106
DT (%) 26 ± 10 25 ± 9 0.52 -2 to 5
APFR (mL/s) 289 ± 115 227 ± 79 <0.001 34 to 90
E/A 2.0 ± 0.8 2.0 ± 0.8 0.71 -0.2 to 1.5
FF (%) 44 ± 11 44 ± 12 0.53 -2 to 3
AFF (%) 23 ± 14 26 ± 10 0.01 -6 to -1
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cides with atrial contraction (3), as assessed with echocardiography on the same day as cardiac 
MR imaging. 
Statistical Analyses
Data were analyzed by using SPSS, version 16.0 (SPSS, Chicago, Ill), software. Results are ex-
pressed as means ± standard deviations. Differences between the means of the continuous data 
were analyzed with t tests for unpaired or paired data, where appropriate. Categorical data were 
analyzed with χ2 testing. Correlations between the 2D velocity-encoded MR imaging, 3D velocity-
encoded MR imaging, and planimetric measurements were assessed by using Pearson correlation 
coefficient and linear regression analyses. Bland-Altman plots were constructed to assess agree-
ment between 2D velocity-encoded MR imaging, 3D velocity-encoded MR imaging, and planime-
tric data (28). P < .05 indicated statistical significance. 
RESULTS
The characteristics of the patients with a corrected TOF and the control subjects are cited in 
Table 1. The duration of the QRS complex was significantly longer in the patients with a corrected 
TOF (mean duration, 131 msec ± 19 versus 94 msec ± 8 for control subjects; P < .001). Mean right 
ventricular stroke volumes were 93 mL ± 28 for the patients with a corrected TOF and 81 mL ± 19 
for the control subjects (P = .12). The mean PV backward flow volume in the corrected TOF group 
was 26 mL ± 24. 
PV Forward Flow Volume
Pooled correlations and agreement between the 2D MR PV forward flow volume, 3D MR PV forward 
flow volume, and planimetric right ventricular stroke volume measurements for both the patients 
with a corrected TOF and the control subjects are illustrated in Figure 3. We observed strong pooled 
correlations between planimetric right ventricular stroke volume and both 2D MR PV forward flow 
volume (r = 0.87, P < .01) and 3D MR PV forward flow volume (r = 0.88, P < .01). Nevertheless, a signi-
ficant difference between 2D MR PV forward flow volume and 3D MR PV forward flow volume was 
observed in the control subjects (mean difference, 10.4 mL ± 6.6; 95% limits of agreement: −2.5 mL, 
23.3 mL) (Table 2). In contrast, in the patients with a corrected TOF, 2D PV forward flow volume and 
3D PV forward flow volume measurements were not significantly different (Table 2).
 
PV Backward Flow Volume
Correlations and agreement between the different MR imaging–based measurements of PV bac-
kward flow volume in the patients with a corrected TOF are illustrated in Figure 4. Although an ex-
cellent correlation between 2D MR PV backward flow volume and 3D MR PV backward flow volume 
was observed (r = 0.97, P < .01), 2D MR and 3D MR PV backward flow volumes were significantly 
different (mean difference, 7.6 mL ± 6.7 mL; 95% limits of agreement: −5.5 mL, 20.7 mL; P < .001) 
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Figure 1: 
Post processing of 3D VE-MRI images. Schematic presentation of post processing of 3D VE-MRI images of the 
tricuspid valve in a healthy subject. Retrospective tracking of the tricuspid valve is performed by positioning a 
plane of interest on the tricuspid valve perpendicular to the flow in every cardiac phase in a four-chamber (a) and 
two-chamber (b) view (cine images: repetition time (TR) 3.9 ms, echo time (TE) 1.5 ms, flip angle 50°). Velocity-
encoded images from three orthogonal directions (TR/TE 7.5 ms/4.3 ms, flip angle 10°) (c-e), reconstructed 
from the position of the valve determined with retrospective valve tracking based on the two-chamber (b) and 
four-chamber (a) views. Through-plane velocity-encoded images (f) are obtained by reformatting of the center 
valvular plane in each cardiac phase. The inner border of the tricuspid annulus is traced for flow analysis. A region 
within the free wall of the right ventricle is traced for background correction. Tricuspid flow velocity in time can 
be presented in a curve (g), from which flow volume can be calculated. Abbreviations: AP: anterior-posterior 
velocity-encoded, FH: feet-head velocity-encoded, RL: right-left velocity-encoded.Comparsion of 2D VE-MRI 
with 3D VE-MRI data in all subjects (n=44)Abbreviations: AFF: atrial filling fraction, APFR: atrial peak filling rate, 
CI: confidence interval, DT: deceleration time, E/A: EPFR divided by APFR, EPFR: early peak filling rate, FF: early 
filling fraction, SD: standard deviation.
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(Table 2). With 2D MR velocity-encoded MR imaging, the PV backward flow volume was signifi-
cantly overestimated compared with the planimetric measurement (mean difference, 11.0 mL ± 
14.0; 95% limits of agreement: −16.4 mL, 38.4 mL; P = .001) (Table 2). In contrast, we observed no 
significant difference between the 3D MR PV and planimetric PV backward flow volumes (mean 
difference, 3.2 mL ± 12.5; 95% limits of agreement: −21.3 mL, 27.7 mL; P = .22). 
TV Flow Volume
Pooled correlations and agreement regarding TV flow volume measurements are illustrated in Fi-
gure 5. A significant difference between 2D MR PV effective flow volume and 2D MR TV effective 
flow volume was observed in both the patients with a corrected TOF (mean difference, 17.6 mL ± 
11; 95% limits of agreement: −4.0 mL, 39.1 mL; P < .001) and the control subjects (mean difference, 
21.4 mL ± 12.8; 95% limits of agreement: −3.7 mL, 46.5 mL; P < .001) (Table 2). In contrast, 3D MR 
PV effective flow and 3D MR TV effective flow measurements were not significantly different, and 
limits of agreement were narrow in both the corrected TOF (mean difference, −1.2 mL ± 4.7; 95% 
limits of agreement: −10.4 mL, 8.0 mL; P = .22) and control (mean difference, 2.0 mL ± 6.0; 95% 
limits of agreement: −9.8 mL, 13.8 mL; P = .16) groups (Table 2). To further compare the accuracies 
of 2D velocity-encoded MR imaging and 3D velocity-encoded MR imaging for effective flow mea-
surements, we compared the absolute value of the differences between TV effective flow and PV 
effective flow between the two techniques and observed a significant difference (mean difference, 
19 mL ± 11; P < .001). Furthermore, 2D TV forward flow volume and 3D TV forward flow volume were 
significantly different in both the corrected TOF group (mean difference, 9.8 mL ± 9.8; 95% limits 
of agreement: −9.4 mL, 29.0 mL; P < .001) and control group (mean difference, 29.3 mL ± 15.0; 95% 
limits of agreement: −0.1 mL, 58.7 mL; P < .001). 
Diastolic Functional Parameters
Comparison of diastolic data between 2D velocity-encoded MR imaging and 3D velocity-encoded 
MR imaging yielded similar EPFR/APFR ratios. However, significant differences in EPFR, APFR, and 
atrial filling fraction were observed (Table 3). In Table 4, 3D velocity-encoded MR imaging diastolic 
parameters are compared between the control subjects and both the patients with a corrected TOF 
who had EDFF and the patients with a corrected TOF who did not have EDFF. We observed no signi-
ficant differences in baseline characteristics between the patients with a corrected TOF who had 
EDFF and those who did not. In the patients with EDFF, the EPFR was significantly increased com-
pared with that in the control subjects (mean EPFRs, 521 mL/sec ± 175 versus 398 mL/sec ± 104; 
95% confidence interval: 27 mL/sec, 238 mL/sec; P = .02). The deceleration time was increased in 
the patients without EDFF compared with that in the control subjects (mean deceleration times, 
28% ± 8 versus 22% ± 5; 95% confidence interval: 0.6%, 11.3%; P = .03). 
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Figure 2: 
Right ventricular time-volume change and time-volume curve. Upper panel: 3D VE-MRI time-flow curve of the 
right ventricle of a healthy subject. The curve is constructed by summation of flow through the tricuspid valve 
and pulmonary valve. APFR: atrial peak filling rate, DT: deceleration time, EPFR: early peak filling rate. Lower pa-
nel: 3D VE-MRI time-volume curve of the right ventricle of a healthy subject. The curve is obtained by integration 
of the time-flow curve. Abbreviations: AFF: atrial filling fraction, FF: early filling fraction. 
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DISCUSSION
Our study represents a comprehensive evaluation of PV and TV flow during one acquisition by using 
3D velocity-encoded MR imaging with retrospective valve tracking in patients with a corrected 
TOF and healthy control subjects. Our study findings show that 3D velocity-encoded MR imaging 
is a reliable tool for assessment of PV forward and backward flow. Furthermore, 3D velocity-
encoded MR imaging assessment of TV flow proved to be more accurate than 2D velocity-encoded 
MR imaging assessment. Finally, 3D velocity-encoded MR imaging enabled evaluation of right 
ventricular diastolic function in the patients who had a corrected TOF with pulmonary regurgitation. 
 
PV Flow
Three-dimensional velocity-encoded MR imaging has been evaluated in vitro and in vivo for as-
sessment of valvular flow in healthy adults and adult patients, and accurate flow assessment was 
demonstrated with this technique (17,19). In children, high steady-state heart rate and respiration 
frequency potentially influence flow measurement accuracy. Our data demonstrate the feasibility 
of 3D velocity-encoded MR imaging for assessment of PV flow in children, with excellent correla-
tions between the 3D velocity-encoded MR imaging and planimetric measurements. A significant 
difference between 2D PV forward flow volume and 3D PV forward flow volume was observed in the 
healthy control subjects. It has been demonstrated that systolic displacement of the PV annulus is 
significantly greater in healthy subjects than in patients with a corrected TOF (29). We suggest that 
the greater pulmonary movement in the control subjects may have caused the observed differences. 
To our knowledge, our study is the first in which 3D velocity-encoded MR imaging was evaluated 
for assessment of pulmonary backward flow. Strong correlations between 2D velocity-encoded 
MR imaging and 3D velocity-encoded MR imaging were observed. However, 2D velocity-encoded 
MR imaging, as compared with planimetry, yielded a significant overestimation of the PV backward 
flow volume, whereas such a difference was not observed with 3D velocity-encoded MR imaging. 
Our data indicate that 3D velocity-encoded MR imaging is an accurate tool for assessment of PV 
backward flow. One of the advantages of 3D velocity-encoded MR imaging in the assessment of pul-
monary backward flow is the possibility to angulate the imaging plane according to the direction of 
the flow jet. We hypothesize that alterations in the direction of the regurgitant flow and movement 
of the pulmonary artery with respect to a fixed imaging plane caused the observed differences. 
TV Flow
Assessment of TV flow with 2D velocity-encoded MR imaging is hampered by movement of the 
TV annulus of up to 24 mm through the fixed imaging plane (14-16), which results in a 15%–25% 
overestimation of the TV forward flow despite through-plane motion correction (18). Three-
dimensional velocity-encoded MR imaging enables flow assessment at the level of the valve and 
perpendicular to the flow direction throughout the cardiac cycle with retrospective valve tracking. 
In accordance with a previous study (19), our study revealed that 3D velocity-encoded MR ima-
Figure 3: 
Pooled correlation and agreement of pulmonary forward flow assessed with 2D VE-MRI, 3D VE-MRI and pla-
nimetry. (a) Left: scatter plot depicting correlation between 2D PV forward flow and planimetry RV-SV, right: 
Bland-Altman plot depicting agreement between 2D PV forward flow and planimetry RV-SV. (b) Left: scatter 
plot depicting correlation between 3D PV forward flow and planimetry RV-SV, right: Bland-Altman plot depicting 
agreement between 3D PV forward flow and planimetry RV-SV. (c) Left: scatter plot depicting correlation 
between 2D PV forward flow and 3D PV forward flow, right: Bland-Altman plot depicting agreement between 2D 
PV forward flow and 3D PV forward flow. Squares: cToF patients, triangles: control subjects. Abbreviations: PV: 
pulmonary valve, RV-SV: right ventricular stroke volume. 
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Figure 4: 
Pooled correlation and agreement of pulmonary backward flow assessed with 2D VE-MRI, 3D VE-MRI and 
planimetry (a) left: scatter plot depicting correlation between 2D PV backward flow and planimetry PV backward 
flow, right: Bland-Altman plot depicting agreement between 2D PV backward flow and planimetry PV backward 
flow. (b): left: scatter plot depicting correlation between 3D PV backward flow and planimetry PV backward 
flow, right: Bland-Altman plot depicting agreement between 3D PV backward flow and planimetry PV backward 
flow. (c): left: scatter plot depicting correlation between 2D PV backward flow and 3D PV backward flow, right: 
Bland-Altman plot depicting agreement between 2D PV backward flow and 3D PV backward flow. Squares: cToF 
patients. Abbreviations: PV: pulmonary valve, TV: tricuspid valve.
Figure 5: 
Pooled correlation and agreement of tricuspid flow assessed with 2D VE-MRI and 3D VE-MRI. (a): left: scatter 
plot depicting correlation between 2D TV forward flow and 3D TV forward flow, right: Bland-Altman plot depicting 
agreement between 2D PV forward and 3D TV forward flow. (b): left: scatter plot depicting correlation between 
2D PV effective flow and 2D TV effective flow, right: Bland-Altman plot depicting agreement between 2D PV 
 effective flow and 2D TV effective flow. (c): left: scatter plot depicting correlation between 3D PV effective flow 
and 3D TV effective flow, right: Bland-Altman plot depicting agreement between 3D PV effective flow and 3D TV 
effective flow. Squares: cToF patients, triangles: controls. Abbreviations: PV: pulmonary valve, TV: tricuspid valve. 
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ging is more accurate than 2D velocity-encoded MR imaging in the assessment of TV flow volumes. 
Two-dimensional velocity-encoded MR imaging yielded a significant difference between PV and 
TV effective flow volumes, mainly owing to an overestimation of the TV flow volume. In contrast, 
3D velocity-encoded MR imaging yielded excellent correlation and agreement between PV and TV 
effective flow volumes. In addition to retrospective valve tracking, 3D velocity-encoded MR ima-
ging assessment of flow through both valves during one acquisition enabled us to rule out heart 
rate variability errors, further improving accuracy. According to our data, 3D velocity-encoded MR 
imaging can play a future role in quantitative assessment of atrioventricular transvalvular flow in 
children with congenital heart disease. 
Diastolic Right Ventricular Function
Directly after surgery, a restrictive right ventricular filling pattern correlates with a slower 
clinical recovery in patients with a corrected TOF (30). The clinical implications of right ventricular 
diastolic dysfunction during long-term follow-up remain unclear. Right ventricular restriction has 
been related to improved exercise capacity, less right ventricular dilatation, and less arrhythmia 
(3). However, others have observed a reduced tolerance for exercise and impaired right ventricular 
filling at dobutamine-induced stress in patients who have a corrected TOF with a restrictive right 
ventricle (8). The use of different diagnostic tools to assess diastolic function may have caused 
these conflicting results (8). The Doppler echocardiographic assessment of right ventricular 
diastolic function in patients with a corrected TOF is often hampered by pulmonary regurgitation. 
With velocity-encoded MR imaging, summation of PV flow and TV flow enables assessment of right 
ventricular diastolic function in the presence of pulmonary regurgitation (23). In our study, 2D and 
3D velocity-encoded MR imaging time-volume curves were compared and yielded similar EPFR/
APFR ratios, a parameter widely used for diastolic functional assessment (31). Nevertheless, 
significant differences in EPFR, APFR, and AFF were observed. Although no reference standard 
is available, on the basis of the more accurate diastolic flow volume measurements obtained with 
3D velocity-encoded MR imaging, we speculate that the diastolic functional data derived with this 
technique are also more reliable. With use of 3D velocity-encoded MR imaging, restrictive right 
ventricular filling was confirmed in the patients who had a corrected TOF with EDFF, as evidenced 
by a higher EPFR (9,32). In addition, 3D velocity-encoded MR imaging detected impaired right 
ventricular relaxation, indicated by an increase in deceleration time, in the patients without EDFF. 
In the future, 3D velocity-encoded MR imaging will aid in the assessment of both right ventricular 
diastolic function and the clinical implications of this abnormality in patients with a corrected TOF. 
Study Limitations
The postprocessing time in 3D velocity-encoded MR imaging, as compared with that in 2D veloci-
ty-encoded MR imaging, is increased because retrospective valve tracking and reformatting are 
performed manually and have been estimated to take 5 minutes per valve (19). Nevertheless, an 
advantage of 3D velocity-encoded MR imaging is the reduced imaging time. Two-dimensional velo-
city-encoded MR imaging with free breathing requires 3 minutes for each valve. With 3D velocity-
Right ventricular imaging: cardiac magnetic resonance3 3.4
encoded MR imaging, all valves can be addressed in one acquisition of approximately 5 minutes, 
depending on the heart rate (19). Especially in children, the reduced imaging time may improve the 
success rate of MR imaging assessment. 
No reference standard is available for the estimation of flow volumes. However, compared with 2D 
velocity-encoded MR imaging, planimetry is hampered much less by cardiac motion and is a widely 
accepted technique for cardiac volumetric assessment. Our study provided an internal validation 
to compare PV effective and TV effective flow volumes and yielded no marked differences among 
the 3D velocity-encoded MR imaging measurements, with narrow limits of agreement. 
In conclusion, 3D velocity-encoded MR imaging is a valid recently introduced technique for 
assessing PV forward and backward flow in patients with a corrected TOF and healthy children. 
Three-dimensional velocity-encoded MR imaging assessment of TV flow in patients with a 
corrected TOF is more accurate than 2D velocity-encoded MR imaging. Finally, the evaluation of 
diastolic function with 3D velocity-encoded MR imaging can facilitate ongoing research of the 
implications of diastolic dysfunction during long-term follow-up in patients with a corrected TOF.
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Table 2. Postoperative parameters 
Continous data presented as median and inter-quartile range. Abbreviation: IQR: inter-quartile range.
ABSTRACT
Objective: Current surgical strategies that aim at preventing pulmonary regurgitation in patients 
with corrected tetralogy of Fallot (cToF) may result in a certain grade of residual pulmonary 
stenosis (PS). The clinical implications of a postoperative residual PS in cToF patients remain 
unclear. Pulmonary valve replacement (PVR) due to pulmonary regurgitation is frequently needed 
during follow-up of cToF patients. The aim of the current study was to determine the role of residual 
PS on the need for PVR during follow-up in cToF patients. 
Design and patients: cToF patients were included if clinical follow-up after primary surgical 
correction had taken place for a minimum of five years. Patient characteristics, surgical parameters 
and postoperative parameters were reviewed, with special focus on the transpulmonic valve 
systolic gradient. 
Main outcome measure: Cox proportional hazards regression analysis was performed to identify 
predictors of PVR. 
Results: Out of 171 cToF patients, 71 (41.5%) underwent PVR after 24.2 years (inter-quartile range: 
16.8 - 31.6 years). Year of birth, older age at corrective surgery and patch use significantly predicted 
PVR during follow-up. In contrast, a mild residual PS in cToF patients (peak systolic gradient 15 to 
30 mmHg) independently reduced the risk of PVR, as compared with patients without PS (hazard 
ratio: 0.47, p=0.02) and with moderate-to-severe PS (hazard ratio: 0.35, p=0.01).
Conclusion: In addition to known risks factors for PVR, a postoperative mild residual PS reduces 
the risk of PVR during follow-up of cToF patients. This finding provides clinical evidence for a 
conservative PS relief during correction of ToF patients. 
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Table 1. Patient characteristics and surgical parameters
Continuous data presented as median and inter-quartile range unless specified. Abbreviations: PA: pulmonary 
artery, PS: pulmonary stenosis, PVR: pulmonary valve replacement, RVOT: right ventricular outflow tract, temp: 
temperature.
PVR (n=71) no PVR (n=100) p-value
Patient characteristics
Follow-up (y) 24.3 (16.5-31.6) 21.3 (12.1-37) 0.59
Year of birth (y) 1972 (1963-1986) 1985 (1961-1996) <0.01
Male/female n (%) 37/34 44/56 0.30
Chromosomal abnormalities n (%) 8 (11) 10 (10) 0.79
Pre-/peri-operative 
Palliative procedure n (%) 24 (33) 28 (28) 0.42
Age at repair (y) 4.9 (1.5-6.7) 1.6 (0.7-8.1) 0.05
Surgical approach n (%) <0.01
         Transventricular 48 (81) 11 (12)
         Transatrial/transpulmonary 11 (18) 50 (54)
Type of PS relief n (%) <0.01
         No patch 13 (20) 52 (80)
         RVOT and/or PApatch 18 (62) 10 (36)
         Transannular patch 38 (54) 33 (46)
Valve morphology n (%) 0.91
         Bicuspid 20 (33) 40 (70)
         Tricuspid 8 (29) 17 (30)
Valve intervention n (%) 41 (65) 34 (38) <0.01
Pulmonary annulus (z-score) -0.84 (-2.0-0.17) -0.295 (-0.1-0.17) 0.136
Cross-clamp time (min), mean (SD) 62 ± 30 61 ± 28 0.98
Minimum temp (°C) 25 (23-27) 27 (25-28) 0.02
PVR (n=71) no PVR (n=100) p-value
QRS duration (s) 0.12 (0.10-0.14) 0.10 (0.80-0.13) 0.05
Pulmonary insufficiency, n (%) 0.05
        None 2 (13) 14 (87)
        Mild 40 (44) 51 (56)
        Moderate-to-severe 28 (45) 34 (55)
Pulmonary stenosis, n (%) 0.15
        None (0-15 mmHg) 31 (45) 38 (55)
        Mild (>15-30 mmHg) 20 (30) 46 (69)
        Moderate-to-severe (>30 mmHg) 13 (46) 15 (53)
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Table 4. Multivariate analysis determinants of PVR in cToF patients at follow-up
Abbreviations: CI: confidence interval, HR: hazard ratio, temp: temperature
Table 3. Univariate analysis of determinants of PVR in cToF patients at follow-up
Abbreviations: CI: confidence interval, HR: hazard ratio, temp: temperature
 HR 95% CI p-value
Patient characteristics
Year of birth (y) 1.10 1.07 - 1.14 <0.01
Male sex 1.19 0.74 - 1.89 0.48
Chromosomal abnormalities 1.84 0.87 - 3.88 0.11
Pre-/peri operative 
Palliation 0.68 0.42 -1.12 0.13
Age at repair (y) 0.90 0.85 - 0.96 <0.01
Transatrial/transpulmonary 3.35 1.53 - 7.36 <0.01
Patch use
      Non-transannular 5.07 2.45 - 10.51 <0.01
      Transannular 9.2 4.79 - 17.83 <0.01
Bicuspid valve 2.81 1.20 - 6.59 0.02
Valve intervention 1.31 0.78 - 2.20 0.31
Pulmonary annulus (z-score) 0.90 0.78 - 1.04 0.16
Cross-clamp time (min) 1.02 1.01 - 1.03 <0.01
Minimum temp (°C) 1.00 0.93 - 1.08 0.97
Postoperative 
QRS interval (s) 0.15 0.00 - 439.47 0.64
Pulmonary regurgitation
      Mild 3.62 0.87 - 14.97 0.76
      Moderate-to-severe 6.20 1.48 - 28.10 0.01
Pulmonary stenosis
      Mild vs. none 0.73 0.42 - 1.29 0.28
      Mild vs. moderate-to-severe 0.55 0.27 - 1.11 0.09
      None vs. moderate-to-severe 0.75 0.39 - 1.43 0.38
 HR 95% CI p-value
Patient characteristics
Year of birth (y) 1.19 1.12 - 1.26 <0.01
Male sex .. .. ..
Chromosomal abnormalities .. .. ..
Pre/ peri-operative
Palliation .. .. ..
Age at repair (y) 1.18 1.10 - 1.27 <0.01
Transatrial/transpulmonary 0.82 0.31 - 2.18 0.70
Patch use
      Non-transannular 5.24 2.28 - 12.06 <0.01
      Transannular 8.13 3.73 - 17.68 <0.01
Bicuspid valve .. .. ..
Valve intervention .. .. ..
Pulmonary annulus (z-score) .. .. ..
Cross-clamp time (min) .. .. ..
Minimum temp (°C) ... .. ..
Postoperative 
QRS interval (s) .. .. ..
Pulmonary regurgitation
      Mild 1.66 0.36 - 7.65 0.51
      Moderate-to-severe 1.54 0.33 – 7.28 0.59
Pulmonary stenosis
      Mild vs. none 0.47 0.25 - 0.88 0.02
      Mild vs. moderate-to-severe 0.35 0.15- 0.81 0.01
      None vs. moderate-to-severe 0.75 0.35 - 1.59 0.45
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Figure 1. Relationship between time to PVR and year of birth
Scatterplot depicting the relationship between the time interval between corrective surgery and pulmonary 
valve replacement and the year of birth. The more recently born cToF patients had a significant shorter time-
interval between corrective surgery and PVR.
Abbreviation: PVR: pulmonary valve replacement.
INTRODUCTION
Surgical repair in patients with tetralogy of Fallot (ToF) is performed by closure of the ventricular 
septal defect and relief of pulmonary stenosis (PS) by infundibulectomy and/or valvotomy. In 
addition, surgical enlargement of the pulmonary annulus and right ventricular outflow tract (RVOT) 
with a patch may be needed. However, this surgical approach often results in significant pulmonary 
regurgitation, especially when a patch is used.(1) Chronic volume overload secondary to significant 
pulmonary valve regurgitation may lead to RV dilatation and dysfunction with important prognostic 
implications.(2;3) In the last decade, pulmonary valve replacement (PVR) has been increasingly 
used in cToF patients during follow-up in order to prevent or reverse adverse RV remodelling 
and dysfunction. Furthermore, to limit the amount of pulmonary regurgitation and its adverse 
effects on the RV, current surgical strategies to relieve PS during repair of ToF aim to limit the 
use of a patch whenever possible.(2;4-6) However, this conservative surgical approach may result 
in a certain degree of residual PS in post-operative cToF patients. Although the benefits of this 
conservative approach have been demonstrated(6), there are no data on the clinical implications of 
a postoperative residual pulmonary systolic gradient in cToF patients. 
A mild residual PS could limit the amount of pulmonary regurgitation in cToF patients and 
consequently, reduce the need for PVR.(4) However, a moderate or severe residual PS is related to 
tricuspid insufficiency and RV failure.(7) Accordingly, the aim of the current study was to investigate 
the influence of various grades of PS on the need for PVR in cToF patients among several clinical, 
surgical and echocardiographic parameters during long-term follow-up in cToF patients. 
METHODS
Study population and design
The study population was selected from a clinical database of the Center for Congenital Heart 
disease Amsterdam-Leiden (CAHAL). In this database, all patients that have undergone surgery 
for congenital heart disease at the Leiden University Medical Center and the Amsterdam 
Academic Medical Center are registered. Patients were included in the current analysis if their 
diagnosis was ToF, and if clinical follow-up had taken place at our institution for a minimum of five 
years postoperatively. Patients with pulmonary atresia, absent pulmonary valve or a complete 
atrioventricular septal defect and patients who received a surgical pulmonary conduit or PVR at 
the time of corrective surgery were excluded. 
Various pre-operative and peri-operative parameters were retrospectively evaluated in the study 
population. Furthermore, the included cToF patients were followed-up from corrective surgery until 
PVR occurred and this time interval was recorded. In the cToF patients who did not undergo PVR, the 
follow-up duration ended at the last clinical visit prior to August 2010. From this follow-up period, 
clinical notes, surgical reports and echocardiographic studies were comprehensively reviewed 
and various parameters were recorded. The first available postoperative echocardiographic study 
Figure 2. Relationship between age at corrective surgery and year of birth
Scatterplot depicting the relation between age at corrective surgery and the year of birth. The more recently 
born cToF patients were significantly younger at corrective surgery.Abbreviation: PVR: pulmonary valve repla-
cement.
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was selected to evaluate pulmonary regurgitation and residual PS. Finally, the influence of clinical, 
surgical and echocardiographic parameters on the risk for PVR was evaluated, with a particular 
focus on the various grades of postoperative residual PS.
Pre-operative and peri-operative parameters
All palliative procedures prior to the corrective operation (such as Blalock-Taussig shunt placement) 
were noted. In addition, the surgical and anaesthetic reports concerning the corrective operation of 
all included patients were recorded. From these reports, the following parameters were reviewed: 
operation date, pulmonary valve morphology (bicuspid or tricuspid pulmonary valve), pulmonary 
artery size, transventricular or transatrial surgery, use of a patch (transannular or non-transannular), 
pulmonary valve interventions (valvotomy, commissurotomy or valve dilatation). The pulmonary 
artery size was assessed with Hegar dilators after relief of the PS during surgery. Pulmonary artery 
size was expressed as z-score, taking into account the patient’s body surface area at the time of 
surgery. Finally, the aortic cross-clamp time and lowest body temperature during the corrective 
surgery were obtained from the anaesthetic reports. 
Postoperative parameters
From the earliest postoperative electrocardiographic (ECG) recordings, the maximum QRS 
duration was obtained. In addition, the earliest postoperative echocardiographic studies were 
comprehensively reviewed. If the echocardiographic study was available in digital format, it was 
reviewed with the use of EchoPac (version 108.1.5 General Electric Medical Systems). Alternatively, 
the data regarding pulmonary regurgitation and stenosis were obtained from the echocardiographic 
notes. Presence and severity of pulmonary regurgitation were recorded. The severity of pulmonary 
regurgitation was assessed and categorized as absent, mild, and moderate-to-severe. In addition, 
with continuous wave Doppler flow recordings, the peak pressure gradient across the RVOT/
pulmonary artery was assessed. Peak systolic pulmonary gradients were arbitrarily categorized 
in none, mild and moderate-to-severe PS (0-15 mmHg, 15-30 mmHg and >30 mmHg, respectively). 
Statistical analysis
Data were tested for the normal distribution by the Kolmogorov-Smirnov test. Continuous data 
with a normal distribution are presented as mean ± standard deviation. Continuous data with no 
normal distribution are presented as median and inter-quartile range (IQR). Categorical data are 
presented as numbers and percentages. Differences between the group of patients with PVR and 
the group of patients without PVR were assessed with the Student’s t-test or Mann-Whitney U-test, 
where appropriate, for continuous variables and with the Chi-square test for categorical variables. 
Linear regression analysis was performed to investigate the relationship between year of birth and 
the time interval between surgical correction and PVR, and the relationship between year of birth 
and age at surgical correction. Univariate and multivariate Cox proportional hazards regression 
analyses were performed to identify pre-operative, peri-operative and post-operative predictors 
of PVR during follow-up. Univariate predictors with p-values <0.1 and ≥70% complete data were 
entered as predictors in the multivariate analysis. Hazard ratios (HR) and 95% confidence intervals 
(CI) were calculated for each variable. A value of p<0.05 was considered significant. Data analysis 
was performed with SPSS software for Windows (version 17.0, SPSS Inc, Chicago, Illinois).
RESULTS
Patient characteristics and follow-up
A total of 171 cToF patients were included in the present analysis. Of these patients, 71 (41.5%) 
underwent PVR during follow-up. Table 1 summarizes the characteristics of all included cToF 
patients. The overall median follow-up duration between corrective surgery and PVR was 24.2 
years (IQR: 16.8 - 31.6 years). Of all PVR procedures, 55 (77.5%) were performed during the last 
decade (2000 to 2010). The age at corrective surgery significantly decreased over the study 
period (r = -0.79, p<0.01; Figure 1). Furthermore, as a result of an earlier re-intervention, the more 
recently born patients had a shorter interval to PVR (r = -0.80, p<0.01), as shown in Figure 2. Finally, 
the overall survival during follow-up after corrective surgery was 95.4%. 
Pre-operative and peri-operative parameters
Table 1 depicts the pre-operative and peri-operative parameters of the included cToF patients. 
Palliative surgical shunts procedures prior to the corrective surgery were performed in 52 patients 
at a median age of 2.3 years (IQR: 7 months - 3.8 years). In 4 patients, 2 palliative procedures 
were performed. Corrective surgery was performed between 1959 and 2005. The median age at 
corrective surgery was 4.9 years in the PVR group, and 1.6 years in the group without PVR (p=0.05). 
Finally, patch use was significantly different in the two groups. In the PVR group, 13 (20%) patients 
had no patch and 38 (54%) patients received a transannular patch. In contrast, in the group without 
PVR, 80% of patients did not have a patch whereas 46% had a transannular patch (p<0.01). 
Post-operative parameters
Table 2 shows the postoperative data, obtained from ECG and echocardiographic recordings. In 
the PVR group, 2 patients (13%) showed no pulmonary regurgitation at the earliest post-operative 
examination, whereas 40 (44%) and 28 (45%) patients presented with mild and moderate-to-
severe pulmonary regurgitation, respectively. In contrast, in the group of patients without PVR, 
these percentages were 87%, 56% and 34% (p=0.05). Finally, the earliest post-operative peak 
systolic gradient across the RVOT/pulmonary artery was recorded. Among the 71 patients that 
underwent PVR, 31 patients (45%) had no residual pulmonary gradient. 
Furthermore, 20 of the PVR patients (30%) had a mild PS and 13 patients (46%) had a moderate-
to-severe residual PS. In the patients without PVR during follow-up, these percentages were 55%, 
69% and 53%, respectively.
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Prediction of PVR during follow-up
Table 3 and Table 4 summarize the results of the univariate and multivariate regression analysis. 
After multivariate regression analysis, the risk of PVR was significantly higher in the cToF patients 
that were more recently born (HR: 1.19, 95% CI: 1.12 - 1.26, p<0.01). In addition, of the surgical 
parameters, older age at surgical repair (HR: 1.18, 95% CI: 1.10 - 1.27, p<0.01) and the use of patch 
to relieve PS during the corrective surgery (non-transannular: HR: 5.24, 95% CI: 2.28 - 12.06, p<0.01, 
transannular patch: HR: 8.13, 95% CI: 3.73 - 17.68, p<0.01) significantly increased the risk of PVR. 
Finally, of the postoperative variables, the group of patients with mild PS showed a significantly 
reduced risk of PVR as compared with the patients without PS (HR: 0.47, 95% CI: 0.25 - 0.88, 
p=0.02) and as compared with the patients with moderate-to-severe PS (HR: 0.35, 95% CI: 0.35 – 
1.59, p=0.01).
DISCUSSION
The current study shows that in cToF patients, an older age at corrective surgery and the use of 
a patch are independent predictors of PVR during long-term follow-up. Furthermore, increasing 
age at surgical correction and a more recent year of birth independently predicted PVR, reflecting 
altered surgical indications over time. Finally, our results demonstrate that a mild postoperative 
residual PS independently reduces the risk of PVR in cToF patients. 
PVR in cToF patients
PVR in cToF patients with pulmonary regurgitation and RV dilatation has proven its benefits. After 
PVR, pulmonary regurgitation decreases, RV volumes normalize and clinical status improves.
(8-10) According to these current insights, the number of cToF patients undergoing PVR has 
increased, and the age at PVR has decreased, as was observed in the results of the present study. 
Nevertheless, PVR is an invasive procedure and furthermore, it places cToF patients at risk for late 
prosthetic valve failure.(11) Accordingly, comprehensive knowledge about predictors of the need 
for PVR in cToF patients is of value to refine clinical counselling, to improve follow-up protocols 
and ultimately, to prevent the need for PVR in cToF patients.
Risk factors for PVR in cToF patients
Previous studies have identified clinical parameters that determine outcome in cToF patients, 
such as age at surgical repair and the use of patch.(1;12;13) Accordingly, these parameters sig-
nificantly predicted PVR in the present study. In addition, the current investigation focused on the 
role of a residual pulmonary systolic gradient during follow-up of cToF patients. To prevent pulmo-
nary regurgitation in cToF patients and its adverse effects on the RV, current surgical strategies 
advocate a conservative relief of PS in ToF patients, primarily by limiting patch use.(4-6) However, 
this conservative surgical approach may lead to a residual PS, and the long-term clinical implicati-
ons of a residual PS remain unclear. In the present analysis, a postoperative mild residual PS was 
observed in 39% of patients, and a moderate-to-severe PS was observed in 16% of patients. Ac-
cording to our results, the presence of a mild residual PS independently reduced the need for PVR 
at follow-up. In a recent experimental study, Kilner and colleagues demonstrated that an increasing 
pulmonary gradient was closely correlated with a reduced regurgitation fraction.(14) Furthermore, 
in a clinical study including 67 cToF patients, Uebing et al. reported a significant relation between 
a smaller postoperative pulmonary annulus area and a reduced severity of pulmonary regurgita-
tion.(4) These studies indicate that after surgical correction of ToF, a mild residual PS reduces the 
need for PVR during follow-up of cToF patients. In contrast, the presence of a moderate-to-severe 
residual PS significantly increased the risk for PVR in the current report. A moderate-to-severe 
outflow tract obstruction is related with reduced RV performance and tricuspid regurgitation(7), 
which are concomitant indications for PVR in cToF patients with pulmonary regurgitation.(15)
Finally, in the present study, the absence of a residual PS increased the risk of PVR during follow-up 
of cToF patients. Extensive infundibulectomy and patching to relieve PS in cToF patients, resulting 
in the absence of a residual gradient, may lead to dilatation and impaired contractility of the RVOT.
(16-18) In a previous report by d’Udekem d’Acoz et al., a total of 189 cToF patients with pulmonary 
regurgitation were compared to 44 PS patients with pulmonary regurgitation after commissurot-
omy. (16) Despite similar grades of pulmonary regurgitation in the two groups, the cToF patients 
showed more RV dilatation.(16) An important difference between surgical correction of ToF and 
surgical correction of isolated PS is the manipulation of the RVOT during ToF correction. The aut-
hors concluded that the resultant postoperative RVOT dilatation and dysfunction in cToF patients 
aggravates the deleterious effect of pulmonary regurgitation on the RV.(16)  Based on these obser-
vations and the results of the current study, there is a delicate equilibrium among the pulmonary 
gradient, the use of a patch and the severity of pulmonary regurgitation, ultimately leading to RV 
dilatation and RV failure which culminates into the decision to perform PVR in cToF patients.
CONCLUSION
This study provides novel insights into the predictive value of peri-operative parameters on 
the need of PVR during follow-up in cToF patients. In addition to known risk factors for PVR, a 
mild residual PS independently reduced the need for PVR. This finding provides clinical evidence 
underscoring the importance of current surgical strategies, advocating a conservative relief of PS 
in ToF patients.
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Prediction of atrial arrhythmia in adult patients 
with congenital heart disease with tissue Doppler 
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Aims: Atrial arrhythmia (AA) is common in adult patients with congenital heart disease (CHD). 
To enable prevention of AA or its complications, timely identification of adult CHD patients at 
risk for AA is crucial. Long total atrial activation times have been related to AA. Tissue Doppler 
imaging permits non-invasive evaluation of the total atrial conduction time (PA-TDI duration). 
The present study evaluated the role of PA-TDI duration in adult CHD patients to predict AA.
Methods and Results: A total of 223 adult CHD patients were followed-up for the occurrence 
of AA after PA-TDI duration assessment. The PA-TDI duration was defined as the time interval 
from the onset of the P-wave on the electrocardiogram to the peak of the A’ wave at the lateral 
atrial wall on TDI tracings. Among various clinical and echocardiographic parameters, the value 
of the PA-TDI duration to predict AA occurrence was investigated. Median follow-up was 39 
months (inter-quartile range 21 to 57 months). A PA-TDI duration ≥126 ms predicted AA during 
follow-up (log rank p<0.001). At multivariate analysis, PA-TDI duration (hazard ratio (HR) 2.02, 
95% confidence interval (CI) 1.07-3.83), prior history of AA (HR 4.85, 95% CI 2.71-8.69) and 
surgical procedures during follow-up (HR 2.33 95% CI 1.26-4.33) independently  predicted the 
occurrence of AA. 
Conclusion: The PA-TDI duration, prior history of AA and surgical procedures during follow-up 
are independent predictors of the occurrence of AA in adult CHD patients. PA-TDI duration is a 
useful tool to identify CHD patients at risk for AA during follow-up.
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Table 2. Univariate and multivariate predictors of atrial arrhythmia in patients with congenital 
heart disease
Abbreviations: AA: atrial arrhythmia, CHD: congenital heart disease, CI: confidence interval, EDV: end-diastolic 
volume, ESV: end-systolic volume, EF: ejection fraction, HR: hazard ratio, PA-TDI: total atrial activation time, as 
assessed with tissue Doppler imaging.
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Table 1. Patient characteristics at baseline and during follow-up 
* ‘Severe CHD’ included the following diagnoses: atrioventricular septum defect, tetralogy of Fallot, D-trans-
position after arterial switch, D-transposition after atrial switch, L-transposition, truncus arteriosus, and tricspid 
atresia. ‘Not severe CHD’ included: anomalous pulmonary venous return, aortic stenosis, ventricular septum 
defect, atrial septum defect, atrial septum defect and ventricular septum defect, coarctation of the aorta, Ebstein’s 
anomaly, patent ductus arteriosus, pulmonary stenosis, pulmonary stenosis and atrial septum defect, pulmonary 
stenosis and ventricular septum defect. Abbreviations: AA: atrial arrhythmia, ACE: angiotensin-converting enzy-
me, CHD: congenital heart disease, EDV: end-diastolic volume, EF: ejection fraction, ESV: end-systolic volume, FU: 
follow-up, PA-TDI: total atrial activation time, as assessed with tissue Doppler imaging. 
INTRODUCTION
Improvements in cardiac surgery have led to increased survival of patients with congenital heart 
disease (CHD). Consequently, the population of adult patients with CHD is growing and aging.1 
During follow-up, atrial arrhythmia (AA) is a frequent clinical problem in this group of patients 
with a lifetime risk over 50% in patients with severe CHD.2 AA in adult patients with CHD is related 
to thrombo-embolic complications, heart failure and increased mortality.2 To enable prevention 
of AA or its complications, timely identification of adult CHD patients at risk for AA is essential.
In CHD patients, longstanding altered atrial hemodynamics, increased atrial pressure and 
surgical atrial scarring promote atrial remodeling and electrical conduction abnormalities.3 
These electrical disturbances include prolonged atrial conduction time, favoring the onset of 
AA.4, 5 Recently, a novel echocardiographic tool using tissue Doppler imaging (TDI), has shown to 
be a fast, easy and reliable method to assess the total atrial conduction time.6 With color-coded 
TDI of the atria, the time interval from the onset of the P-wave on the electrocardiogram to the 
peak of the A’ wave on the TDI tracings of the lateral atrial wall can be measured (so-called PA-TDI 
duration). The PA-TDI duration reflects the total atrial conduction time, and has been shown to be 
a predictor of AA in patients with cardiac disease.6-8 However, the value of the PA-TDI duration 
to predict AA in CHD patients has not been evaluated. The current study investigated the clinical 
and echocardiographic predictors of AA in adult CHD patients. Specifically, the value of PA-TDI 
duration to predict the occurrence of AA in adult CHD patients was assessed. 
METHODS
Patient population and data collection
The present population included adult patients with CHD, who were followed-up for the occurrence 
of AA from the first available TDI echocardiogram in sinus rhythm (baseline) until November 2010. 
Patients without sinus rhythm at baseline or without further clinical follow-up visits were excluded 
from the analysis. AA was defined as atrial tachycardia, atrial flutter, or atrial fibrillation on surface 
electrocardiogram (ECG), 24 or 48 hours Holter ECG or implantable cardioverter-defibrillator 
device recordings. 
Clinical and echocardiographic data were retrieved from the departmental Cardiology Information 
System (EPD-Vision®, Leiden University Medical Center) and the echocardiographic database, res-
pectively. All adult CHD patients underwent a complete clinical evaluation at baseline. The CHD 
diagnosis was specified to be ‘severe CHD’ or ‘not severe CHD’, as described previously.9 In addition, 
the use of beta-blockers, anti-arrhythmic medication or angiotensin-converting enzyme (ACE) in-
hibitors at baseline was recorded. Furthermore, the presence of hypertension at baseline (systolic 
pressure >140 mmHg and/or diastolic pressure >90 mmHg) and any surgical procedures during fol-
low-up were documented. In addition, baseline echocardiographic variables included dimensions 
AA (n= 57) No AA (n=166) p-value
Clinical parameters
Age (y) 51 ± 13 48 ± 12 0.245
Male/female, n (%) 30/27 (53/47) 79/87 (48/52) 0.511
Severe CHD*, n (%) 30 (53) 57 (34) 0.015
Prior history of AA, n (%) 35 (61) 26 (16) <0.001
Medication, n (%)
        Beta-blocker 31 (54) 25 (15) <0.001
        Anti-arrhythmic 5 (9) 10 (6) 0.475
        ACE inhibitor 21 (36) 32 (19) 0.007
Hypertension, n (%) 5 (9) 23 (14) 0.318
Surgical procedure during  follow-up, n (%) 14 (25) 15 (9) 0.003
Echocardiographic parameters
Systemic ventricle EDV (ml) 124 ± 46 118 ± 49 0.441
Systemic ventricle ESV (ml) 68 ± 34 61 ± 32 0.187
Systemic ventricle EF (%) 46 ± 13 48 ± 11 0.118
PA-TDI (ms) 152 ± 33 121 ± 24 <0.001
Predictor Univariate analysis
HR 95% CI p-value
Severity of CHD 1.61 0.96 - 2.71 0.074
History of AA 6.38 3.69 - 11.03 <0.001
Gender 0.84 0.50 -1.41 0.510
Hypertension 0.74 0.29 - 1.84 0.512
Surgical procedure 2.91 1.58 - 5.34 0.001
Systemic ventricle EDV 1.00 0.99 -1.01 0.554
Systemic ventricle ESV 1.00 0.99 - 1.01 0.316
Systemic ventricle EF 0.99 0.96 - 1.01 0.247
PA-TDI dichotomized 3.66 2.03 - 6.61 <0.001
Multivariate analysis
HR 95% CI p-value
4.85 2.71 - 8.69 <0.001
… … …
… … …
2.33 1.26 - 4.33 0.007
…   
   
   
2.02 1.07 - 3.83 0.031
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entered as variables in the multivariate analysis using the enter method. None of the significant 
univariate predictors had a linear correlation coefficient >0.7 and therefore, multicollinearity 
between the parameters was unlikely. Hazard ratios and 95% confidence intervals (CI) were 
calculated for each independent variable. Data were analyzed using the SPSS 17.0 software 
(SPSS Inc, Chicago, Illinois). A p-value of <0.05 was considered statistically significant. 
RESULTS
Patient population
A total of 223 adult CHD patients were included (mean age 49 ± 12 years, 49% male). During a 
median follow-up duration of 39 months (inter-quartile range 21 to 57 months), a total of 57 (26%) 
patients presented with AA. Table 1 displays the clinical and echocardiographic characteristics 
of both groups of adult CHD patients (AA during follow-up vs. no AA during follow-up). The 
proportion of patients with severe CHD was significantly larger in the group of patients with AA 
compared to the group of patients without AA (53% vs. 34%, p=0.015). A total of 61% of patients 
with AA during follow-up had a prior history of AA. No differences between the two groups were 
observed for the presence of hypertension. Surgical procedures were performed during follow-
up in 29 patients (5 atrioventricular valve repairs or replacements, 17 pulmonary or aortic valve 
replacements, 5 atrial septum defect closures, 2 other procedures). In the group with AA during 
follow-up, surgical procedures were more frequently performed (25% vs. 9%, p=0.003). 
Figure 1. PA-TDI duration measurement
Example of the assessment of PA-TDI duration in a Tetralogy of Fallot patient. A sample volume is placed on the 
lateral wall of the left atrium just above the mitral valve. The PA-TDI duration is the time from the onset of the 
P-wave to the peak of the A’ wave in the velocity graph (white arrow). In this patient, the PA-TDI duration is 120 
ms. Abbreviation: PA-TDI: total atrial activation time, as assessed with tissue Doppler imaging.
and systolic function of the systemic ventricle and the total atrial conduction time as measured 
with TDI (PA-TDI). Among the several clinical and echocardiographic parameters, the independent 
determinants of AA occurrence during follow-up were identified. Subsequently, the value of the 
PA-TDI duration to predict the occurrence of AA in adult CHD was assessed.
Echocardiography
Transthoracic echocardiographic images were acquired with a commercially available system 
equipped with a 3.5 MHz transducer (Vivid-7, GE Vingmed Ultrasound AS, Horten, Norway). 
Subjects were in the left lateral decubitus position during image acquisition. Standard two-
dimensional images were acquired from the parasternal (long- and short-axis) and apical views (2-, 
4-chamber and long-axis) and digitally stored in cine-loop format. Analyses were performed off-
line using EchoPac version 108.1.5 (General Electric Medical Systems). The end-diastolic and end-
systolic volumes of the systemic ventricle were measured in the apical 2- and 4-chamber views, 
and the ejection fraction was calculated. Furthermore, TDI images from the apical 4-chamber view 
were obtained. The color frame rate was ≥120 frames/s, and at least three consecutive beats 
were recorded. The PA-TDI duration was determined, as previously described.6 In brief, a sample 
volume was placed at the lateral wall of the left-sided atrium, just above the atrioventricular valve 
annulus. Next, the PA-TDI duration, defined as the time from onset of the P-wave of the surface 
ECG to the peak of the A’ wave on the TDI tracings of the lateral atrial wall was assessed (Figure 1). 
The PA-TDI duration was averaged from three cardiac cycles. 
Atrial arrhythmia
Patients were followed-up at six to12 monthly intervals for the occurrence of AA. AA was 
determined on the basis of electrocardiographic findings consistent with the diagnosis of atrial 
flutter, atrial tachycardia or atrial fibrillation on 12-lead electrocardiograms and 24 hours electro-
cardiogram Holter recordings.10 In patients with an ICD, stored electrocardiographic information 
was interrogated every six months, and episodes of AA were recorded. 
Statistical Analysis
Continuous variables are expressed as mean ± standard deviation. Categorical variables are 
presented as numbers and percentages. Differences between the patients with and without AA 
during follow-up were analyzed using the unpaired Student t-test for continuous data and the 
Chi-square test for categorical data. The study population was divided according to the optimal 
PA-TDI duration cut-off value for the prediction of AA occurrence. The optimal PA-TDI cut-off 
value was determined with receiver operating characteristic (ROC) curve analysis. Cumulative 
event rates were calculated with the Kaplan-Meier survival analysis and the time-to-event data 
with respect to the occurrence of AA were compared with the log-rank test between the two 
groups of patients, dichotomized based on the PA-TDI cut-off value. In addition, univariate and 
multivariate Cox proportional hazards regression analyses were performed to identify clinical and 
echocardiographic predictors for the occurrence of AA. Only significant univariate predictors were 
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repairs.12-14 In the current study, prior history of AA and surgical procedures during follow-up were 
related to AA. Furthermore, the present evaluation showed that the assessment of PA-TDI duration 
with echocardiography provided an additional parameter to further improve the stratification of 
CHD patients for AA occurrence.  
PA-TDI duration in CHD patients
In CHD patients, the principal pathophysiological substrate for AA is provided by electrical re-entry 
through atrial areas with delayed electrical conduction.3, 15-17 These areas result from surgical atrial 
scar tissue (e.g. after Fontan and Mustard/Senning procedure, closure of atrial septal defect, or 
atriotomy in tetralogy of Fallot correction) or atrial fibrosis in patients with longstanding pressure 
or volume overload of the atria.3, 15-17 These sites of delayed electrical conduction prolong the time 
required for atrial electrical activation. Prolonged total atrial conduction time is a reliable predictor 
of AA.4, 5 Currently, the gold standard for assessing total atrial conduction time is the P-wave 
duration as assessed with signal-averaged electrocardiograms.4, 5 However, this is a time-consuming 
technique and therefore not suitable for routine clinical use. The novel echocardiographic modality 
of TDI enables assessment of the total atrial activation time by measuring the PA-TDI duration, 
a readily and feasible noninvasive method to identify patients with a prolonged atrial conduction 
Figure 2. Kaplan-Meier curve for freedom from atrial arrh ythmia
Kaplan-Meier curve depicting freedom from atrial arrhythmia of CHD patients according to PA-TDI duration, 
dichotomized based on ROC curve analysis. Abbreviations: AA atrial arrhythmia, PA-TDI: total atrial activation 
time, as assessed with tissue Doppler imaging. 
On echocardiography, no significant differences in dimensions and ejection fraction of the 
systemic ventricle were observed between the two groups (Table 1). Interestingly, the PA-TDI 
duration was significantly longer in the group with AA during follow-up as compared with the 
group with no AA during follow-up (152 ± 33 ms vs. 121 ± 24 ms, p<0.001). 
Prediction of AA during follow-up
The ROC curve analysis to identify the optimal PA-TDI cut-off value to predict AA yielded a cut-
off value of 126 ms (area under the curve 0.76). Subsequently, this cut-off value for PA-TDI 
duration was used to dichotomize the population, and the time-to-event data with respect to the 
occurrence of AA was evaluated with Kaplan-Meier survival analysis.
The Kaplan-Meier curves showed a significantly higher cumulative event rate in the group of adult 
CHD patients with longer PA-TDI duration (≥126 ms) as compared with adult CHD patients with a 
shorter PA-TDI duration (<126 ms) (Chi-square: 21.10, log rank p<0.001) (Figure 2). The cumulative 
event rates in the group with a PA-TDI duration ≥126 ms were 20%, 26%, 36% and 43% at 12, 24, 
36 and 48 months, respectively. In contrast, in the group of patients with a PA-TDI duration <126 
ms, these event rates were 5%, 6%, 8% and 8%, for the respective time frames. 
Table 2 shows the hazard ratios for the univariate predictors for the occurrence of AA during 
follow-up. Prior history of AA, surgical procedure during follow-up and PA-TDI duration were 
significant univariate predictors. Finally, at multivariate analysis, prior history of AA (hazard 
ratio: 4.85, 95% CI: 2.71 to 8.69, p<0.001) surgical procedure during follow-up (hazard ratio: 2.33, 
95% CI: 1.26 to 4.33, p=0.007) and the PA-TDI duration (hazard ratio: 2.02, 95% CI: 1.07 to 3.83, 
p=0.031) were independent predictors of the occurrence of AA during follow-up. 
DISCUSSION
The present evaluation demonstrates that in adult CHD patients, long total atrial activation time 
as assessed with echocardiographic techniques (PA-TDI duration) is associated with increased 
risk of AA occurrence during follow-up.  Particularly, the risk of AA occurrence during follow-up 
was twofold in adult CHD patients with a PA-TDI duration ≥126 ms compared with adult CHD 
patients with a PA-TDI duration <126 ms. 
Atrial arrhythmia in CHD patients
AA is common during long-term follow-up in adult CHD patients. In a recent population-based 
study, Bouchardy et al. reported a lifetime risk of AA of 63% in patients with severe CHD and of 
47% in patients without severe CHD.2 AA is an important clinical burden in adult CHD patients as 
it is associated with the occurrence of stroke, heart failure, cardiac interventions and increased 
mortality.2 Particularly, in patients with severe CHD, the occurrence of AA may further impair 
a compromised hemodynamic condition.2, 11 Previous studies have identified various clinical 
predictors of AA in adult patients with CHD, such as CHD diagnosis and type and number of surgical 
4 Prediction of outcome of CHD patients with cardiac imaging 4.2
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time. Recently, Merckx and co-workers validated PA-TDI duration against the P-wave duration on 
signal-averaged electrocardiograms.6 The authors observed a strong correlation between the two 
techniques (r=0.91). In addition, subsequent studies demonstrated the value of PA-TDI to predict 
AA in various groups of patients with heart disease with or without prior AA.7, 8, 18 In the current 
study, the PA-TDI duration independently predicted the occurrence of AA during follow-up of 
CHD patients. This finding may have important implications. Timely identification of CHD patients 
at risk for AA provides an opportunity for preventive measures for AA occurrence (such as anti-
tachycardia pacing or surgical treatment of an underlying hemodynamic problem)10, 16, 19, 20 or for 
indication of anticoagulant therapy to prevent complications of AA (such as stroke).10, 16 Future 
studies are warranted to identify the cut-off values of PA-TDI duration for risk stratification of AA 
in the various diagnostic subgroups with CHD. 
CONCLUSION
In conclusion, the PA-TDI duration, prior history of AA and surgical procedures during follow-up 
were independently associated with the occurrence of AA in adult CHD patients. PA-TDI duration is 
a useful tool for the identification of CHD patients at risk for AA during clinical follow-up.
4 Prediction of outcome of CHD patients with cardiac imaging 4.2
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RIGHT VENTRICULAR IMAGING: ECHOCARDIOGRAPHY
The first part of this thesis aimed to characterize ventricular mechanics and performance with 
advanced echocardiographic imaging techniques in patients with congenital heart disease (CHD), 
with particular focus on the right ventricle (RV). In chapter 2.1, an overview was provided on the 
current role of cardiac resynchronization therapy (CRT) in CHD and pediatric patients with heart 
failure. CRT is a novel therapy and typically involves atrio-biventricular pacing. CRT has demonstrated 
to improve left ventricular (LV) function and outcome of adult patients with LV failure by inducing a 
more synchronous contraction pattern. Based on the current clinical evidence, CRT is a promising 
therapy to improve cardiac performance and clinical outcome of CHD and pediatric patients with 
heart failure, in particular in those with LV failure as a result of chronic RV pacing. However, trials 
reporting on the long-term effects of CRT in CHD and pediatric patients are warranted. Furthermore, 
no trials have been performed to assess the adult selection criteria for CRT (New York Heart 
Association functional class III or IV despite optimized pharmacological therapy, left ventricular 
ejection fraction (LVEF) <35% and QRS duration >120 ms) in CHD and pediatric patients. The various 
anatomical substrates in CHD patients (systemic LV, systemic RV, single ventricle) may result in 
patterns of cardiac dyssynchrony that are not accurately characterized by the adult criteria. Future 
trials are needed to establish appropriate guidelines for CHD patient selection for CRT, taking into 
account the different anatomical subgroups. 
Subsequently, the role of conventional and advanced echocardiographic techniques to response 
to CRT in CHD and pediatric patients was discussed in detail in chapter 2.1. In adult trials, the 
assessment of dyssynchrony with echocardiography has been shown to predict a favorable response 
to CRT. At present, few studies are available on cardiac mechanics and dyssynchrony parameters 
that predict CRT response in CHD and pediatric patients. Therefore, studying LV and RV mechanics 
with various (advanced) imaging modalities can provide a definition of cardiac dyssynchrony in CHD 
and pediatric patients. 
Accordingly, the promising results of CRT have encouraged the research on LV and RV mechanics 
in pediatric and CHD patients, which was the focus of the subsequent chapters of this thesis. First, 
understanding ventricular mechanics in healthy children can help optimize the benefits of pacing 
strategies such as CRT in pediatric and CHD patients with heart failure. Chapter 2.2 aimed to provide 
reference values of peak systolic velocities and timings of peak systolic velocities of the LV and RV, 
as assessed with tissue Doppler imaging (TDI) in healthy children. Peak systolic velocities increased 
significantly with age at both ventricles, reflecting cardiac maturation. Within the LV, no relevant 
intra-ventricular time differences were observed at any age. This observation of a synchronous 
contraction of the LV is in agreement with adult studies, and provides an empirical basis for the 
application of CRT in pediatric candidates with LV failure. 
In contrast, within the RV of healthy children, a significant mechanical time delay was observed 
between the peak systolic velocity at the RV free wall (RVFW) and the intra-ventricular septum (IVS) 
and between the RVOT and the RV free wall (RVFW). In a subsequent study, this phenomenon of a 
mechanical time delay between the outlet and inlet regions of the RV was also observed with speckle 
tracking strain imaging, as described in chapter 2.3. In this study, the longitudinal deformation pattern 
of the RVFW and RVOT was evaluated in healthy children and in patients with corrected tetralogy 
of Fallot (cToF). As assessed with speckle tracking strain imaging, longitudinal deformation of the 
RVOT preceded longitudinal deformation of the RVFW in children with a structurally normal RV. In 
cToF patients, this mechanical activation sequence was also observed. However, in the cToF patients, 
the RVOT deformation was significantly delayed, causing a reduction of the mechanical time delay 
within the RV. Furthermore, the reduced time delay was related to impairment in RV performance. 
The observed mechanical activation pattern of the healthy RV, with longitudinal motion and 
deformation of the RVOT preceding that of the RVFW, seems to conflict with the theory of a 
peristalsis-like contraction pattern of the RV segments. This peristalsis theory postulates that 
the RV body contracts prior to the RVOT and was mainly derived from experimental animal studies. 
However, data from these experiments did not uniformly point towards a peristalsis-like pattern 
of RV contraction. Importantly, two directions of motion of the RVOT have been explored in these 
studies: transversal and longitudinal. In individuals with a structurally normal RV, a peristalsis-like 
pattern of RV contraction was only observed in the transversal direction. However, in the longitudinal 
direction, the peristalsis-like pattern was not observed, which is in agreement with our data. The 
presence of a mechanical delay during contraction of the structurally normal RV has important 
clinical implications for the treatment of RV dysfunction with CRT. The pathophysiological basis 
of CRT is the restoration of electromechanical dyssynchrony. With the observed mechanical delay 
within the healthy RV, this concept of resynchronization may not be applicable to the RV. Additional 
studies to confirm this model of RV sequential contraction are warranted prior to the application of 
CRT in patients with RV failure.
In chapter 2.4, ventricular-ventricular interaction was studied with speckle tracking strain imaging 
by assessing the relationship between longitudinal RV and LV strain and LV rotation in cToF patients 
and in healthy subjects. Despite a normal LV ejection fraction (as assessed with cardiac magnetic 
resonance [CMR]), subclinical dysfunction of both the RV and LV was observed with speckle tracking 
strain imaging in the cToF patients. At a regional level, analysis with two-dimensional speckle tracking 
revealed a homogeneous reduction of longitudinal RV strain in cToF patients in all segments, whereas 
at the LV, impairment in longitudinal strain and rotational mechanics was only observed at the mid and 
apical levels. Furthermore, a close relationship was observed between global RV and LV mechanics. 
This close relationship was most pronounced at the apical levels of the RV and LV, indicating that the 
observed adverse ventricular-ventricular interactions may start at the apical level in cToF patients. 
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These conclusions were endorsed by a subsequent study in chapter 2.5 that showed pronounced 
volume increase in cToF patients with chronic volume overload at the apical level of the RV. In this study, 
a segmental analysis of the RV was performed with real-time three-dimensional echocardiography 
(RT3DE). In healthy subjects as well as in cToF patients, RV volumes and ejection fraction were 
analysed at a global and regional (inlet, apical trabecular and outlet) level. Global RV volumes were 
significantly increased in cToF patients. The segmental analysis pointed out that the volume increase 
in cToF patients was most pronounced at the apical trabecular segment. According to these results 
and the results of chapter 2.4, the apical trabecular part plays a central role in the adaptive response 
of the RV to volume overload in cToF patients. Furthermore, the regional volume increase at the apex 
of the RV may account for the observed adverse ventricular-ventricular interaction at the apex. As 
a result of the volume increase at the apex, altered apical geometry of the RV may distort regional 
fiber orientation, which could have a deleterious effect on systolic biventricular performance. Future 
studies in cToF and other CHD patients with RV dilatation may need to focus on the apical trabecular 
segment of the RV to determine criteria for therapeutic intervention.
RIGHT VENTRICULAR IMAGING: CARDIAC MAGNETIC RESONANCE
The second part of this thesis aimed to investigate the role of advanced cardiac magnetic resonance 
(CMR) techniques to characterize RV mechanics in CHD patients. CMR plays an increasing role during 
clinical follow-up of CHD patients, especially in those with complex CHD. Chapter 3.1 provided an 
overview of the current clinical applications of CMR in various subgroups of post-operative CHD 
patients. Furthermore, an overview of advanced CMR techniques in CHD patients and their clinical 
value was presented in this chapter. One of these advanced CMR techniques is the assessment of 
myocardial velocities and timings with tissue-velocity magnetic resonance imaging (TV-MRI). In 
chapter 3.2 a direct comparison between TV-MRI and TDI was performed to assess peak systolic 
velocities and timings of peak systolic velocities within the RV in cToF patients and in healthy 
subjects. The results demonstrated that TV-MRI and TDI can be used interchangeably for the clinical 
evaluation of RV mechanics in healthy subjects and in cToF patients. Furthermore, with both TV-MRI 
and TDI, the peak systolic velocity at the RVOT occurred prior to the peak systolic velocity at the 
RVFW in cToF patients as well as in healthy subjects. These results underpin the observations on the 
temporal activation pattern of the RV as described in chapters 2.2 and 2.3. 
Chapter 3.3 extended the validation of TV-MRI to assess RV mechanics by comparing diastolic 
velocities between TV-MRI and TDI in cToF patients and healthy subjects. The assessment of diastolic 
function is relevant in cToF patients, since RV end-diastolic volume and pulmonary regurgitation 
(two parameters strongly related to adverse outcome in cToF patients) are diastolic parameters. 
Conflicting results have been published on the clinical implications of global diastolic dysfunction 
in cToF patients. However, TV-MRI enables the assessment of diastolic performance of the RV at a 
regional level. Diastolic velocities of the RVOT had not been investigated previously. During surgical 
correction of tetralogy of Fallot, manipulation of the RVOT is almost invariably needed to relieve the 
pulmonary stenosis. As a result, regional scar tissue may lead to functional abnormalities of the RVOT. 
In chapter 3.3, regional diastolic velocities (early diastolic velocity: E’, late diastolic velocity: A’, and 
diastolic performance: E’/ A’) were measured at the RVFW and at the RVOT with TV-MRI and with TDI in 
cToF patients and in controls. It was demonstrated that TV-MRI and TDI can be used interchangeably 
for the assessment of regional diastolic velocities and performance of the RV. Furthermore, the 
regional diastolic velocities and diastolic performance at the RVFW and RVOT were impaired in cToF 
patients. At the RVOT, the observed impaired diastolic performance was independently related to RV 
dilatation. This observation was in accordance with previous studies that pointed out the independent 
role of RVOT integrity to prevent RV dilatation in cToF patients. Accordingly, the assessment of 
regional RV diastolic performance with TDI and TV-MRI yielded insight into the pathophysiological 
mechanism leading to RV dilatation in cToF patients. More trials are needed to further investigate the 
observed relation between diastolic performance of the RVOT and RV dilatation. 
In chapter 3.4, novel three-dimensional three-directional velocity-encoded flow imaging with 
retrospective valve tracking (3D flow) was validated for the assessment of RV flow volumes. 3D flow 
was compared with conventional two-dimensional velocity-encoded flow imaging (2D flow) for the 
assessment of flow volumes over the pulmonary valve and the tricuspid valve in cToF patients and in 
healthy subjects. Planimetry was used as the reference standard. The study demonstrated that 3D flow 
is more accurate than 2D flow for the assessment of both pulmonary valve flow volumes as well as for 
tricuspid valve flow volumes. An important advantage of 3D flow is the retrospective valve tracking, 
enabling angulation of the imaging plane according to the position and the direction of the flow jet. 
Adjustment of the imaging plane is especially important for the assessment of flow at the tricuspid 
valve, since this valve may move up to 24 mm during image acquisition. Furthermore, during 3D flow 
assessment, the pulmonary and tricuspid valve flow is acquired simultaneously. The simultaneous 
assessment of various valves during 3D flow acquisition reduces scan time. Furthermore, with the 
use of 3D flow, global diastolic function of the RV in cToF patients with pulmonary regurgitation can 
be evaluated. The assessment of diastolic function of the RV in patients with pulmonary regurgitation 
is complicated, since diastolic filling occurs from two sources; the tricuspid valve and the pulmonary 
valve. The simultaneous assessment of flow over both valves during 3D flow enables accurate 
summation of both flow volume curves during diastole. Summation of the tricuspid and pulmonary 
flow volumes during diastole provides time-volume curves, reflecting the diastolic filling pattern 
of the RV. Hence, 3D flow-derived RV time-volume curves permit the evaluation of global diastolic 
function of the RV in patients with pulmonary regurgitation. It was shown in chapter 3.4 that diastolic 
assessment with 3D flow was able to discriminate between patients and controls. Furthermore, 
3D flow assessment of diastolic function discriminated cToF patients with a restrictive RV filling 
pattern from those without RV restriction. In conclusion, the advanced MRI applications of 3D flow 
and TV-MRI provide novel parameters for the assessment of RV diastolic function at a global and 
regional level, respectively. The evaluation of global and regional diastolic RV function with these 
advanced CMR techniques can facilitate ongoing research on the clinical implications of RV diastolic 
dysfunction during long-term follow-up in CHD patients.
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PREDICTION OF OUTCOME
The prediction of clinical outcome is an important goal of clinical studies on cardiac imaging 
techniques. The last part of this thesis focused on the prediction of clinical outcome of CHD patients 
with the use of conventional and advanced echocardiographic techniques. Chapter 4.1 investigated 
clinical predictors for the need for pulmonary valve replacement. In particular the relation between 
residual pulmonary stenosis, as assessed with conventional Doppler echocardiography, and the 
need for pulmonary valve replacement during long term follow-up of cToF patients was investigated. 
Current surgical strategies to relieve pulmonary stenosis in cToF patients aim to limit the amount 
of patch use whenever possible, since patch use is related to pulmonary regurgitation. However, 
this ‘restrictive approach’ may result into a (mild) degree of residual pulmonary stenosis in post-
operative cToF patients. A mild residual pulmonary stenosis may reduce the amount of pulmonary 
regurgitation and consequently, may reduce the need for pulmonary valve replacement during 
follow-up of cToF patients. Indeed, the results of our study indicated that a mild gradient over the 
pulmonary artery is independently associated with a reduced risk of pulmonary valve replacement. 
These findings underscore the importance of the current surgical strategies in cToF patients that 
advocate a restrictive surgical relief of the pulmonary stenosis in ToF patients. Furthermore, 
knowledge on the clinical implications of a mild residual pulmonary stenosis improves patient-
based counseling during clinical follow-up of cToF patients. 
Finally, in chapter 4.2, the advanced echocardiographic application of TDI was used for the 
prediction of atrial arrhythmias in a cohort of adult CHD patients. With TDI of the atria, the time 
interval from the onset of the P-wave on the electrocardiogram to the peak of the A’ wave on the TDI 
tracings of the lateral atrial wall can be measured (PA-TDI duration). In CHD patients, the principal 
pathophysiological substrate for atrial arrhythmias is provided by electrical re-entry through atrial 
areas with delayed electrical conduction. These sites of delayed electrical conduction prolong the 
time required for atrial electrical activation. Prolonged total atrial conduction time is a reliable 
predictor of atrial arrhythmias. The PA-TDI duration reflects the total atrial conduction time, 
and has been shown to be a predictor of atrial arrhythmias in adult patients with ‘acquired’ heart 
disease. In our study, the PA-TDI duration was independently associated with the occurrence of 
atrial arrhythmia in adult CHD patients. Therefore, the PA-TDI duration can be a useful tool for the 
identification of CHD patients at risk for atrial arrhythmias during clinical follow-up.
CONCLUSIONS
In this thesis, important new insights were gained in the electromechanical activation and 
deformation pattern of the RV with the use of advanced echocardiographic and MRI techniques. The 
obtained insights have clinical implications for future treatment strategies in CHD patients with RV 
failure. The population of patients with CHD is growing, and RV failure is frequently observed in 
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this population. Nevertheless, the pathophysiology of RV failure remains incompletely understood. 
In current clinical practice, the application of CRT has recently gained ground in the treatment 
of patients with LV failure. The beneficial results of CRT in adult patients with LV failure have 
encouraged studies on RV mechanics and performance, as presented in this thesis. With the use of 
three different noninvasive advanced imaging techniques (TDI, speckle tracking strain imaging, TV-
MRI) it was demonstrated in this thesis that a considerable mechanical delay during longitudinal 
systolic contraction is present in the healthy RV. In addition, this mechanical delay was related to 
the performance of the RV. Accordingly, the concept of resynchronization by the application of CRT 
seems not directly applicable in patients with RV failure, and this should be an important starting 
point for future studies on pacing strategies in patients with RV failure. 
Additional insight into RV mechanics and performance in the presence of volume overload was 
obtained by studying the RV of cToF patients at a regional level. It was demonstrated that adverse 
RV remodeling after chronic volume overload in cToF patients starts at the apical level. Furthermore, 
adverse ventricular-ventricular interaction, leading to subclinical LV dysfunction, was also most 
apparent at the apical level. At present, there is ongoing debate on the optimal cut-off values for 
pulmonary valve replacement in cToF patients. The results of this thesis indicate that future trials 
on cut-off values may need to focus specifically on the apical trabecular part of the RV. Finally, 
novel insight was obtained on the role of the (surgically remodeled) RVOT in the pathophysiological 
pathway leading to RV dilatation in cToF patients. Both the study on regional diastolic velocities as 
well as the report on the clinical predictors of the need for pulmonary valve replacement pointed out 
that in cToF patients, the integrity and function of the RVOT is important in the pathophysiological 
mechanism leading to RV dilatation. Accordingly, a targeted intervention on the RVOT in cToF 
patients undergoing pulmonary valve replacement could lead to improved outcomes.




Beeldvorming van de rechter hartkamer: echocardiografie
Het eerste deel van dit proefschrift had als doel om met behulp van echocardiografie het 
elektromechanische activatiepatroon van de hartkamers in kaart te brengen bij patiënten met 
aangeboren hartafwijkingen. In het bijzonder werd in dit proefschrift gefocust op de rechter 
hartkamer. Hoofdstuk 2.1 geeft een overzicht van de gepubliceerde onderzoeken over cardiale 
resynchronisatietherapie (CRT) bij patiënten met aangeboren hartafwijkingen en kinderen met 
hartfalen. CRT is een nieuwe therapie die veel gebruikt wordt bij volwassen patiënten met hartfalen. 
Bij CRT wordt gebruikgemaakt van een pacemaker die op beide hartkamers is aangesloten. Met deze 
pacemakertherapie wordt een synchrone contractie van het hart beoogd, wat een positief effect 
heeft bij mensen met een falende linker hartkamer. Uit de huidige gepubliceerde onderzoeken 
over CRT bij patiënten met aangeboren hartafwijkingen en kinderen met hartfalen kan worden 
geconcludeerd dat CRT een veelbelovende therapie is in deze patiëntenpopulatie. Echter, onderzoek 
naar de langetermijneffecten is vereist. Daarnaast zijn de inclusiecriteria voor CRT bij volwassenen 
(New York Heart Assoccation functioneren in klasse III of IV ondanks optimale medicamenteuze 
therapie, linker hartkamer ejectiefractie <35%, QRS duur >120 ms) niet onderzocht bij patiënten 
met aangeboren hartafwijkingen en kinderen met hartfalen. Vervolgens werd in hoofdstuk 2.1 
beschreven of conventionele en geavanceerde echocardiografietechnieken kunnen voorspellen 
welke patiënten met aangeboren hartafwijkingen en kinderen met hartfalen baat hebben bij CRT. De 
groep patiënten met aangeboren hartafwijkingen is zeer heterogeen en kan worden onderverdeeld 
in anatomische subgroepen: patiënten waarbij de linker hartkamer de grote bloedsomloop 
ondersteunt, patiënten waarbij de rechter hartkamer de grote bloedsomloop ondersteunt en 
patiënten met één hartkamer. Deze subgroepen kunnen afwijkende contractiepatronen van 
de hartkamers vertonen die niet worden ondervangen door de inclusiecriteria voor CRT bij 
volwassenen met hartfalen. Vervolgstudies moeten zich richten op inclusiecriteria voor CRT bij 
patiënten met congenitale hartafwijkingen en kinderen met hartfalen. Met behulp van geavanceerde 
beeldvormende technieken kan het contractiepatroon van de hartkamers bij kinderen en patiënten 
met aangeboren hartafwijkingen gedetailleerd in kaart worden gebracht. 
Primair is inzicht in het contractiepatroon van de hartkamers bij gezonde kinderen van belang om 
het resultaat van CRT en eventuele andere pacemakertherapieën te optimaliseren. In hoofdstuk 2.2 
werd een studie beschreven naar referentiewaarden van pieksnelheden tijdens de contractie van 
de hartkamer, tijd tot pieksnelheid, en tijdsverschillen tussen de pieksnelheden op verschillende 
locaties binnen de hartkamers bij gezonde kinderen gemeten met ‘tissue Doppler imaging’ 
echocardiografie (TDI). In de studie werd een leeftijdsafhankelijke toename van pieksnelheden 
tijdens contractie in beide hartkamers geobserveerd. Daarnaast werden in de linker hartkamer 
zeer kleine tijdsverschillen geobserveerd tussen pieksnelheden tijdens contractie bij kinderen 
van alle leeftijden. Deze data over het contractiepatroon van de linker hartkamer vormen een 
empirische onderbouwing voor studies naar afwijkende contractiepatronen (dissynchronie) en 
CRT voor de linker hartkamer bij kinderen met hartfalen. In tegenstelling tot de bevindingen in de 
linker hartkamer, werd in de rechter hartkamer een groot tijdsverschil geobserveerd tussen het 
optreden van de pieksnelheden tussen de rechterkamerintstroom en het interventrikulaire septum, 
alsook tussen de rechterkamerinstroombaan en de rechterkameruitstroombaan. Dit tijdsverschil 
werd ook geobserveerd in een studie naar deformatie van hartspierweefsel met ‘speckle 
tracking’ echocardiografie in hoofdstuk 2.3. In deze studie werd het deformatiepatroon van het 
hartspierweefsel van de rechter hartkamer onderzocht bij gezonde kinderen en bij patiënten met 
een chirurgische gecorrigeerde tetralogie van Fallot (cToF) (een aangeboren hartafwijking waarbij 
frequent disfunctie van de rechter hartkamer word gezien). De longitudinale samentrekking van 
hartspierweefsel tijdens contractie werd bestudeerd in the rechterkamerinstroombaan en in de 
rechterkameruitstroombaan. De maximale longitudinale verkorting tijdens contractie had eerder 
plaats in de uitstroombaan dan in de instroombaan bij gezonde kinderen. Dit deformatiepatroon 
van de rechter hartkamer werd ook geobserveerd bij de cToF patiënten. Echter, het geobserveerde 
tijdsverschil was veel korter bij de patiënten, en dit was gerelateerd met een slechtere functie van 
de rechter hartkamer. De observatie dat de rechterkameruitstroombaan eerder samentrekt dan 
de rechterkamerinstroombaan is in tegenspraak met de theorie dat rechter hartkamercontractie 
volgens een peristaltisch patroon verloopt. Volgens deze theorie, die voornamelijk gebaseerd 
is op dierexperimenteel onderzoek, contraheert de rechterkamerinstroombaan vóór de 
rechterkameruitstroombaan. Echter, de data van deze onderzoeken wijzen niet eenduidig op 
een peristaltische contractie van de rechter hartkamer. Het contractieparoon van de rechter 
hartkamer werd in twee richtingen geanalyseerd; longitudinaal en transversaal. Het peristaltische 
contractiepatroon werd alleen geobserveerd in de transversale richting, en niet in de longitudinale 
richting. Deze data komen overeen met de observaties in onze studie.
De observatie van een tijdsverschil in het longitudinale contractiepatroon van de gezonde 
rechter hartkamer heeft belangrijke consequenties voor eventuele behandeling van rechter 
hartkamerdisfunctie met CRT. De insteek voor behandeling met CRT is het resynchroniseren van 
een dissynchroon contractiepatroon. Echter, dit concept lijkt niet van toepassing op de rechter 
hartkamer wanneer er van nature een tijdsverschil bestaat tijdens contractie. Meer studies zijn 
nodig naar het contractiepatroon van de rechter hartkamer alvorens CRT kan worden toegepast bij 
patiënten met een falende rechter hartkamer. 
In hoofdstuk 2.4 werd speckle tracking echocardiografie gebruikt om de interactie tussen beide 
hartkamers te bestuderen. Met behulp van speckle tracking werd de longitudinale samentrekking 
van beide hartkamers en de rotatie van de linker hartkamer bestudeerd bij gezonde kinderen en bij 
cToF patiënten. Ondanks een normale ejectiefractie van de linker hartkamer, was de longitudinale 
samentrekking verminderd in beide hartkamers. Analyse van de longitudinale samentrekking op 
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regionaal niveau liet zien dat de samentrekking van de rechter hartkamer van cToF patiënten in zijn 
geheel was verminderd, terwijl in de linker hartkamer de longitudinale samentrekking alsook de 
rotatie alleen was verminderd in het midden en aan de punt van het hart. Daarnaast werd en nauwe 
relatie geobserveerd tussen de longitudinale samentrekking van de linker- en rechter hartkamer. 
Deze relatie was het sterkst aan de punt van het hart. Dit wijst erop dat een nadelige interactie 
tussen beide hartkamers bij cToF patiënten aanvangt aan de punt van het hart. Deze conclusie 
werd bevestigd door een studie naar volumetoename van de rechter hartkamer bij cToF patiënten 
in hoofdstuk 2.5. In dit hoofdstuk werd segmentele volumeanalyse van de rechter hartkamer met 
‘real time’ driedimensionale echocardiografie (RT3DE) verricht. Volumina en ejectiefractie van de 
gehele rechter hartkamer en van de regionale segmenten (instroom, apicale segment [punt van 
rechter hartkamer], uitstroom) werden geanalyseerd met RT3DE bij gezonde kinderen en bij cToF 
patiënten. Bij de cToF patiënten werd een toename in het globale volume van de rechter hartkamer 
geobserveerd. Met de segmentele analyse werd aangetoond dat deze toename het grootst was in 
het apicale segment. 
Naar aanleiding van de observaties in de hoofdstukken 2.4 en 2.5 kan worden geconcludeerd 
dat het apicale segment een belangrijke rol speelt in de respons van de rechter hartkamer op 
chronische volumebelasting (zoals bij cToF patiënten, als gevolg van lekkage van de longslagader). 
Daarnaast zou de regionale toename in volume in het apicale segment de oorzaak kunnen zijn 
van de nadelige interactie tussen beide hartkamers die werd geobserveerd in hoofdstuk 2.4. Een 
veranderde geometrie van de rechter hartkamer door volumetoename aan de punt van het hart 
kan de oriëntatie van de hartspiervezels ter plaatse verstoren, wat een negatief effect heeft op de 
functie van beide hartkamers. Toekomstige studies naar grenswaarden (volumina) voor interventie 
bij cToF patiënten en andere patiënten met volumetoename van de rechter hartkamer zou zich 
wellicht moeten richten op het apicale segment van de rechter hartkamer.
Beeldvorming van de rechter hartkamer: magnetic resonance imaging (MRI)
In het tweede deel van dit proefschrift werd de rol van conventionele en geavanceerde MRI technieken 
voor het in kaart brengen van het contractiepatroon van de rechter hartkamer onderzocht. MRI 
van het hart speelt een steeds belangrijkere rol tijdens de controle van patiënten met aangeboren 
hartafwijkingen, in het bijzonder bij patiënten met complexe aangeboren hartafwijkingen. In 
hoofdstuk 3.1 werd een overzicht gegeven van de huidige toepassingen van MRI in verschillende 
subgroepen van patiënten met aangeboren hartafwijkingen. Verder werd een overzicht gegeven van 
nieuwe MRI technieken en wat deze kunnen betekenen bij patiënten met aangeboren hartafwijkingen. 
Eén van deze nieuwe MRI technieken is ‘tissue-velocity MRI’ (TV-MRI) waarmee pieksnelheid en tijd 
tot pieksnelheid, naar analogie van de TDI techniek, in het hartspierweefsel kunnen worden gemeten. 
In hoofdstuk 3.2 werden TV-MRI en TDI metingen van de rechter hartkamer bij cToF patiënten en 
gezonde kinderen met elkaar vergeleken. De studie liet zien dat beide MRI technieken dezelfde 
resultaten genereren. Daarnaast werd in zowel cToF patiënten als in gezonde kinderen met beide 
technieken geobserveerd dat de pieksnelheid van de rechterkameruitstroombaan eerder plaats 
heeft dan de pieksnelheid van de rechterkamerinstroombaan. Deze resultaten onderschrijven de 
eerdere observaties met betrekking tot het contractiepatroon van de rechter hartkamer in de 
hoofdstukken 2.2 en 2.3.
Vervolgens werd in hoofdstuk 3.3 TV-MRI verder gevalideerd door pieksnelheden tijdens de 
relaxatie van de rechter hartkamer te vergelijken tussen TDI en TV-MRI bij cToF patiënten en 
gezonde kinderen. De relaxatiefunctie van de rechter hartkamer bij cToF patiënten is relevant 
omdat twee belangrijke parameters die de prognose cToF patiënten sterk beïnvloeden (lekkage 
van de longslagader en volume van de rechter hartkamer) gemeten worden tijdens de relaxatiefase 
van de rechter hartkamer. Echter, de resultaten van eerder onderzoek naar de prognostische 
waarde van disfunctie van de rechter hartkamer tijdens relaxatie spraken elkaar tegen. TV-MRI kan 
nieuw inzicht geven in de relaxatie van de rechter hartkamer doordat het kan worden toegepast 
op regionaal niveau. Het relaxatiepatroon van de uitstroombaan van de rechter hartkamer was 
niet eerder onderzocht. Bij cToF patiënten is de uitstroombaan van de rechter hartkamer bijna 
altijd chirurgisch gemodelleerd. Daardoor kan littekenweefsel zijn ontstaan dat ter plaatse van 
de uitstroombaan het relaxatiepatroon verstoort. In hoofdstuk 3.3 werden met behulp van TDI en 
TV-MRI regionale pieksnelheden tijdens relaxatie van de rechter hartkamer gemeten ter plaatse 
van de uitstroombaan en instroombaan bij cToF patiënten en bij gezonde kinderen. De gemeten 
relaxatiefunctie was significant verminderd in de instroombaan en de uitstroombaan bij de cToF 
patiënten. Bovendien was de relaxatiefunctie in de uitstroombaan onafhankelijk gerelateerd aan 
de volumetoename van de rechter hartkamer. Geconcludeerd kan worden dat het meten van de 
regionale relaxatiefunctie van de rechter hartkamer met TDI en TV-MRI inzicht kan geven in het 
ziekteproces van de rechter hartkamer bij cToF patiënten. Toekomstige onderzoeken zouden zich 
moeten richten op de relatie tussen de relaxatiefunctie van de rechterkameruitstroombaan en het 
volume van de rechter hartkamer. 
Hoofdstuk 3.4 beschreef de validatie van driedimensionale MRI voor meting van bloedstroom-
volumina in de rechter hartkamer. Driedimensionale MRI werd vergeleken met conventionele 
tweedimensionale MRI voor het meten van bloedstroomvolumina over de longslagaderklep en de 
tricuspidalisklep (de klep tussen rechterboezem en rechter hartkamer) bij cToF patiënten en bij 
gezonde kinderen. Planimetrie, de gouden standaard voor volumemetingen met MRI, werd gebruikt 
als referentie. De resultaten van de studie lieten zien dat driedimensionale MRI nauwkeuriger 
is dan de conventionele tweedimensionale MRI metingen. Een belangrijk voordeel van de 
driedimensionale MRI techniek is de mogelijkheid om de bloedstroommetingen gedurende de 
gehele contractie op de exacte locatie van de (bewegende) hartklep te laten plaatsvinden. Eerder 
is aangetoond dat de verplaatsing van de tricuspidalisklep tijdens de contractie een belangrijke 
beperking vormt van tweedimensionale MRI voor het meten van bloedstroomvolumina. Daarnaast 
worden de metingen van de longslagaderklep en de tricuspidalisklep bij driedimensionale 
MRI simultaan verkregen. Dit biedt, naast verkorting van de scantijd, als voordeel dat de 
bloedstroomcurves van beide metingen bij elkaar opgeteld kunnen worden voor een nauwkeurige 
weergave van de volumeveranderingen van de rechter hartkamer tijdens de relaxatie 
(vullingsfase). Bij cToF patiënten met lekkage van de longslagader wordt de rechter hartkamer 
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tijdens de relaxatiefase niet alleen gevuld met bloed door de tricuspidalisklep, maar ook met 
bloed door de longslagaderklep (de lekkage). Het optellen van de beide bloedstroomcurves tijdens 
de relaxatiefase geeft bij deze patiënten een nauwkeurige weergave van de het vullingpatroon 
van de rechter hartkamer, wat de globale relaxatiefunctie van de rechter hartkamer reflecteert. 
Samengevat kunnen zowel 3D MRI metingen van bloedstroomvolumina en TV-MRI worden toegepast 
om relaxatiefunctie van de rechter hartkamer op respectievelijk globaal en regionaal niveau te 
meten. Door de validatie van deze geavanceerde MRI technieken wordt toekomstig onderzoek naar 
de prognostische waarde van globale en regionale afwijkingen in relaxatie van de rechter hartkamer 
in cToF patiënt mogelijk gemaakt.
Prognostische waarde van echocardiografie
Een belangrijk doel van studies naar beeldvormende technieken van het hart is het verkrijgen van 
inzicht in de prognostische waarde van de verkregen beelden. Het laatste deel van dit proefschrift 
had als doel om de prognostische waarde van conventionele en nieuwe echocardiografische 
technieken in kaart te brengen. In hoofdstuk 4.1 wordt de relatie tussen restvernauwing van de 
longslagader, welke wordt gemeten met conventionele Doppler echocardiografie, en de noodzaak 
tot longslagaderklepvervanging op de lange termijn bij cToF patiënten. De huidige chirurgische 
technieken die gebruikt worden om de vernauwing van de longslagader van ToF patiënten te 
behandelen zijn erop gericht om zo weinig mogelijk gebruik te maken van prothesemateriaal, omdat 
dit gerelateerd is aan het optreden van lekkage van de longslagaderklep. Echter, deze chirurgische 
strategie kan ertoe leiden dat de vernauwing van de longslagader niet helemaal wordt opgeheven, 
en er een lichte restvernauwing overblijft. Deze lichte vernauwing kan als gevolg hebben dat minder 
lekkage van de longslagader optreedt. Dit zou de noodzaak tot vervanging van de longslagaderklep 
op de lange termijn kunnen doen verminderen. De resultaten van onze studie in hoofdstuk 4.1 wezen 
er inderdaad op dat minder longslagaderklepvervangingen werden verricht in de groep cToF patiënten 
met een lichte vernauwing van de longslagader. Deze resultaten onderschrijven het belang van de 
huidige chirurgische strategieën, en geven daarnaast houvast voor de counseling van cToF patiënten 
met een lichte vernauwing van de longslagader. 
Tot slot werd in hoofdstuk 4.2 een studie beschreven naar de toepassing van TDI om boezemaritmieën 
(ritmestoornissen van de boezem) te voorspellen bij volwassen patiënten met aangeboren hart-
afwijkingen. Met TDI van de boezems kan het tijdsinterval tussen de elektrische relaxatiefase van de 
boezem (P) en de mechanische relaxatiefase van de boezem (A) worden gemeten (het zogenoemde 
PA-TDI interval). Het belangrijkste ziekteproces dat ten grondslag ligt aan boezemaritmieën is een 
verminderde elektrische geleiding in de boezems. Verminderde elektrische geleiding voorspelt 
boezemaritmieën en kan kwantitatief worden weergegeven met het PA-TDI interval bij volwassen 
patiënten zonder aangeboren hartafwijkingen. In onze studie in hoofdstuk 4.2 was het PA-TDI interval 
ook onafhankelijk gerelateerd aan het optreden van boezemaritmieën bij volwassen patiënten met 
aangeboren hartafwijkingen. Het PA-TDI interval is dus een bruikbare toepassing voor de identificatie 
van patiënten met aangeboren hartafwijkingen met een verhoogd risico op boezemaritmieën. 
Conclusies
Door dit proefschrift zijn de inzichten in het mechanische activatiepatroon van de rechter hart-
kamer sterk verbeterd. De resultaten van de studies in dit proefschrift hebben consequenties 
voor de toekomstige behandeling van patiënten met een falende rechter hartkamer. De groep van 
patiënten met aangeboren hartafwijkingen wordt steeds groter, en falen van de rechter hartkamer 
komt in deze populatie frequent voor. Toch wordt het exacte mechanisme achter falen van de rechter 
hartkamer nog niet helmaal begrepen. De goede resultaten na behandeling met CRT bij patiënten 
met een falende linker hartkamer hebben ertoe geleid dat er meer onderzoek wordt gedaan naar 
het mechanische activatiepatroon van de rechter hartkamer in relatie tot de functie van de rechter 
hartkamer, zoals in dit proefschrift. Met behulp van drie verschillende non-invasieve geavanceerde 
beeldvormende technieken (TDI, speckle tracking en TV-MRI) werd in dit proefschrift aangetoond 
dat er een aanzienlijk tijdsverschil in mechanische activatie binnen de gezonde rechter hartkamer 
plaatsvindt. Dit tijdsverschil is bovendien gerelateerd aan de functie van de rechter hartkamer. 
Daarom is het concept van ‘resynchronisatie’ van de contractie, zoals wordt beoogd met CRT in de 
linker hartkamer, niet direct toepasbaar op patiënten met een falende rechter hartkamer. Deze 
bevinding zal in toekomstige studies naar pacemakerstrategieën voor patiënten met een falende 
rechter hartkamer als uitgangspunt moeten worden gebruikt. 
Door de rechter hartkamer op regionaal niveau te bestuderen, werd nog meer inzicht verkregen 
in de functie en mechanische activatie van de rechter hartkamer. Bij patiënten met een vergrote 
rechter hartkamer als gevolg van volume overbelasting (door longslagaderkleplekkage) werd met 
RT3DE geobserveerd dat het apicale segment (punt van het hart) het meest was vergroot. Verder 
werd met ‘speckle tracking’ de nadelige invloed van de vergrote rechter hartkamer op de linker 
hartkamer op regionaal niveau bestudeerd. Deze nadelige invloed was het meest uitgesproken aan 
de punt van het hart. Op dit moment is er discussie over het juiste moment (welke afkapwaarde) van 
ingrijpen (bijv door middel van longslagaderklepvervanging) bij cToF patiënten met een vergrote 
rechter hartkamer. De resultaten van dit proefschrift suggereren dat toekomstige studies zich 
specifiek zouden moeten richten op de punt van het hart om afkapwaarden te formuleren die het 
tijdstip van interventie kunnen markeren. 
Tot slot werden nieuw inzichten verkregen in de rol van de uitstroombaan van de rechter hartkamer in 
het mechanisme dat leidt tot een vergrote rechter hartkamer bij cToF patiënten. Twee afzonderlijke 
studies in dit proefschrift suggereren dat de integriteit en functie van de uitstroombaan van de 
rechter hartkamer een belangrijke rol spelen bij patiënten met een vergrote rechter hartkamer. 
Een gerichte interventie aan de uitstroombaan van de rechter hartkamer bij patiënten die een 
longslagaderklepvervanging ondergaan zou daarom kunnen leiden tot een verbetering van de 
prognose van cToF patiënten. 
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